<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6288298</article-id><article-id pub-id-type="pmcid-ver">PMC6288298.1</article-id><article-id pub-id-type="pmcaid">6288298</article-id><article-id pub-id-type="pmcaiid">6288298</article-id><article-id pub-id-type="pmid">30564232</article-id><article-id pub-id-type="doi">10.3389/fimmu.2018.02793</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Proteomics, Bioinformatics and Structure-Function Antigen Mining For Gonorrhea Vaccines</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Baarda</surname><given-names initials="BI">Benjamin I.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/276361/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Martinez</surname><given-names initials="FG">Fabian G.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/641883/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sikora</surname><given-names initials="AE">Aleksandra E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/239953/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University</institution>, <addr-line>Corvallis, OR</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>Vaccine and Gene Therapy Institute, Oregon Health and Science University</institution>, <addr-line>Beaverton, OR</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Michael W. Russell, University at Buffalo, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Joseph U. Igietseme, Centers for Disease Control and Prevention (CDC), United States; Trevor F. Moraes, University of Toronto, Canada</p></fn><corresp id="c001">*Correspondence: Aleksandra E. Sikora <email>aleksandra.sikora@oregonstate.edu</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><issue-id pub-id-type="pmc-issue-id">305241</issue-id><elocation-id>2793</elocation-id><history><date date-type="received"><day>31</day><month>8</month><year>2018</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2018</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>18</day><month>12</month><year>2018</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-10-04 03:25:21.823"><day>04</day><month>10</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2018 Baarda, Martinez and Sikora.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Baarda, Martinez and Sikora</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-09-02793.pdf"/><abstract><p>Expanding efforts to develop preventive gonorrhea vaccines is critical because of the serious health consequences combined with the prevalence and the dire possibility of untreatable gonorrhea. Reverse vaccinology, which includes genome and proteome mining, has proven successful in the discovery of vaccine candidates against many pathogenic bacteria. Here, we describe proteomic applications including comprehensive, quantitative proteomic platforms and immunoproteomics coupled with broad-ranging bioinformatics that have been applied for antigen mining to develop gonorrhea vaccine(s). We further focus on outlining the vaccine candidate decision tree, describe the structure-function of novel proteome-derived antigens as well as ways to gain insights into their roles in the cell envelope, and underscore new lessons learned about the fascinating biology of <italic toggle="yes">Neisseria gonorrhoeae</italic>.</p></abstract><kwd-group><kwd><italic toggle="yes">Neisseria gonorrhoeae</italic></kwd><kwd>vaccine</kwd><kwd>proteomics</kwd><kwd>antigen</kwd><kwd>reverse vaccinology</kwd><kwd>bioinformatics</kwd><kwd>protein structure-function</kwd><kwd>membrane vesicles</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Division of Intramural Research, National Institute of Allergy and Infectious Diseases<named-content content-type="fundref-id">10.13039/100006492</named-content></funding-source></award-group></funding-group><counts><fig-count count="4"/><table-count count="0"/><equation-count count="0"/><ref-count count="210"/><page-count count="21"/><word-count count="18042"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Worldwide, over 78 million people are estimated to acquire the sexually transmitted infection gonorrhea every year (<xref rid="B1" ref-type="bibr">1</xref>). Female reproductive health is disproportionately affected by this disease and half of infected women show no symptoms (<xref rid="B2" ref-type="bibr">2</xref>&#8211;<xref rid="B4" ref-type="bibr">4</xref>). Serious health consequences are associated with untreated or insufficiently treated gonorrhea, including pelvic inflammatory disease, inflammation of the fallopian tubes, pre-term delivery, miscarriage, or ectopic pregnancy (<xref rid="B5" ref-type="bibr">5</xref>&#8211;<xref rid="B7" ref-type="bibr">7</xref>). Additionally, infants born vaginally to infected mothers are exposed to the disease in the birth canal and are thus at risk of developing a sight-threatening conjunctivitis (<xref rid="B8" ref-type="bibr">8</xref>). Although the health consequences to men are not as severe as for women and predominantly manifest as uncomplicated urethritis accompanied by a neutrophil-rich exudate (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B9" ref-type="bibr">9</xref>), gonorrhea can ascend to the epididymis or the testes and may require surgical removal of the infected site (<xref rid="B10" ref-type="bibr">10</xref>&#8211;<xref rid="B12" ref-type="bibr">12</xref>). Infertility can occur in both females and males without proper treatment (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B13" ref-type="bibr">13</xref>).</p><p>The bacterium responsible for gonorrhea, <italic toggle="yes">Neisseria gonorrhoeae</italic> (<italic toggle="yes">Ng</italic>), is a highly adaptable pathogen. Its natural competence and plastic genome have contributed to the extensive spread of antibiotic resistance. Through a number of horizontally acquired genes and chromosomal mutations, <italic toggle="yes">Ng</italic> has become resistant to every antibiotic used for its treatment (<xref rid="B14" ref-type="bibr">14</xref>&#8211;<xref rid="B16" ref-type="bibr">16</xref>). The Centers for Disease Control and Prevention (CDC) in the United States currently recommend a dual therapy of intramuscular ceftriaxone combined with oral azithromycin as a first-line treatment for uncomplicated gonorrhea (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). However, the first isolates resistant to this combination therapy have begun to emerge (<xref rid="B19" ref-type="bibr">19</xref>). Three new therapeutics for gonorrhea treatment are being evaluated in clinical trials (<xref rid="B20" ref-type="bibr">20</xref>), but considering the speed with which the gonococcus develops antibiotic resistance (<xref rid="B15" ref-type="bibr">15</xref>), new drugs will not provide a long-term solution. The development and introduction of a protective vaccine against gonorrhea should therefore be prioritized to limit its spread.</p><p>Thus far, only two gonorrhea vaccines, using either killed whole organisms or purified pilin protein, have progressed to clinical trials. Despite robust antibody responses in both trials, neither vaccine provided protection against acquiring the disease after immunization (<xref rid="B21" ref-type="bibr">21</xref>&#8211;<xref rid="B24" ref-type="bibr">24</xref>). These failures are likely due to a number of factors. Pilin proteins undergo extensive antigenic variation through frequent recombination with transcriptionally silent <italic toggle="yes">pilS</italic> gene cassettes (<xref rid="B25" ref-type="bibr">25</xref>&#8211;<xref rid="B28" ref-type="bibr">28</xref>). Experimental infections have demonstrated that multiple pilin variants are isolated from a single individual, and that these variants are antigenically distinct from the inoculating parent strain (<xref rid="B29" ref-type="bibr">29</xref>&#8211;<xref rid="B31" ref-type="bibr">31</xref>). Further, pilin proteins are subjected to phase variation, where protein expression transitions between &#8220;on&#8221; and &#8220;off&#8221; states through slipped-strand repair of upstream repeat regions (<xref rid="B32" ref-type="bibr">32</xref>). Antigenic and phase variation of pilin during infection likely contributed to the failure of both vaccine trials. Another factor that may have led to the whole cell vaccine's inability to protect from infection is the presence of the reduction modifiable protein (Rmp; also known as protein III) in the vaccine. Localized to the outer membrane, Rmp is highly conserved and immunogenic, yet antibodies induced by this antigen actively prevent assembly of the complement membrane attack complex in immune serum (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>). These challenges illustrated the necessity for new approaches in gonorrhea vaccine development.</p><p>In the intervening years, vaccine progress has been slow. One of the difficulties is that <italic toggle="yes">Ng</italic> infection rarely, if ever, leads to an adaptive immune response (<xref rid="B35" ref-type="bibr">35</xref>&#8211;<xref rid="B38" ref-type="bibr">38</xref>). For this reason, mechanisms of protection against gonorrhea are unknown (<xref rid="B24" ref-type="bibr">24</xref>), which makes the evaluation of the potential efficacy of vaccine candidates prior to expensive immunization studies challenging. The serum bactericidal activity of antibodies generated during an immune response strongly predicts protection for vaccines against <italic toggle="yes">N. meningitidis</italic> [<italic toggle="yes">Nm</italic>; (<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>)], a frequent causative agent of meningitis, so the ability of gonococcal antigens to elicit bactericidal antibodies is currently used as a surrogate mechanism of protection (<xref rid="B41" ref-type="bibr">41</xref>). Based on this criterion, 14 <italic toggle="yes">Ng</italic> antigens with functions in colonization and invasion, nutrient acquisition, and immune evasion have been proposed for inclusion in a gonorrhea vaccine [reviewed in (<xref rid="B41" ref-type="bibr">41</xref>)]. Immunization with each of the candidate proteins, cyclic loop peptides, or lipooligosaccharide epitope mimics elicited bactericidal antibodies, although studies for seven of the antigens were performed only in <italic toggle="yes">Nm</italic> (<xref rid="B41" ref-type="bibr">41</xref>).</p><p>Despite the difficulties in developing a vaccine against gonorrhea, several recent advances suggest that a protective vaccine is now within reach. The first was the development of a female mouse model of lower genital tract infection, in which mice are treated with 17-&#946; estradiol and a cocktail of antibiotics to increase susceptibility to <italic toggle="yes">Ng</italic> and to reduce the overgrowth of vaginal commensal bacteria, respectively (<xref rid="B42" ref-type="bibr">42</xref>). This model has enabled the study of the immune response to gonococcal infection in a whole organism for which extensive genetic and immunological tools are available (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). A series of elegant studies, combining information gathered from experimental murine infections and tissue culture experiments, demonstrated <italic toggle="yes">Ng</italic> actively suppresses the generation of a productive adaptive immune response. Both mouse splenic mononuclear cells and human dendritic cells infected with <italic toggle="yes">Ng</italic> produced elevated levels of interleukin (IL)-6, tumor necrosis factor-&#945; (TNF-&#945;), IL-1&#946;, and IL-23, a set of cytokines that promote terminal differentiation of T-cells toward T helper 17 (Th17) cells (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Production of IL-17 is a characteristic marker of a Th17 response and promotes neutrophil recruitment through the induction of granulocyte-colony stimulating factor and chemokines (<xref rid="B45" ref-type="bibr">45</xref>). In support of gonorrhea promoting Th17 differentiation during an active infection, elevated levels of IL-17 were discovered in female mice challenged with <italic toggle="yes">Ng</italic> (<xref rid="B46" ref-type="bibr">46</xref>). Gonococci are also able to divert T-cell differentiation away from an adaptive Th1/Th2 response by inducing the production of transforming growth factor (TGF)-&#946; and IL-10 (<xref rid="B47" ref-type="bibr">47</xref>&#8211;<xref rid="B49" ref-type="bibr">49</xref>). Furthermore, <italic toggle="yes">Ng</italic> stimulates the differentiation of macrophages toward a regulatory phenotype and prevents macrophage antigen display. Through these immunosuppressive activities, the gonococcus is able to further inhibit the generation of a protective T-cell response (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>). The knowledge gained through these studies into the sophisticated methods <italic toggle="yes">Ng</italic> uses to promote its own survival and prevent triggering an adaptive immune response will enable a more informed strategy for vaccine development and help avoid the failures of the past.</p><p>In studies making use of the insights gathered from a better knowledge of the immune evasion strategies employed by the gonococcus, mice treated intravaginally with micro-encapsulated IL-12 and either infected with a common laboratory strain, FA1090, or immunized with membrane vesicles (MVs) collected from FA1090 were protected against subsequent infections up to 6 months after the initial treatment, even when challenged with heterologous strains (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>). IL-12 treatment promoted a Th1 response, as well as enhancing serum immunoglobulin A (IgA) and vaginal IgA and IgG levels (<xref rid="B54" ref-type="bibr">54</xref>).</p><p>Lessons can also be learned from the successful development of the licensed four-component <italic toggle="yes">Nm</italic> serogroup B vaccine, 4CMenB (BEXSERO; GlaxoSmithKline). This bacterium presented a daunting vaccination challenge for a number of years due to the polysaccharide capsule surrounding group B meningococci, which is structurally identical to the polysialic acid carbohydrate found on the surface of many human cells. Because of this similarity, immunization with the group B capsule is minimally immunogenic and/or may result in the generation of autoantibodies (<xref rid="B55" ref-type="bibr">55</xref>). To circumvent this problem, a subunit vaccine was developed by identifying conserved open reading frames in the whole genome sequence of <italic toggle="yes">Nm</italic> serogroup B, a strategy termed reverse vaccinology (<xref rid="B55" ref-type="bibr">55</xref>&#8211;<xref rid="B59" ref-type="bibr">59</xref>). Out of nearly 600 vaccine candidates identified with this strategy, 350 were successfully expressed and purified from <italic toggle="yes">Escherichia coli</italic>, 28 elicited bactericidal antibodies, and only three recombinant proteins&#8212;two of which are composed of a fusion of two proteins&#8212;were combined with MVs to formulate 4CMenB (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>). Finally, a retrospective study found that immunization with another <italic toggle="yes">Nm</italic> serogroup B vaccine, MeNZB, containing the same MVs as 4CMenB, was 31% effective at preventing gonorrhea (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>). The MeNZB vaccine is no longer available, but these seminal studies provide strong evidence that a protective gonorrhea vaccine is possible.</p><p>A comparison of the number of antigens evaluated for the serogroup B vaccine with the number currently being investigated for a gonorrhea vaccine illustrates how far gonorrhea research lags behind meningitis research and emphasizes that new strategies are necessary to increase the pool of vaccine candidates under consideration. An innovative way to address this gap was to perform reverse vaccinology antigen mining using subcellular fractionation coupled with high-throughput quantitative proteomics followed by bioinformatics (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>), which identified numerous stably expressed proteins and suggested that formulation of a subunit vaccine against gonorrhea would be successful. Both genome- and proteome-based reverse vaccinology approaches have become more prevalent since the technique was introduced (<xref rid="B56" ref-type="bibr">56</xref>). Candidate vaccine antigens have been identified through whole-genome screens of a number of medically important pathogens (<xref rid="B65" ref-type="bibr">65</xref>&#8211;<xref rid="B69" ref-type="bibr">69</xref>). As the availability of bacterial genome sequences has increased, more detailed analyses have become possible, including comparative genomics. One weakness of using whole genome sequences to search for vaccine candidate antigens is that the pathogens do not necessarily express the proteins discovered through this approach. Transcriptome analysis provides a way to circumvent this limitation but a low correlation between transcriptomic and proteomic data has been well established [reviewed in (<xref rid="B70" ref-type="bibr">70</xref>)]. For this reason, we have chosen to pursue proteomic-based reverse vaccinology, as proteomic studies reveal the biologically relevant population of proteins expressed during exposure to the conditions under examination (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B71" ref-type="bibr">71</xref>). Proteomic approaches also have the potential to specifically identify surface-exposed proteins without the need for extensive bioinformatic predictions (<xref rid="B72" ref-type="bibr">72</xref>).</p><p>In this article, we provide an overview of proteomic and bioinformatic approaches that have been utilized for gonorrhea antigen mining. Our focus will also be on functional and structural characterization of proteome-derived antigens to determine their role in gonococcal pathogenesis and physiology as well as to inform the development of next generation vaccines based on structural vaccinology.</p></sec><sec id="s2"><title>Proteomic Technologies Applied for Gonorrhea Antigen Mining</title><p>Surface-localized proteins represent attractive vaccine candidates, as they are important foci for the immune system and play pivotal roles in bacterial physiology as well as host-pathogen interactions. Naturally elaborated MVs (NeMVs) and MVs extracted from cell evelopes (CE) by either lithium or deoxycholate treatment (LeOMVs or DeOMVs, respectively) contain surface-localized proteins, other outer membrane and periplasm-derived proteins, and commonly cytoplasmic proteins (<xref rid="B73" ref-type="bibr">73</xref>&#8211;<xref rid="B79" ref-type="bibr">79</xref>). In addition to proteins, MVs contain lipopolysaccharide and DNA of chromosomal, plasmid, or phage origin, as well as RNA (<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B80" ref-type="bibr">80</xref>). NeMVs are purified and concentrated from culture supernatants by separating intact cells from already-formed NeMVs (Figure <xref ref-type="fig" rid="F1">1</xref>). Le-MVS and De-MVs are extracted from bacterial cells with detergent, reducing the content of reactogenic LPS/LOS and also many lipoproteins (<xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B82" ref-type="bibr">82</xref>). Including different types of MVs in vaccine formulations has led to some of the most effective vaccines against bacterial diseases (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B83" ref-type="bibr">83</xref>). Remarkably, following a nationwide implementation of 4CMenB, a recent study showed &gt;80% vaccine-mediated protection against current <italic toggle="yes">Nm</italic> B strains in the United Kingdom (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>).</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Outline of proteomics approaches used for mining of <italic toggle="yes">Neisseria gonorrhoeae</italic> vaccine antigens. Description is provided in the main text. SG, standard growth conditions; &#8211;Iron, iron deprivation; +NHS, addition of normal human serum; &#8211;O<sub>2</sub>, anaerobic growth conditions; MVs, membrane vesicles; CE, CE; 2 D, two-dimensional; 2 DE, two-dimensional electrophoresis; iTRAQ, isobaric tagging for absolute quantitation; MS/MS, mass spectrometry analysis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-09-02793-g0001.jpg"/></fig><p>For all these reasons, the identification of CE and MV antigens is a key objective of proteomics-driven vaccinology. It is however, a difficult task, because membrane proteins are commonly low abundant, hydrophobic, have a basic charge, and can be of high molecular weight. Therefore, comprehensive antigen mining of bacterial CE and MVs necessitates extensive subcellular fractionation procedures coupled with high-throughput quantitative proteomics and extensive bioinformatics (Figure <xref ref-type="fig" rid="F1">1</xref>). In addition, multidimensional protein identification technology combats these challenges by using a combination of two different kinds of liquid chromatography (2D-LC) that separates proteins prior to their identification, greatly diminishing the complexity of the sample at the peptide level and resulting in the identification of a superior number of proteins (<xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B86" ref-type="bibr">86</xref>).</p><p>Accordingly, to interrogate the <italic toggle="yes">Ng</italic> CE and MVs for new antigens, three independent proteomic technologies and experimental designs have been applied for the first time in the gonorrhea field (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). In the earliest proteomic mining, four common laboratory <italic toggle="yes">Ng</italic> strains (FA1090, MS11, F62, and 1291) were cultured under standard growth conditions in liquid medium to mid-logarithmic phase and subjected to fractionation, sodium carbonate extraction, and ultracentrifugation steps to isolate NeMVs and CE proteins [Figure <xref ref-type="fig" rid="F1">1</xref>; (<xref rid="B63" ref-type="bibr">63</xref>)]. Subsequently, these subproteomes were trypsinized and labeled with four different isobaric tags (114, 115, 116, and 117) targeting &#949;-amine group of lysine in peptides for relative and absolute quantitation (iTRAQ). After labeling, the samples were pooled and the peptide mixture was subjected to fractionation by 2D-LC followed by MS/MS for protein detection and quantitation. This multiplexed high-throughput proteomics approach enabled identification of 533 and 168 common proteins in the CE and MVs, respectively, in all four <italic toggle="yes">Ng</italic> strains in biological replicate experiments. Strain FA1090 was arbitrarily selected as the reference strain for calculating the protein abundance. After applying rigorous criteria, Zielke et al. (<xref rid="B63" ref-type="bibr">63</xref>) eliminated up to 68% of identified proteins. Among these proteins, 305 and 46 were uniformly present in the CE and MVs, respectively, in four strains. A total of 22 proteins were present at different levels in both analyzed subproteomes of these strains. Overall, these studies led to identification of a plethora of proteins that were either novel or had not been characterized in <italic toggle="yes">Ng</italic>. In this group were ubiquitous proteins localized to the CE and MVs: LPS-transport protein LptD (OstA, Imp), BamA, BamE, a predicted extracellular protein NGO1063 (SliC), and outer membrane proteins NGO1205 (ZnuD), NGO1344 (AsmA), NGO1956 (TamA), NGO1985 (BamG), NGO2111 (Slam2), NGO2121 (MlaA), NGO2139 (MetQ), and NGO2054 (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). We focus on these proteome-derived antigens in the later sections of this article.</p><p>In the second proteomics-driven antigen mining approach for gonorrhea vaccine(s), our group was interested in discovering antigens induced in response to host-relevant environmental stimuli as they may represent novel protective antigens in distinct niches in the human host (<xref rid="B64" ref-type="bibr">64</xref>). Therefore, the model <italic toggle="yes">Ng</italic> strain FA1090 was subjected to aerobic (SG) and anaerobic (&#8211;O<sub>2</sub>) conditions, iron deprivation (&#8211;Iron), and exposure to normal human sera (+NHS; Figure <xref ref-type="fig" rid="F1">1</xref>), followed by CE protein extraction, trypsinization, iTRAQ labeling, and 2D-LC MS/MS (<xref rid="B64" ref-type="bibr">64</xref>). Three biological experiments yielded 751 common proteins with 17, 32, and 367 proteins with altered expression compared to SG in the presence of NHS, upon iron deprivation, and during anaerobic growth, respectively. In addition, 259 proteins were ubiquitously expressed under all conditions. There were many newly identified ubiquitous and differentially expressed CE proteins and potential new antigens including Slam2 and NGO1688 (both positively regulated by low iron), and ZnuD, which was induced under oxygen limitation (<xref rid="B64" ref-type="bibr">64</xref>).</p><p>In addition to the aforementioned approaches, we applied classical immunoproteomics to identify potential cross-reactive antigens in native MVs derived from <italic toggle="yes">Ng</italic> FA1090 that were intravaginally inoculated concurrently with interleukin-12 (Figure <xref ref-type="fig" rid="F1">1</xref>) and showed protection against heterologous <italic toggle="yes">Ng</italic> strains in the female mouse model of lower genital tract infection (<xref rid="B52" ref-type="bibr">52</xref>). Our approach relied on 2 DE SDS-PAGE separation of <italic toggle="yes">Ng</italic> native MVs coupled with immunoblotting with sera from MV-immunized mice (Figure <xref ref-type="fig" rid="F1">1</xref>). The overall MV proteome maps were created by staining proteins in a fluorescent stain. After the superimposition of antigenic maps (2D Immunoblot) with proteome maps, matching spots were excised and the proteins were subjected to trypsin digestion and MS/MS-based identification. The blotted protein maps consistently showed two spots of masses corresponding to 45 kDa and 43 kDa that were identified by MS/MS as translation elongation factor-Tu (EF-Tu) and a putative periplasmic polyamine-binding protein, PotF3, respectively. Supporting these findings, both proteins were also identified in our quantitative proteomic profiling of MVs derived from four common gonococcal isolates (<xref rid="B63" ref-type="bibr">63</xref>).</p></sec><sec id="s3"><title>Bioinformatics for Gonorrhea Vaccines</title><p>After the mining and discovery of potential new antigens, insights can be gained into their suitability in a vaccine formulation through bioinformatic analyses to predict their function, subcellular localization, and post-translational modifications (Figure <xref ref-type="fig" rid="F2">2</xref>). In our studies, we employed PSORTb (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B88" ref-type="bibr">88</xref>), SOSUI-GramN (<xref rid="B89" ref-type="bibr">89</xref>), and CELLO (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>) algorithms to infer protein localization within the cell and to identify proteins discovered in the CE or MVs that localized to the outer membrane (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). While each method considers the physiochemical properties of the amino acids that make up the protein, follow up computations differ between algorithms. To increase the accuracy of the subcellular localization predictions in our studies, we utilized a majority-votes strategy in which proteins were assigned to cellular compartments based on the results of at least two of the three methods (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). To provide additional confidence in the localization predictions, searches for signal sequences recognized by signal peptidase (SPase) I or SPaseII can also be performed. The SignalP 4.1 server<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> can be used as a tool to detect signal peptides (SP; Figure <xref ref-type="fig" rid="F3">3</xref>) associated with targeting to secretory pathways and cleaved by SPaseI (<xref rid="B92" ref-type="bibr">92</xref>, <xref rid="B93" ref-type="bibr">93</xref>), while the LipoP 1.0 server<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref> detects lipoprotein signal peptides (LSP; Figure <xref ref-type="fig" rid="F3">3</xref>) associated with cleavage by SPaseII and further processing through the lipoprotein maturation pathway (<xref rid="B94" ref-type="bibr">94</xref>). Lipoproteins are characterized by an invariant cysteine residue that is modified with two or three acyl chains, which allows a hydrophilic protein to remain anchored to the membrane (<xref rid="B95" ref-type="bibr">95</xref>). Depending on secondary sorting signals, which are not well understood, lipoproteins may be anchored to either the inner or outer membrane and may face the periplasm or the extracellular milieu. Surface-exposed lipoproteins may be involved in nutrient acquisition, cell wall homeostasis, and adhesion to host cells (<xref rid="B95" ref-type="bibr">95</xref>), properties which we will discuss in more detail below. Finally, lipoproteins exposed to the extracellular milieu act as ligands for Toll-like receptor (TLR) 2 and may thus contribute to activating an adaptive immune response (<xref rid="B95" ref-type="bibr">95</xref>), a feature which makes them intriguing targets for vaccine development.</p><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Vaccine candidate decision tree. Description is provided in the main text.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-09-02793-g0002.jpg"/></fig><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Proteome-derived antigen domain schematics. ORFs were examined for the presence of domains using KEGG, NCBI, UNIPROT, and literature searches. The presence of signal peptides was determined using the SignalP 4.1 and LipoP 1.0 servers. <bold>(A)</bold> BamA with a signal peptide, five POTRA domains, and an OMP &#946;-barrel domain. <bold>(B)</bold> TamA protein with a signal peptide, three POTRA domains and an OMP &#946;-barrel domain. <bold>(C)</bold> LptD with a signal peptide, N terminal &#946;-JELLYROLL domain, and &#946;-barrel OstA_C domain. <bold>(D)</bold> Slam 2 with a signal peptide and C terminal &#946;-barrel domain (a DUF560 domain). <bold>(E)</bold> ZnuD comprises a signal peptide, plug domain, a Ton-B dependent receptor domain, and an OMP &#946;-barrel domain. <bold>(F)</bold> MlaA with a signal peptide and predicted MlaA domain. <bold>(G)</bold> BamE containing a lipoprotein signal peptide and SmpA_OmlA domain. <bold>(H)</bold> BamG is composed of a lipoprotein signal peptide and two BON domains. <bold>(I)</bold> NGO2054 contains a Lambda-Bor domain that overlaps with a lipoprotein signal peptide, as well as a Fragile Site Associated protein C-terminus (FSA-C). <bold>(J)</bold> SliC containing a lipoprotein signal peptide and MliC protein family domain. <bold>(K)</bold> MetQ comprises a lipoprotein signal peptide and a NlpA domain <bold>(L)</bold> AsmA includes an AsmA domain. Schematics are not to scale. SP, signal peptide; LSP, lipoprotein signal peptide; BON, bacterial OsmY and nodulation; FSA-C, Fragile site-associated protein C-terminus; OMP, outer membrane protein.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-09-02793-g0003.jpg"/></fig><p>An additional analysis that can be performed to complement the prediction of subcellular localization includes functional category predictions through searches for Clusters of Orthologous Groups (COG). This analysis involves a phylogenetic comparison of the proteome-derived vaccine candidates to a database of proteins with known or predicted functions to determine to which cellular process(es) the protein is likely to contribute (<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>). The results are grouped into four broad categories&#8212;Cellular Processes and Signaling, Information Storage and Processing, Metabolism, and Poorly Characterized&#8212;each of which can then be broken down further. Altogether, proteins can be clustered into one or more of 25 categories. Although the NCBI COG database<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref> does not contain information for <italic toggle="yes">Ng</italic>, COG data is available for <italic toggle="yes">Nm</italic>, which allows for functional analysis using a closely related organism. Insights gained into the function of the proteome-derived vaccine candidates will enable a more rational vaccine design approach, in which candidate antigens involved in multiple functions or in functional categories critical to bacterial fitness can be preferentially chosen in the vaccine decision tree and evaluated for their protective capabilities (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><p>The proliferation of genomic data also benefits proteomics-driven reverse vaccinology. Of particular utility to gonorrhea vaccine research is the publically available <italic toggle="yes">Neisseria</italic> Multi Locus Sequence Typing database<xref ref-type="fn" rid="fn0004"><sup>4</sup></xref> [<italic toggle="yes">Neisseria</italic> PubMLST, developed by Keith Jolley and sited at the University of Oxford; (<xref rid="B98" ref-type="bibr">98</xref>)], which has collected whole or partial genome sequence data from nearly 47,000 <italic toggle="yes">Neisseria</italic> isolates as of August 19, 2018. Annotation of the <italic toggle="yes">Neisseria</italic> pan-genome is underway, which would further facilitate vaccine development by identifying antigens that are present across the known population of <italic toggle="yes">Ng</italic> isolates, as well as proteins that are uniquely associated with highly antibiotic resistant strains. The wealth of information available from this database enables bioinformatic analyses of antigen conservation across numerous sequenced isolates. For example, in our characterization of a novel surface exposed lysozyme inhibitor of C-type lysozyme encoded by the <italic toggle="yes">ngo1063</italic> open reading frame, SliC, use of the <italic toggle="yes">Neisseria</italic> PubMLST database revealed the existence of only 10 closely related alleles with 9 single nucleotide polymorphic sites across nearly 5,000 <italic toggle="yes">Ng</italic> isolates. Further, 98% of isolates in the database possessed a single <italic toggle="yes">sliC</italic> allele (<xref rid="B99" ref-type="bibr">99</xref>), indicating that this protein is highly conserved and its inclusion in a vaccine could provide broad protection without the need for multiple antigenic variants.</p><p>Another analysis made possible by the information present in the PubMLST database is to map polymorphisms to available structural data (Figure <xref ref-type="fig" rid="F2">2</xref>). If highly prevalent polymorphisms are found on surface-exposed portions of the proteins, multiple recombinant proteins that incorporate the most common variants may need to be included in a vaccine to provide protection against a broader range of strains. While structural data will not necessarily be available immediately for all vaccine candidates, another computational analysis method may still enable prediction of surface exposed polymorphisms. Prediction of transmembrane helices by hidden Markov modeling using the TMHMM 2.0 server<xref ref-type="fn" rid="fn0005"><sup>5</sup></xref> can reveal protein regions predicted to be internal, transmembrane, or external (<xref rid="B100" ref-type="bibr">100</xref>). Combining data from PubMLST with the results of TMHMM predictions can suggest which polymorphisms are likely to be surface exposed. Importantly, this analysis must be accompanied by surface-exposure assessments, as we discuss below, and may not be accurate for lipoproteins where the lipid anchor could be the only portion of the protein embedded in the membrane.</p><p>Additionally relevant to vaccine research are bioinformatic tools designed to predict the immunogenicity and protective capability of candidate antigens. Depending on whether the desired immune response is humoral (B-cell mediated) or cellular (T-cell mediated), numerous tools exist to predict whether antigen-derived peptides possess epitopes that are likely to be recognized by either of the major histocompatibility complex (MHC) class I or II proteins, the transporter associated protein (TAP) responsible for translocating peptides across the endoplasmic reticulum to MHC molecules for surface display, or B cell receptors. MHC I predictive tools have been estimated to be 90&#8211;95% accurate, although MHC II predictions are less reliable. Structural information is required for accurate B cell receptor binding predictions, as B cells and antibodies recognize the protein's native form. Certain tools use biochemical properties of the protein's constituent amino acids to predict likely B cell receptor binding sites. More accurate techniques require the protein's 3D structure as input [prediction tools extensively reviewed in (<xref rid="B101" ref-type="bibr">101</xref>)]. These prediction strategies may be useful to filter out antigens that are not likely to generate an immune response. However, follow-up immunological testing in the mouse as described below will be required to establish whether the response is protective or whether, as in the case of Rmp, the immunogenic response actively blocks the action of the adaptive immune system (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>).</p></sec><sec id="s4"><title>Vaccine Decision Tree</title><p>Subsequent to proteomic identification and bioinformatic analysis, candidate antigens should be assessed for their suitability for inclusion in a vaccine. Here, we suggest a decision tree for the evaluation of vaccine candidate proteins (Figure <xref ref-type="fig" rid="F2">2</xref>). To determine the expression characteristics of each vaccine candidate, they should initially be expressed and purified from a heterologous host, such as <italic toggle="yes">E. coli</italic>, and used to immunize rabbits or mice to collect polyclonal immune serum specific to the protein under investigation. These sera can then be used for several informative studies, such as confirmation of localization predictions by probing subcellular fractions to determine in which compartment(s) the protein is predominantly located. Immune sera can be used to interrogate the abundance of proteins after proteolytic shaving of intact cells, an experiment which will demonstrate whether proteins are accessible to external proteases (<xref rid="B64" ref-type="bibr">64</xref>). Protein accessibility to antibodies can also be directly investigated by immunoblotting analysis of intact cells spotted onto membranes and comparison of the signal to lysed cells using known surface-exposed proteins as controls (<xref rid="B64" ref-type="bibr">64</xref>). Antisera generated against vaccine candidates coupled with fluorescently labeled secondary antibodies can also be used to establish antigenic surface exposure through fluorescence-activated cell sorting analyses (<xref rid="B68" ref-type="bibr">68</xref>). Furthermore, primary antisera coupled with gold nanoparticle-labeled secondary antibodies can be employed in electron microscopy studies of surface exposure. With this type of study, not only can surface exposure be confirmed, but the localization, distribution and overall abundance of surface proteins can also be directly observed (<xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B103" ref-type="bibr">103</xref>). Serum raised against a candidate antigen additionally enables studies to accompany conservation predictions performed during initial bioinformatic analyses. In our assessments of candidate antigens, we employed a panel of at least 36 genetically, geographically, and temporally distinct <italic toggle="yes">Ng</italic> isolates, including the 2016 WHO reference strains (<xref rid="B104" ref-type="bibr">104</xref>), to examine whether the expression of each antigen is consistent across heterogeneous strains, as well as to determine whether the epitope(s) recognized by the antiserum are conserved in diverse gonococci and meningococci (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B99" ref-type="bibr">99</xref>). Finally, to determine the likelihood that immunization with vaccine candidate antigens will be protective, antiserum raised against each antigen can be used to assess the protein's ability to elicit bactericidal and/or opsonophagocytic antibodies (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B43" ref-type="bibr">43</xref>). As mentioned previously, it is unknown whether antibodies' bactericidal or opsonophagocytic properties will predict their protective capabilities (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B41" ref-type="bibr">41</xref>). However, one or both characteristics is likely to contribute to a productive adaptive immune response, so this examination is useful in the absence of established protective mechanisms.</p><p>Studies that can be performed in tandem with antiserum-enabled investigations involve characterizations of the antigens' function(s) in gonococcal physiology and pathogenesis (Figure <xref ref-type="fig" rid="F2">2</xref>). We discuss these investigations in greater detail in a later section. In broad terms, the experiments associated with functional characterization are designed to assess the effects of conditional or isogenic knockout mutations on the ability of <italic toggle="yes">Ng</italic> to thrive <italic toggle="yes">in vitro</italic> under standard conditions as well as during exposure to stimuli relevant to infection, its ability to adhere to and invade epithelial cells, and its ability to colonize female mice during experimental infection in the murine model of lower genital tract infection or transgenic mice (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). The overarching goal of these experiments is to determine the effects of the loss of each vaccine candidate, as antibodies are known to block protein function. In <italic toggle="yes">Ng</italic>, neutralizing antibodies against the nitrite reductase AniA inhibited its enzymatic activity (<xref rid="B105" ref-type="bibr">105</xref>). Neutralizing antibodies were also demonstrated to prevent MetQ-mediated gonococcal adhesion to epithelial cells (<xref rid="B106" ref-type="bibr">106</xref>), and were able to abrogate <italic toggle="yes">in vitro</italic> lysozyme inhibition by the <italic toggle="yes">Neisserial</italic> adhesin complex protein (ACP), a dual-function protein involved in adhesion and defense against lysozyme attack (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B107" ref-type="bibr">107</xref>&#8211;<xref rid="B109" ref-type="bibr">109</xref>). Additionally, <italic toggle="yes">Nm</italic> and <italic toggle="yes">Ng</italic> IgA1 protease-mediated IgA cleavage was inhibited by sera collected from both acute and convalescent meningitis patients (<xref rid="B110" ref-type="bibr">110</xref>). More specifically, antibodies that block protein function are elicited by immunization with each of the recombinant protein components of the 4CMenB vaccine&#8212;factor H binding protein (fHbp), Neisserial heparin binding antigen (NHBA), and <italic toggle="yes">Neisseria</italic> adhesin A (NadA). Antibodies against fHbp abrogate factor H binding and thus enhance meningococcal serum sensitivity (<xref rid="B111" ref-type="bibr">111</xref>). Both NHBA and NadA are involved in bacterial adherence, and neutralizing antibodies against either protein reduce the ability of <italic toggle="yes">Nm</italic> to adhere to epithelial cells (<xref rid="B112" ref-type="bibr">112</xref>, <xref rid="B113" ref-type="bibr">113</xref>). Non-neutralizing antibodies provide protection against viruses (<xref rid="B114" ref-type="bibr">114</xref>, <xref rid="B115" ref-type="bibr">115</xref>); however, similar data are scarce for bacteria (<xref rid="B114" ref-type="bibr">114</xref>). Targeting bacterial virulence factors or physiologically important proteins with a vaccine could discourage mutations that would allow the protein to evade immune detection, thereby improving the vaccine's success. The exclusive focus on targeting virulence factors in a vaccine is not vital, however, as demonstrated by immunization with the <italic toggle="yes">S. agalactiae</italic> surface immunogenic protein (Sip), which induces a strong protective response (<xref rid="B116" ref-type="bibr">116</xref>) but has no reported function in the pathogenesis of group B streptococci. It is possible that the antigens eventually formulated into a successful gonorrhea vaccine will not generate neutralizing antibodies, but evidence suggests antibodies that block protein function to some extent are elicited in the majority of immune responses effective at protecting against bacterial pathogens.</p><p>An additional study that can be used to inform vaccine design involves antigen structural elucidation, either alone or in complex with antibodies directed against the target protein. We discuss structural studies that have been performed on proteome-derived vaccine candidates in a subsequent section. Not only does the structure of a protein give insights into its function, but it also enables allele mapping, as discussed in the previous bioinformatics section (Figure <xref ref-type="fig" rid="F2">2</xref>). Traditionally, structural characterization is performed through X-ray crystallography (<xref rid="B117" ref-type="bibr">117</xref>), although advances in nuclear magnetic resonance spectroscopy also allow for the structural elucidation of small proteins (<xref rid="B118" ref-type="bibr">118</xref>, <xref rid="B119" ref-type="bibr">119</xref>). Co-crystallization with antibodies can reveal the mechanism(s) of action of the antibodies against the target protein (<xref rid="B120" ref-type="bibr">120</xref>&#8211;<xref rid="B122" ref-type="bibr">122</xref>). This strategy requires the use of antigen binding fragments of monoclonal antibodies (mAbs), which are more technically challenging, time-consuming, and expensive to produce than polyclonal antibodies (<xref rid="B123" ref-type="bibr">123</xref>). For this reason, co-crystallization is likely to be pursued only after further evaluation of the antigen's immunogenicity and protective capabilities as part of a vaccine. A complementary technique that can be pursued for difficult-to-crystallize antigen/antibody complexes is cryo-electron microscopy, in which single molecules embedded in a flash-frozen matrix are visualized with an electron microscope. This technique was successfully employed to elucidate the structure of an integral membrane ion channel protein (<xref rid="B124" ref-type="bibr">124</xref>), as well as the interaction interface between an antibody fragment that successfully neutralized a range of influenza virus variants and the receptor site of the influenza virus hemagglutinin protein (<xref rid="B125" ref-type="bibr">125</xref>). One limitation of cryo-electron microscopy is that structural resolution tends to be poorer than with the use of other techniques. However, recent technical advances have been able to improve acquired structures to near-atomic resolution [&lt;4&#197;; (<xref rid="B126" ref-type="bibr">126</xref>)]. Although cryo-electron microscopy may circumvent some limitations of X-ray crystallography or nuclear magnetic resonance, mAbs will still be required for evaluating antigen/antibody interactions.</p><p>Finally, if the results of the evaluation studies suggest that a protein may be a suitable vaccine component, its immunogenicity and ability to elicit a protective response will be investigated through protection and clearance studies performed in the female mouse model of gonorrhea (Figure <xref ref-type="fig" rid="F2">2</xref>). To date, only an extremely limited number of studies have been published examining the ability of vaccine formulations to accelerate clearance and protect against subsequent infection in the mouse model. These studies include intranasal immunization with MVs, which was associated with enhanced clearance in one study (<xref rid="B127" ref-type="bibr">127</xref>), but not in another (<xref rid="B24" ref-type="bibr">24</xref>). However, intravaginal immunization with MVs combined with microencapsulated IL-12 both accelerated gonococcal clearance and protected mice from subsequent infection (<xref rid="B52" ref-type="bibr">52</xref>). Active intraperitoneal immunization with a peptide mimic of a conserved LOS epitope recognized by the 2C7 mAb or passive immunization with the mAb itself both shortened disease duration (<xref rid="B128" ref-type="bibr">128</xref>). Finally, mice immunized in the rear footpads with viral replicon particles (VRPs; viral derivatives that deliver antigens after a single replication cycle) loaded with the outer membrane porin PorB, combined with a subsequent booster immunization comprised of recombinant refolded PorB and an adjuvant, cleared experimental infections significantly more quickly than control mice (<xref rid="B24" ref-type="bibr">24</xref>). Follow up experiments suggested that this protection was likely associated with the adjuvant effect of the VRP itself, rather than a specific protective effect of the PorB antigen (<xref rid="B24" ref-type="bibr">24</xref>). These studies, and their paucity, reveal the need to accelerate and expand systematic immunization studies that examine the protective effects of antigens individually and in combination. Additionally, the effects of the presence or absence of adjuvants with each antigen formulation should be examined, as different adjuvants can drive specific adaptive immune responses (Figure <xref ref-type="fig" rid="F2">2</xref>). Currently, vaccines that induce a balanced Th1/Th2 responses are considered optimal [reviewed in (<xref rid="B129" ref-type="bibr">129</xref>)] and are important in defending against gonorrhea (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>). Examples of FDA-approved adjuvants that should be evaluated based on these considerations include alum, which drives a Th2 response; monophosphoryl lipid A, a detoxified LPS derivative that acts as a TLR4 agonist to stimulate a Th1 response; and oligonucleotides enriched in cytosine phosphoguanine (CpG) islands (<xref rid="B129" ref-type="bibr">129</xref>, <xref rid="B130" ref-type="bibr">130</xref>), which are TLR9 agonists that mediate Th1 and CD8 cellular immune responses but also increase antibody titers (<xref rid="B131" ref-type="bibr">131</xref>). To optimize the chance of developing an effective vaccine, the route of immunization, as well as different antigen delivery systems that potentiate immune responses, should be considered and investigated. Numerous delivery systems are in clinical and pre-clinical stages of development, including virus-like particles, emulsions, liposomes, polymer-based systems, hydrogels, and implants [reviewed in (<xref rid="B129" ref-type="bibr">129</xref>, <xref rid="B130" ref-type="bibr">130</xref>)]. Finally, evaluation of subunit vaccines beyond their ability to accelerate clearance and protect against subsequent infection will include quantification of antigen-specific IgG and IgA antibody titers in serum and vaginal mucosal secretions, evaluation of antibodies' bactericidal and opsonophagocytic activities, and examination of the cellular immune response.</p><p>While we recognize that the decision tree presented here may appear daunting, it is important to remember that traditional vaccinology has failed to deliver a successful gonorrhea vaccine. Development of new vaccines is not trivial. The challenges inherent in protecting against this highly adaptable pathogen necessitate creative and flexible approaches. The decision tree and the generation of effective gonorrhea vaccines will be shaped by lessons learned from the <italic toggle="yes">Ng</italic> biology and epidemiology as well as new delivery systems and technologies. A strength of our proposed decision tree is that, regardless of whether an antigen is ultimately formulated into a vaccine, more information will be gained into <italic toggle="yes">Ng</italic> pathophysiology and the gonorrhea research field will be accelerated.</p></sec><sec id="s5"><title>Elucidation of Function of the Proteome-Derived Vaccine Candidates</title><p>We propose a vaccine-induced immune response that targets antigens important for CE homeostasis, bacterial pathogenesis, or overall viability may not only protect against the acquisition of subsequent gonorrhea infections but may also enhance immune system efficacy by weakening the gonococcus, thus accelerating the clearance of ongoing infections. A vaccine that employs this strategy could conceivably be used for therapeutic interventions in addition to preventative purposes. Studies evaluating the effectiveness of a vaccine against herpes simplex virus type 2 (HSV-2) provide a precedent for a therapeutic vaccine. In both guinea pigs (<xref rid="B132" ref-type="bibr">132</xref>) and humans (<xref rid="B133" ref-type="bibr">133</xref>, <xref rid="B134" ref-type="bibr">134</xref>), vaccination against HSV-2 tended to decrease the lesion rate and reduced viral shedding for at least 12 months&#8212;an evaluation criterion for efficacy of HSV-2 antiviral agents (<xref rid="B134" ref-type="bibr">134</xref>). A neutralizing antibody response was key for the vaccine's immunotherapeutic activity (<xref rid="B132" ref-type="bibr">132</xref>). For this reason, determining the function of antigens proposed for inclusion in a vaccine is useful to predict the potential physiological effects of an immune response that blocks protein function. The scientific literature contains a wealth of information that can be used as a starting point to facilitate functional characterization. Numerous gonococcal proteins have homologs that have been investigated in <italic toggle="yes">E. coli</italic> or <italic toggle="yes">Nm</italic>. However, these studies should be approached with a modicum of caution, as protein function may differ between species. For example, we determined that LptD is essential in <italic toggle="yes">Ng</italic> (<xref rid="B63" ref-type="bibr">63</xref>), similar to findings in <italic toggle="yes">E. coli</italic> (<xref rid="B135" ref-type="bibr">135</xref>, <xref rid="B136" ref-type="bibr">136</xref>). In contrast, this protein is dispensable for <italic toggle="yes">Nm</italic> (<xref rid="B137" ref-type="bibr">137</xref>). Furthermore, fHbp, which is a surface-exposed protein that contributes to <italic toggle="yes">Nm</italic> serum resistance, has no signal peptide for outer membrane localization in gonococci, nor does loss of <italic toggle="yes">Ng</italic> fHbp alter bacterial susceptibility to human serum (<xref rid="B138" ref-type="bibr">138</xref>). The potential for distinct protein function, even among closely related species, emphasizes the importance of performing independent studies to examine the role of homologous proteins in the organism being targeted by the vaccine.</p><p>A common tool for the study of protein function is a bacterial strain with a knockout mutation in the protein of interest. This can be accomplished through homologous recombination-mediated allelic replacement of the genetic locus with an antibiotic resistance marker, as we have performed in our studies (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B99" ref-type="bibr">99</xref>), or through gene inactivation by targeted transposon insertion mutagenesis (<xref rid="B139" ref-type="bibr">139</xref>). Of course, attempting to knock out an essential gene with this strategy will be unsuccessful, as transformation efforts will not result in any colonies, or off-target mutations may occur that lead to antibiotic resistance but do not affect the target gene. Neither outcome is desirable. Our strategy to circumvent this difficulty has been to place the gene of interest at an unlinked locus under the control of an inducible promoter, then to replace the native gene with an antibiotic resistance cassette while inducing protein expression from the heterologous locus (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B140" ref-type="bibr">140</xref>, <xref rid="B141" ref-type="bibr">141</xref>). With this technique, the effects of protein depletion, as well as protein stability, can be studied for essential genes. Using knockout mutant strains of non-essential genes, protein function can be assessed by exposing bacteria to different stress conditions and monitoring for growth. We evaluate bacterial survival under conditions relevant to human infection, including iron starvation, exposure to human serum, and anoxia, with the hypothesis that bacteria deficient in proteins important to a rapid or appropriate response to any of the conditions will be non-viable or will not grow as robustly as wild type bacteria (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B142" ref-type="bibr">142</xref>). CE permeability and stress can be evaluated by exposure to different antibiotics, either with the use of Etest antimicrobial test strips<xref ref-type="fn" rid="fn0006"><sup>6</sup></xref> or serial dilutions of bacteria inoculated onto solid medium supplemented with antibiotics (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B99" ref-type="bibr">99</xref>). Additionally, overproduction of MVs is a general marker of CE stress (<xref rid="B143" ref-type="bibr">143</xref>&#8211;<xref rid="B145" ref-type="bibr">145</xref>), so a comparison of MV production between wild type and mutant bacteria can suggest the level of CE stress resulting from the loss of a protein (<xref rid="B79" ref-type="bibr">79</xref>). Qualitative or quantitative proteomic profiling of supernatants collected from liquid cultures can give insights into the extent of membrane leakage or cellular lysis associated with deficiency of each vaccine candidate (<xref rid="B146" ref-type="bibr">146</xref>, <xref rid="B147" ref-type="bibr">147</xref>). Finally, <italic toggle="yes">in vitro</italic> tissue culture experiments can inform whether the protein under investigation is involved in, or has substrates that contribute to, the ability of <italic toggle="yes">Ng</italic> to adhere to, invade, and survive within human cervical epithelial cells (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B106" ref-type="bibr">106</xref>, <xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B149" ref-type="bibr">149</xref>).</p><p>An innovative technique that we adapted for the first study of its kind in <italic toggle="yes">Ng</italic> is the use of phenotype microarrays [PMs; (<xref rid="B147" ref-type="bibr">147</xref>)]. Developed by Biolog<xref ref-type="fn" rid="fn0007"><sup>7</sup></xref>, each PM is a 96-well microtiter plate pre-formulated with varying concentrations of numerous diverse compounds to assess bacterial nutritional requirements and sensitivity to chemical agents, including antibiotics and osmolytes (<xref rid="B150" ref-type="bibr">150</xref>, <xref rid="B151" ref-type="bibr">151</xref>). <italic toggle="yes">Ng</italic> nutritional requirements are well established. Glucose, pyruvate, and lactate are the only carbon sources the gonococcus is able to utilize (<xref rid="B152" ref-type="bibr">152</xref>). Therefore, we focused solely on chemical sensitivity PMs to assess the ability of seven vaccine candidates to defend against osmotic shock, as well as their physiological roles during exposure to CE-perturbing agents including metals, antimicrobial peptides, small hydrophobic molecules, and dyes (<xref rid="B147" ref-type="bibr">147</xref>). In our investigation with a comprehensive screen of over 1,000 conditions, we discovered 323 conditions that affected at least one of the mutant strains tested. Using these data, we generated a dendrogram based on the similarity between the effects of the loss of each protein, which revealed that the defects associated with knockout mutations of BamG or MlaA were the most distinct from the other five strains tested. The results of PM screening suggested these two antigens would be the most suitable to include in a vaccine, due to the extensive chemical sensitivities associated with the loss of either protein (<xref rid="B147" ref-type="bibr">147</xref>).</p><p>Although <italic toggle="yes">in vitro</italic> experiments are useful for predicting protein function, it is impossible to simultaneously account for all factors that will be encountered during infection of the host. For this reason, infection studies in the female mouse model are invaluable (Figure <xref ref-type="fig" rid="F2">2</xref>). Experimental infections with a single strain can be used to determine whether the bacterial load or infection duration is altered in the absence of a target protein (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B153" ref-type="bibr">153</xref>). Alternatively, competitive infections between the mutant strain and wild type bacteria can be performed to minimize mouse-to-mouse variation and to directly associate fitness phenotypes with the loss of a protein (<xref rid="B153" ref-type="bibr">153</xref>). Finally, to determine whether the protein under investigation contributes to bacterial response to hormones, ovariectomized mice can be utilized to decrease hormonal influence over infection characteristics (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B153" ref-type="bibr">153</xref>).</p><p>The studies outlined above will facilitate vaccine development by identifying antigens with roles in maintaining gonococcal fitness under stress conditions, including during active infections.</p></sec><sec id="s6"><title>Function of Proteomic-Derived Antigens in CE Homeostasis and Nutrient Acquisition</title><p>In the following sections, we discuss insights into function-structure of 12 proteomics-derived antigens (Figure <xref ref-type="fig" rid="F3">3</xref>). We have already verified surface-exposure for a majority of these vaccine candidates, as well as their expression and conservation among diverse <italic toggle="yes">Ng</italic> isolates. We have also established that BamA, TamA, LptD, MetQ, and NGO2054 elicit bactericidal antibodies that cross-react with heterologous <italic toggle="yes">Ng</italic> strains (<xref rid="B64" ref-type="bibr">64</xref>). Our initial characterization of these vaccine candidates in <italic toggle="yes">Ng</italic>, in addition to studies of the functions of homologous proteins in <italic toggle="yes">Nm</italic> show that many of them play different roles in the CE homeostasis or in nutrient acquisition. Maintaining the integrity of the OM, as well as acquiring nutrients, are critical for bacterial survival in hostile environments, such as those encountered during infection of the host. As a gram-negative bacterium, <italic toggle="yes">Ng</italic> possesses a typical CE, composed of a cytoplasmic or inner membrane, a cell wall made up of peptidoglycan, and an asymmetric OM (Figure <xref ref-type="fig" rid="F4">4</xref>). The outer membrane of <italic toggle="yes">Neisseria spp</italic> contains LOS, rather than the more typical LPS, which reflects their niche as mucosal pathogens (<xref rid="B154" ref-type="bibr">154</xref>). LOS acts as a buffer region for protection against environmental insult and contributes to pathogenesis through several mechanisms (<xref rid="B154" ref-type="bibr">154</xref>, <xref rid="B155" ref-type="bibr">155</xref>).</p><fig id="F4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>Schematic of proteomics-derived antigens MetQ, SliC, LptD, BAM, and TAM function-structure and organization in <italic toggle="yes">Neisseria gonorrhoeae</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-09-02793-g0004.jpg"/></fig><p>Three of our antigens (BamA, BamE, and BamG) are components of the &#946;-barrel assembly machinery (BAM) system (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B156" ref-type="bibr">156</xref>), which is responsible for folding and inserting &#946;-barrel proteins into the bacterial outer membrane (<xref rid="B157" ref-type="bibr">157</xref>, <xref rid="B158" ref-type="bibr">158</xref>). Until recently this critical protein complex has been primarily investigated in <italic toggle="yes">E. coli</italic>, where it consists of the central &#946;-barrel &#8220;Omp85&#8221; protein BamA, assisted by four lipoproteins (BamB-E). In contrast to <italic toggle="yes">E. coli</italic>, gonococcal BAM lacks BamB and contains a surface-displayed BamE [Figure <xref ref-type="fig" rid="F4">4</xref>; (<xref rid="B79" ref-type="bibr">79</xref>)]. Further, <italic toggle="yes">Neisseria</italic> possess an additional non-essential accessory protein RmpM (<xref rid="B159" ref-type="bibr">159</xref>). Similarly to other gram-negative bacteria, BamA and BamD are essential for <italic toggle="yes">Ng</italic> cell viability, and depletion of either BAM component results in OMP misfolding, as well as defects in protein stability and assembly (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B160" ref-type="bibr">160</xref>&#8211;<xref rid="B162" ref-type="bibr">162</xref>). BamA is responsible for folding and inserting virtually all &#946;-barrel OMPs in the OM (<xref rid="B158" ref-type="bibr">158</xref>). In contrast, BamE is not essential, which enables study of its effects on the CE. Our comprehensive analyses, including PMs, showed that the loss of BamE renders <italic toggle="yes">Ng</italic> susceptible to a wide range of compounds including detergents, antimicrobial peptides, other membrane-perturbing agents, and antibiotics (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B147" ref-type="bibr">147</xref>). Enhanced production of MVs is a marker of CE stress (<xref rid="B143" ref-type="bibr">143</xref>). Accordingly, the &#916;<italic toggle="yes">bamE</italic> mutant produced significantly increased amounts of MVs in comparison to WT bacteria. Additionally, the MV protein profile exhibited distinct alterations, suggesting that certain proteins were specifically targeted for packaging into MVs (<xref rid="B79" ref-type="bibr">79</xref>). Finally, removal of BamE appeared to destabilize the BamA-D interaction, which resulted in BamD localized on the cell surface of BamE-deprived <italic toggle="yes">Ng</italic> (<xref rid="B79" ref-type="bibr">79</xref>). The aberrant BamD localization in the absence of BamE could further increase membrane perturbations by interference with proper OMP insertion by BamA.</p><p>We recently discovered that one of our proteome-derived vaccine candidates, NGO1985, is a previously unrecognized accessory lipoprotein within the BAM complex and therefore renamed this protein BamG (<xref rid="B156" ref-type="bibr">156</xref>). Included in BamG is a lipoprotein signal peptide, which targets the protein for surface display (<xref rid="B156" ref-type="bibr">156</xref>), as well as two bacterial OsmY and nodulation (BON) domains (Figure <xref ref-type="fig" rid="F3">3H</xref>). BON domains are proposed to bind phospholipids based on the finding that <italic toggle="yes">E. coli</italic> OsmY prevents the inner membrane from shrinking during osmotic shock, although this hypothesis was not experimentally verified (<xref rid="B163" ref-type="bibr">163</xref>&#8211;<xref rid="B165" ref-type="bibr">165</xref>). In <italic toggle="yes">Ng</italic>, our initial probing with detergents and PM analyses revealed an extensive sensitivity phenome associated with lack of BamG, suggesting that BamG, through its interaction with the BAM complex, plays a critical function in CE biogenesis (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B147" ref-type="bibr">147</xref>, <xref rid="B156" ref-type="bibr">156</xref>).</p><p>LptD belongs to the low abundant, large and complex class of BAM substrates that are also heavily dependent on SurA, Skp and FkpA chaperones (<xref rid="B166" ref-type="bibr">166</xref>). LptD, together with OM-localized LptE (Figure <xref ref-type="fig" rid="F4">4</xref>), are constituents of the lipopolysaccharide transport (LptA-F) complex, and are crucial for inserting LPS into the outer leaflet of the <italic toggle="yes">E. coli</italic> outer membrane (<xref rid="B167" ref-type="bibr">167</xref>). The Lpt system appears not to function in a completely conserved manner in gram-negative bacteria, as both <italic toggle="yes">Ng</italic> and <italic toggle="yes">E. coli</italic> LptD are essential (<xref rid="B63" ref-type="bibr">63</xref>), whereas <italic toggle="yes">Nm</italic> can survive without LOS and none of the Lpt components are important for bacterial viability (<xref rid="B168" ref-type="bibr">168</xref>).</p><p>For the bacterial CE to exert its barrier function, the outer leaflet of the outer membrane must be a homogeneous layer of LOS. If this LOS layer is disrupted, phospholipids may diffuse from the inner leaflet and weaken the barrier function of the outer membrane. The Mla (maintenance of lipid asymmetry) system, which is conserved across gram-negative bacteria and is composed of MlaA-F, removes misplaced phospholipids from the outer leaflet and re-integrates them into the inner membrane to mitigate the detrimental effects of altered membrane asymmetry. The outer membrane component of the Mla system, MlaA, has primarily been studied in <italic toggle="yes">E. coli</italic>, where its deletion enhances bacterial susceptibility to membrane perturbing agents (<xref rid="B169" ref-type="bibr">169</xref>). In <italic toggle="yes">Ng</italic>, MlaA is encoded by the <italic toggle="yes">ngo2121</italic> locus and comprises a signal peptide and a MlaA domain (Figure <xref ref-type="fig" rid="F3">3F</xref>). Gonococcal MlaA is annotated as a lipoprotein, although we have previously noted that it does not contain the invariant cysteine residue required for lipid modification (<xref rid="B147" ref-type="bibr">147</xref>). However, a lipoprotein signal peptide is present in homologs from <italic toggle="yes">E. coli, K. pneumoniae</italic>, and <italic toggle="yes">S. marcescens</italic> (<xref rid="B169" ref-type="bibr">169</xref>, <xref rid="B170" ref-type="bibr">170</xref>). We are currently investigating the implications of the lack of MlaA lipidation in <italic toggle="yes">Ng</italic>. Combining antibiotic susceptibility testing using Etests with PM screening, we have established that compounds targeting the CE, including antimicrobial peptides, are more effective against <italic toggle="yes">Ng</italic> lacking MlaA than wild type bacteria. Resistance to antibiotics acting against cytoplasmic targets was unaltered (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B147" ref-type="bibr">147</xref>, <xref rid="B171" ref-type="bibr">171</xref>), suggesting a specific outer membrane defect (<xref rid="B169" ref-type="bibr">169</xref>). Additionally, the &#916;<italic toggle="yes">mlaA</italic> knockout showed increased vulnerability to oxidative stress-inducing compounds (<xref rid="B147" ref-type="bibr">147</xref>) and produced more MVs than wild type bacteria (<xref rid="B171" ref-type="bibr">171</xref>). Together, these findings suggest that MlaA is required for maintenance of outer membrane homeostasis and is involved in MV biogenesis (<xref rid="B172" ref-type="bibr">172</xref>).</p><p>Bacterial lipoproteins play numerous roles in cellular physiology, adhesion to host cells, modulation of inflammatory processes, and transport of virulence factors into host cells. Proper lipoprotein localization is critical for protein function (<xref rid="B173" ref-type="bibr">173</xref>). The proteome-derived vaccine candidates BamE, BamG, SliC, MetQ, and NGO2054 are newly described <italic toggle="yes">Ng</italic> lipoproteins (Figure <xref ref-type="fig" rid="F3">3</xref>). NGO2111 is homologous to the <italic toggle="yes">Nm</italic> surface lipoprotein assembly modulator Slam2, which is involved in translocating the hemoglobin-haptoglobin utilization protein to the cell surface (<xref rid="B174" ref-type="bibr">174</xref>). Slam2 is highly conserved amongst <italic toggle="yes">Neisseria</italic> isolates and is not found in <italic toggle="yes">E. coli</italic> (<xref rid="B175" ref-type="bibr">175</xref>, <xref rid="B176" ref-type="bibr">176</xref>). <italic toggle="yes">Ng</italic> Slam2 contains a signal peptide and a 14-stranded &#946;-barrel domain, which has also been annotated as a DUF560 domain (Figure <xref ref-type="fig" rid="F3">3D</xref>; 147, 176). In our PM study, we found no conditions that uniquely affected a &#916;<italic toggle="yes">slam2</italic> mutant, although 36 compounds were either beneficial or detrimental to the growth of this strain, in common with one or more of 6 other mutants (<xref rid="B147" ref-type="bibr">147</xref>). These results suggested that Slam2 exerts an indirect effect on CE integrity, potentially through an undiscovered lipoprotein substrate.</p><p>Another gonorrhea vaccine candidate we investigated in our PM study was NGO1344, which contains an AsmA domain (Figure <xref ref-type="fig" rid="F3">3L</xref>) and is homologous to the AsmA protein from <italic toggle="yes">E. coli</italic> and <italic toggle="yes">Nm</italic>. In <italic toggle="yes">E. coli</italic>, loss of AsmA decreased LPS synthesis (<xref rid="B177" ref-type="bibr">177</xref>); however, a similar phenotype was not observed in a <italic toggle="yes">Nm</italic> &#916;<italic toggle="yes">asmA</italic> mutant (<xref rid="B178" ref-type="bibr">178</xref>). Our analysis of cell lysis indicated that loss of <italic toggle="yes">Ng</italic> AsmA resulted in elevated levels of several cytoplasmic proteins in culture supernatants, especially when grown in the chemically-defined Graver-Wade liquid medium (<xref rid="B147" ref-type="bibr">147</xref>). Fifty-three membrane-perturbing compounds affected the viability of a &#916;<italic toggle="yes">asmA</italic> mutant, including polymyxin B and bile salts (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B147" ref-type="bibr">147</xref>). Clustering analyses suggested that the loss of AsmA resulted in phenotypes similar to those observed upon BamE deletion (<xref rid="B147" ref-type="bibr">147</xref>). Our results indicate that gonococcal AsmA contributes to CE integrity.</p><p>We also examined the role of the small lipoprotein NGO2054 in CE homeostasis. This protein is comprised of a lipoprotein signal peptide, a Lambda-Bor motif that contributes to serum resistance in <italic toggle="yes">E. coli</italic> (<xref rid="B179" ref-type="bibr">179</xref>), and a region with homology to the C-terminus of the fragile site-associated protein involved in adipocyte differentiation in mammalian cells [Figure <xref ref-type="fig" rid="F3">3I</xref>; (<xref rid="B180" ref-type="bibr">180</xref>)]. A &#916;<italic toggle="yes">ngo2054</italic> mutant was the least affected in our PM screen; only 27 compounds altered its growth (<xref rid="B147" ref-type="bibr">147</xref>). Thus, although we have established that NGO2054 is surface exposed, well conserved, and elicits bactericidal antibodies (<xref rid="B64" ref-type="bibr">64</xref>), its function within the CE remains enigmatic.</p><p>Metal co-factors such as zinc and iron are critical to facilitate cellular and enzymatic processes within pathogenic bacteria. During infection, bacteria rely on scavenging these metals from the host. To combat against bacterial pathogens, host organisms sequester available metals at the site of infection, a strategy termed nutritional immunity. The <italic toggle="yes">Neisserial</italic> outer membrane zinc uptake protein ZnuD overcomes host-imposed zinc depletion (<xref rid="B181" ref-type="bibr">181</xref>). In <italic toggle="yes">Ng</italic>, ZnuD is encoded by the <italic toggle="yes">ngo1205</italic> locus, which includes an amino terminal signal peptide, a plug domain, as well as a TonB &#946;-barrel (Figure <xref ref-type="fig" rid="F3">3E</xref>). In support of its role as a zinc uptake protein, a <italic toggle="yes">Nm</italic> &#916;<italic toggle="yes">znuD</italic> mutant was more sensitive to the bactericidal effects of neutrophil extracellular traps (<xref rid="B182" ref-type="bibr">182</xref>), which contain calprotectin that sequesters zinc ions (<xref rid="B183" ref-type="bibr">183</xref>). Additionally, meningococci deficient in ZnuD were attenuated in a systemic infection model (<xref rid="B181" ref-type="bibr">181</xref>), although &#916;<italic toggle="yes">znuD</italic> gonococci exhibited no survival defect during intracellular infection of cervical epithelial cells (<xref rid="B184" ref-type="bibr">184</xref>). We performed our PM analysis on <italic toggle="yes">Ng</italic> &#916;<italic toggle="yes">znuD</italic> bacteria to examine the contribution of ZnuD to CE integrity. Thirty-seven conditions altered the growth of bacteria lacking ZnuD, including the divalent cation chelator ethylenediaminetetraacetic acid (<xref rid="B147" ref-type="bibr">147</xref>). Our results provide support for the role of ZnuD as a zinc uptake protein and suggest that downstream effects to the CE occur from the decreased ability to acquire zinc.</p><p>Translocation of solutes across the CE is mediated by ABC transporters, which utilize the hydrolysis of ATP to transport molecules. A substrate binding protein is necessary to capture the substrate. Our proteome-derived vaccine candidate MetQ (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>), which was highly conserved in <italic toggle="yes">Ng</italic> as well as <italic toggle="yes">Nm</italic> (<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B64" ref-type="bibr">64</xref>), is homologous to the <italic toggle="yes">E. coli</italic> methionine binding protein MetQ [also known as NlpA; (<xref rid="B106" ref-type="bibr">106</xref>)] and is annotated with a lipoprotein signal peptide and a NlpA domain (Figure <xref ref-type="fig" rid="F3">3K</xref>). The presence of an operon upstream from <italic toggle="yes">metQ</italic>, composed of an ATP-binding protein (MetN) and a transmembrane permease (MetI) (<xref rid="B106" ref-type="bibr">106</xref>), provides additional support for the role of MetQ as the substrate binding protein in an ABC transport system. Surface plasmon resonance experiments demonstrated that <italic toggle="yes">Ng</italic> MetQ binds L-methionine with nanomolar affinity (<xref rid="B106" ref-type="bibr">106</xref>). These findings, in combination with our experiments demonstrating that <italic toggle="yes">Ng</italic> MetQ is surface exposed, highly conserved, and elicits strongly bactericidal antibodies (<xref rid="B64" ref-type="bibr">64</xref>), suggest MetQ is a promising vaccine candidate. Targeting MetQ could interfere with methionine transport and result in downstream protein synthesis defects.</p><p>The studies described here illustrate the myriad cellular processes in which our proteome-derived vaccine candidates participate. A subunit vaccine composed of several of these antigens has the potential to compromise gonococcal fitness independent of factors beyond a neutralizing antibody response.</p></sec><sec id="s7"><title>Function of SliC and MetQ in Pathogenesis</title><p>Bacterial pathogenicity is influenced by the number of infecting bacteria, the route of entry, the presence of host defense barriers, and bacterial virulence factors. <italic toggle="yes">Ng</italic> pathogenesis involves a collection of factors: pili, Opa proteins, LOS, and peptidoglycan all contribute to infection and are important for optimal pathogenesis (<xref rid="B6" ref-type="bibr">6</xref>). The study of protein function has the potential to reveal previously unrecognized virulence factors. A perfect example is our discovery of the surface-exposed inhibitor of C-type lysozyme, SliC (<xref rid="B99" ref-type="bibr">99</xref>). Through bioinformatic analyses, we determined SliC, encoded by the <italic toggle="yes">ngo1063</italic> locus, contained a lipoprotein signal peptide and a domain similar to membrane-bound lysozyme inhibitors of C-type lysozyme (MliC domain; Figure <xref ref-type="fig" rid="F3">3J</xref>). Bacterial proteinaceous lysozyme inhibitors protect the cell wall against host lysozyme attack during infection (<xref rid="B185" ref-type="bibr">185</xref>). Lysozyme inhibitor proteins were not known to exist in <italic toggle="yes">Neisseria</italic> until the recent discovery that the <italic toggle="yes">Neisserial</italic> adhesin complex protein (ACP) is inhibitory toward human (HL) and hen egg white lysozyme (HEWL), both of which are C-type lysozymes (<xref rid="B108" ref-type="bibr">108</xref>). The activity of SliC as a lysozyme inhibitor was comprehensively examined using an assay that involved fluorescently labeled peptidoglycan. Pre-incubation of wild type SliC with HL or HEWL completely obstructed peptidoglycan hydrolysis. In contrast, SliC mutated in two residues predicted to be key for the protein's interaction with lysozyme (S83A and K103A) showed no inhibition of cell wall hydrolysis with the addition of HL or HEWL (<xref rid="B99" ref-type="bibr">99</xref>). Subsequently, bio-layer interferometry was used to assess the kinetic interaction between SliC and lysozyme. This analysis revealed moderate binding between SliC and HL <italic toggle="yes">in vitro</italic> (K<sub>D</sub> 11 &#956;M), with one SliC molecule binding two HL molecules [Figure <xref ref-type="fig" rid="F4">4</xref>; (<xref rid="B99" ref-type="bibr">99</xref>)]. Surprisingly, cells that lacked SliC showed no difference to wild type when exposed to increasing levels of HL <italic toggle="yes">in vitro</italic>. However, a double SliC/ACP knockout was strongly attenuated during HL exposure (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B109" ref-type="bibr">109</xref>), suggesting that one lysozyme inhibitor compensates for the lack of the other protein. Despite this compensatory activity, <italic toggle="yes">Ng</italic> bacteria lacking SliC were up to 250-fold less fit during a competitive infection with WT bacteria in the mouse model (<xref rid="B99" ref-type="bibr">99</xref>). Further, bacteria complemented with a SliC S83A/K103A mutant were also significantly attenuated during competitive infections (<xref rid="B99" ref-type="bibr">99</xref>). <italic toggle="yes">In vitro</italic> adhesion and invasion assays revealed no difference between &#916;<italic toggle="yes">sliC</italic> and WT bacteria, which indicated that the attenuation observed in the mouse was not due to defects in the mutant's ability to adhere to or invade epithelial cells. Finally, &#916;<italic toggle="yes">sliC</italic> bacteria were as fit as WT during competitive infections in a lysozyme-deficient mouse, which provided conclusive evidence that the inhibitory activity of SliC against host lysozyme is critical for gonococcal colonization (<xref rid="B99" ref-type="bibr">99</xref>).</p><p>Substrate binding components of ABC transporters may be localized to the outer surface and may contribute to cell adherence (<xref rid="B186" ref-type="bibr">186</xref>, <xref rid="B187" ref-type="bibr">187</xref>). MetQ from <italic toggle="yes">Ng</italic> was therefore assessed for its ability to mediate bacterial adhesion and invasion of cervical epithelial cells. Gonococci lacking MetQ exhibited a 2.4-fold decrease in adherence and a 1.5-fold lower level of invasion compared to the wild type strain. These findings were comparable to the level of adherence and invasion within transformed primary cervical epithelial cells (<xref rid="B106" ref-type="bibr">106</xref>). Additionally, bacterial survival in primary monocytes and macrophages was evaluated, to determine whether MetQ exerts a protective role against immune cells or other similar factors. Cells lacking MetQ displayed a 2.3-fold reduction of viability in primary monocytes and a 1.5-fold decline in macrophages. MetQ-deficient gonococci were also significantly attenuated upon exposure to human serum (<xref rid="B106" ref-type="bibr">106</xref>). The results of this study indicated MetQ, in addition to its role as a methionine transport protein, contributes to the ability of <italic toggle="yes">Ng</italic> to adhere to and invade epithelial cells and protects against the innate immune system.</p><p>The study of vaccine candidates' contributions to bacterial pathogenesis benefits vaccine development by revealing potential vulnerabilities that can be exploited through rational vaccine design to cripple the invading bacterial pathogen.</p></sec><sec id="s8"><title>Structure of Proteomic-derived Antigens</title><p>Structure-based antigen design offers new possibilities in vaccine development and improvement by delivering novel immunogens and informing about protective epitopes (<xref rid="B188" ref-type="bibr">188</xref>). This approach, in combination with sequencing data and computational biology studies (<xref rid="B189" ref-type="bibr">189</xref>), can drive rational optimization of vaccines as we discussed above (Figure <xref ref-type="fig" rid="F2">2</xref>). In this section, we will focus on summarizing structural investigations that have been performed on our proteome-derived vaccine candidates. To this end, only the structures of <italic toggle="yes">Ng</italic> BamA and BamE have been solved (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B190" ref-type="bibr">190</xref>). However, <italic toggle="yes">Nm</italic> crystal structures of MetQ and ZnuD are available in addition to LptD, BamA, BamE, and TamA obtained from different bacterial species, all of which provide information about antigen architecture and conformational conservation.</p><p>The first BamA crystal structure was solved from <italic toggle="yes">Ng</italic> and revealed a 16-strand &#946;-barrel domain within the outer membrane, connected to five N-terminal periplasmic polypeptide transport-associated (POTRA) domains [Figure <xref ref-type="fig" rid="F3">3A</xref>; (<xref rid="B190" ref-type="bibr">190</xref>)]. The BamA crystal structure from <italic toggle="yes">E. coli</italic> displayed a high level of flexibility between POTRA<sub>5</sub> and the &#946;-barrel domain, suggesting that the POTRA domains assist in transferring the substrate to the &#946;-barrel domain of BamA (<xref rid="B191" ref-type="bibr">191</xref>). A prominent difference was found in BamA conformation in <italic toggle="yes">Ng</italic> compared to BamA in <italic toggle="yes">Haemophilus ducreyi</italic>, where the last &#946;-strands within the barrel are tightly meshed with hydrogen bonds, providing more rigidity. However, in <italic toggle="yes">Ng</italic>, the last &#946;-strand is bound to the first by only two hydrogen bonds, which allows the pore itself to twist. The POTRA<sub>5</sub> domain of BamA in <italic toggle="yes">Ng</italic> is positioned closely to the barrel, with periplasmic loops 3, 4, 5, and 7 stabilizing the closed conformation. This is highly different in <italic toggle="yes">H. ducreyi</italic>, as the POTRA region hinges outwards ~70&#176;, which does not allow POTRA<sub>5</sub> to interact with the &#946;-barrel periplasmic loops (<xref rid="B190" ref-type="bibr">190</xref>). The difference in the interaction between POTRA<sub>5</sub> and the &#946;-barrel may act as a secondary mechanism to prevent unregulated solute entry into the pore and may compensate for the lack of hydrogen bonding in <italic toggle="yes">Ng</italic> BamA. Further analysis of the <italic toggle="yes">Ng</italic> BamA crystal structure revealed the hydrophobic belt along the C-terminal strand was narrower (~9&#197;) than the opposite side of the barrel [~20 &#197;; (<xref rid="B190" ref-type="bibr">190</xref>)]. The authors of this study hypothesize that this reduced width may disrupt the lipid membrane environment and act to allow easier insertion of the OMP into the membrane (<xref rid="B190" ref-type="bibr">190</xref>). Based on the configuration of BamA, two hypotheses have been proposed for the mechanism of OMP folding and insertion, depending on the complexity of the substrate protein. Complex proteins take advantage of a lateral opening event facilitated by a conformational switch of loop 6 and the gating motion of the POTRA domains. The nascent OMP is threaded through the &#946;-barrel and uses exposed strands of BamA as a template for proper barrel formation through a transient OMP-BamA complex until the new OMP buds off into the OM. Simple substrates may bypass the BamA &#946;-barrel completely and may be inserted directly into the destabilized portions of the membrane through their interactions with the POTRA domains (<xref rid="B190" ref-type="bibr">190</xref>). Recent studies suggest that OMP binding to BamD induces conformational changes in the extracellular loops of BamA for substrate folding and membrane insertion (<xref rid="B192" ref-type="bibr">192</xref>). Thus, antibodies against these extracellular loops may interfere with proper OM biogenesis and cause severe downstream effects to OM integrity.</p><p>Gonococcal BamE includes a lipoprotein signal peptide, as well as a predicted SmpA_OmlA domain [Figure <xref ref-type="fig" rid="F3">3G</xref>; (<xref rid="B193" ref-type="bibr">193</xref>)] In <italic toggle="yes">E. coli</italic>, X-ray crystallography showed BamE interacts exclusively with BamA, and does not contact other accessory lipoproteins. Instead, BamE directly assists OMP folding through its interaction with BamA. In contrast to <italic toggle="yes">E. coli</italic>, where the native form of BamE appears to be a periplasmic monomer (<xref rid="B194" ref-type="bibr">194</xref>), <italic toggle="yes">Ng</italic> BamE is a surface-exposed dimer that also includes an additional C-terminal helix not present in other solved structures of BamE (<xref rid="B79" ref-type="bibr">79</xref>). Isolation of proteins from native membranes should definitively establish which conformation is the active state. The dimeric form of BamE possesses structural homology to &#946;-lactamase inhibitors, which has led to the hypothesis that BamE has a secondary function as a &#946;-lactamase inhibitor (<xref rid="B195" ref-type="bibr">195</xref>, <xref rid="B196" ref-type="bibr">196</xref>). Surface-exposed dimers of BamE in <italic toggle="yes">Ng</italic> may therefore act as a first line of defense against &#946;-lactam antimicrobials. In support of this secondary function of BamE, <italic toggle="yes">Ng</italic> &#916;<italic toggle="yes">bamE</italic> mutants were more sensitive to several different &#946;-lactam antimicrobials (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B147" ref-type="bibr">147</xref>). Further investigation will be required to determine whether BamE contributes to antibiotic resistance. If BamE does in fact possess dual functions, a neutralizing immune response could both interfere with OM integrity as well as enhance antibacterial efficacy.</p><p>Autotransporter biogenesis relies on a passenger-transport complex to assist in the translocation of autotransporters across the outer membrane. The translocation and assembly module (TAM) comprises a two-membrane complex containing a &#946;-barrel OMP TamA and inner membrane protein TamB, a nanomachine required for virulence of pathogenic bacteria [Figure <xref ref-type="fig" rid="F4">4</xref>; (<xref rid="B197" ref-type="bibr">197</xref>)]. This complex facilitates the folding and insertion of the autotransporter domain and has been hypothesized to assist in proper effector domain folding. Effector domains are responsible for protein activity and frequently contribute to virulence (<xref rid="B198" ref-type="bibr">198</xref>). Consistent with its role in translocation, TamA contains a &#946;-barrel structure homologous to BamA (<xref rid="B199" ref-type="bibr">199</xref>) and has been hypothesized to be the result of a duplication event that arose from the evolutionary convergence of BamA and TamB (<xref rid="B200" ref-type="bibr">200</xref>). In <italic toggle="yes">E.coli</italic>, the TamA structure was determined at 2.25 &#197; resolution, revealing a sixteen stranded &#946;-barrel ring structure from amino acids 265-577 on the C-terminus, and three POTRA domains between amino acids 22-264 on the N-terminus [Figure <xref ref-type="fig" rid="F3">3</xref>; (<xref rid="B201" ref-type="bibr">201</xref>)]. The POTRA domains wind ~50&#197;, oriented toward the periplasm in a semi-circle arrangement (<xref rid="B201" ref-type="bibr">201</xref>). The initial contact between substrate and TamA is facilitated by interactions between TamB and the POTRA domains, which act as a hinge mechanism (<xref rid="B197" ref-type="bibr">197</xref>, <xref rid="B200" ref-type="bibr">200</xref>). Additional crystal structure analysis showed a kink in the C-terminal &#946;-strand pointing inward, which weakened the lateral wall, implying a possible gate for substrates to route toward the lipid bilayer (<xref rid="B201" ref-type="bibr">201</xref>). The kink resulted in a weak &#946;-strand pair of strand 1 and 16, because of three main chain hydrogen bonds. The kink on &#946;-strand 16 results in a large gap between the ends of strands 1 and 15 near the POTRA<sub>3</sub> attachment site. This cleft promotes insertion of the substrate, mediated by interactions between the &#946;-barrel and the POTRA domains. The folding and insertion process is hypothesized to begin when an autotransporter's &#946;-barrel domain engages with POTRA<sub>3</sub> within the periplasm and is guided toward the barrel of TamA. The structure of TamA also includes a closed extracellular lid from amino acids 456-495. Salt bridge interactions between the lid and the &#946;-barrel are mediated by Arg477 in the lid and Asp521 in the barrel (<xref rid="B201" ref-type="bibr">201</xref>). Targeting the epitopes responsible for stabilizing the interaction between lid and &#946;-barrel with an immune response could interfere with proper TamA function.</p><p>The crystal structures of the core LPS assembly LptDE protein complexes from several bacteria, including medically important pathogens, have been obtained, with only two full-length structures of <italic toggle="yes">Shigella flexneri</italic> and <italic toggle="yes">Klebsiella pneumoniae</italic> LptDE (<xref rid="B167" ref-type="bibr">167</xref>, <xref rid="B202" ref-type="bibr">202</xref>). Overall, these studies revealed a strong structural conservation of the two-protein plug and barrel assembly and demonstrated that LptE was integrated within the 26-stranded, C-shaped &#946;-barrel architecture of LptD. All LptDE structures have a negatively charged lumen which may facilitate LPS/LOS insertion (<xref rid="B202" ref-type="bibr">202</xref>). Additionally, LptD contains a periplasmic &#946;-jellyroll domain, which is structurally similar to LptA and facilitates LPS/LOS transit through the periplasm [Figure <xref ref-type="fig" rid="F3">3C</xref>; (<xref rid="B167" ref-type="bibr">167</xref>)]. The N terminal domain of LptD undergoes a 21&#176; rotation, which may aid assembly or influence flexibility of the LptCAD scaffold (<xref rid="B202" ref-type="bibr">202</xref>). The LptD &#946;-barrel is large compared to other &#946;-barrel OMPs. Its dimensions accommodate large substrates and facilitate efficient transport. Further, a kink was present in the first two &#946;-strands of the &#946;-barrel due to two proline residues in &#946;1 and &#946;2 (<xref rid="B167" ref-type="bibr">167</xref>), and they have been experimentally verified to play a pivotal function in the lateral opening of the barrel (<xref rid="B202" ref-type="bibr">202</xref>). The interaction between LptD and LptE is dependent on polar connections within the LptD &#946;-barrel inner cavity; thus, LptE supports LptD structural maintenance, as well as export of LPS to the outer leaflet. Disruption of the interaction between LptD and LptE would be catastrophic to proper Lpt complex function (<xref rid="B167" ref-type="bibr">167</xref>). Due to the significance of LOS, immune system interference with LptD, and thus LOS transport, would severely alter gonococcal CE composition, weakening the bacterium and reducing its pathogenic capabilities.</p><p>The crystal structure of the outer membrane component of the MlaA-F system, MlaA, was recently attained from X-ray crystallography of MlaA proteins from <italic toggle="yes">Serratia marcescens</italic> and <italic toggle="yes">K. pneumoniae</italic>. MlaA is a monomeric &#945;-helical OMP. Its six amphipathic &#945;-helices facilitate the transport of polar phospholipid headgroups while residing within the hydrophobic interior of the outer membrane. The structure of MlaA allows diffusion of outer leaflet phospholipids exclusively (<xref rid="B170" ref-type="bibr">170</xref>). It is unclear how the phospholipid is transferred to MlaC, as the MlaA pore does not appear to permit the passage of acyl chains. Interactions between MlaA and MlaC have been hypothesized to induce a conformational change in MlaA, potentially by shifting helix 6 through a gate opening mechanism to enable phospholipid transfer to occur (<xref rid="B170" ref-type="bibr">170</xref>). <italic toggle="yes">K. pneumoniae</italic> and <italic toggle="yes">S. marcescens</italic> MlaA proteins were found in complex with the outer membrane pore OmpF in a 3:3 or a 1:3 ratio, respectively (<xref rid="B170" ref-type="bibr">170</xref>). The MlaA-porin interplay, mediated by van der Waals interactions, does not appear to significantly influence porin, although the presence of the porin appears to prevent MlaA aggregation (<xref rid="B170" ref-type="bibr">170</xref>). Normal function is based on proper architecture of the interaction and linkage of these two proteins. Targeting the maintenance of OM lipid asymmetry through a vaccine could sensitize bacteria to components of the immune system that target the outer membrane.</p><p><italic toggle="yes">Neisserial</italic> MetQ was originally believed to bind to D-methionine (<xref rid="B203" ref-type="bibr">203</xref>, <xref rid="B204" ref-type="bibr">204</xref>). However, structural elucidation from <italic toggle="yes">Nm</italic> revealed L-methionine in the binding pocket, which could not be displaced, even when the protein was heterologously expressed in <italic toggle="yes">E. coli</italic> in minimal medium containing only D-methionine. In support of these findings, and in contrast to the protein's annotation as a D-methionine binding protein, concrete data indicate that D-amino acids are not incorporated into proteins during ribosomal synthesis; L-amino acids are required (<xref rid="B205" ref-type="bibr">205</xref>). Biologically, aminoacyl-tRNA synthetases distinguish cognate L-amino acids against noncognate proteinogenic L-amino acids and also nonproteinogenic D-amino acids, thus regulating components for protein biosynthesis (<xref rid="B206" ref-type="bibr">206</xref>). However, <italic toggle="yes">E. coli</italic> MetQ is able to bind both D- and L-enantiomers with high affinity (<xref rid="B207" ref-type="bibr">207</xref>). Structural comparisons revealed similarities between <italic toggle="yes">Nm</italic> MetQ and L-methionine binding protein Tp32 from <italic toggle="yes">Treponema pallidum</italic> as well as the dipeptide GlyMet-binding protein Pg110 from <italic toggle="yes">Staphylococcus aureus</italic>, despite low sequence similarity (<xref rid="B204" ref-type="bibr">204</xref>). <italic toggle="yes">Nm</italic> MetQ is made up of 15 alpha helices and 10 &#946;-strands, split into two domains, I and II, corresponding to residues 43-119 and 236-281; and 120-235, respectively. The two domains are connected by a hinge region and display a Venus flytrap-like structure, which is typical of periplasmic substrate binding proteins. The methionine binding site is within the crevasse of these two globular lobes (<xref rid="B204" ref-type="bibr">204</xref>). Residues critical for proper methionine coordination within the binding pocket include Arg156, which forms a salt bridge with the carboxyl group of L-methionine; Asn215, which forms one of two hydrogen bonds to the nitrogen of L-methionine; and Asn 238, which forms the second hydrogen bond and appears to be responsible for the stereospecificity of <italic toggle="yes">Neisserial</italic> MetQ (<xref rid="B204" ref-type="bibr">204</xref>). MetQ is a surface-displayed lipoprotein (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B106" ref-type="bibr">106</xref>) and thus it remains to be elucidated how L-methinonine is transported through the periplasm to the inner membrane (Figure <xref ref-type="fig" rid="F4">4</xref>).</p><p>The structure of ZnuD, a member of the TonB-dependent receptor (TbdR) family, was first crystalized in <italic toggle="yes">Nm</italic> by single isomorphous replacement, combined with opposing signals for native and seleno-derived ZnuD crystals (<xref rid="B181" ref-type="bibr">181</xref>). The crystal structure of ZnuD revealed a 22-stranded &#946;-barrel pore architecture similar to that of siderophore domains common to the TbdR family, which includes the amino-terminal plug domain between residues 1-147 and its pore-forming domain from residues 148-734 on the carboxyl terminus [Figure <xref ref-type="fig" rid="F3">3E</xref>; (<xref rid="B181" ref-type="bibr">181</xref>)]. The plug domain of ZnuD is required for normal function of TonB in the inner membrane. In contrast to most TbdR proteins, which are involved in iron and cobalamin uptake, ZnuD was the first zinc TbdR structure solved (<xref rid="B208" ref-type="bibr">208</xref>). Due to the importance of metal co-factor acquisition, other gram-negative bacteria like <italic toggle="yes">E.coli</italic> use ZnuD ABC transporters to overcome zinc-deficient conditions (<xref rid="B209" ref-type="bibr">209</xref>). A key feature of meningococcal ZnuD is the extracellular loops. These loops are arranged in a way that displays a &#8220;comb&#8221; scaffold, allowing the uptake of zinc. Substrate binding can induce multiple conformational changes that are reversed upon zinc release (<xref rid="B181" ref-type="bibr">181</xref>). Key residues assisting in coordination of the zinc ion are Asp99, His100, Glu340 and His499. All four residues are highly conserved within the binding pocket across three intermediate structures (native ZnuD, ZnuD co-crystallized with cadmium, and ZnuD soaked with zinc). The binding pocket is sealed through interactions between the apical loop of the plug and extracellular loop 6. Due to the flexibility of ZnuD, remodeling of the alpha helices and &#946;-strands occurs throughout different binding states. Zinc transport through the &#946;-barrel channel usually requires TonB activation (<xref rid="B181" ref-type="bibr">181</xref>). Molecular dynamic simulations found TonB exclusively interacts with the plug domain, which is unfolded upon TonB activation (<xref rid="B181" ref-type="bibr">181</xref>). Further investigation using X-ray absorption spectroscopy was performed to determine whether ZnuD specifically binds zinc, or if it interacts with heme as well (<xref rid="B181" ref-type="bibr">181</xref>). Superimposition of the ZnuD crystal framework with the hemophore receptor HasR found a similar &#8220;lock-key&#8221; feature, although ZnuD was determined not to be a heme uptake protein (<xref rid="B181" ref-type="bibr">181</xref>, <xref rid="B210" ref-type="bibr">210</xref>). Importantly, meningococcal ZnuD stimulates a bactericidal antibody response that recognizes peptides 233-309, 430-459, and 706-722. These peptides correspond to extracellular loops 3, 6, and 11. Loop 3 is the most immunogenic and performs a pivotal role in blocking access to the zinc binding pocket. A secondary feature of loop 3 is that it shifts to a rigid &#946;-strand conformation upon zinc binding and back to a flexible alpha helix when the substrate is released (<xref rid="B181" ref-type="bibr">181</xref>). Despite the significant <italic toggle="yes">Nm</italic> ZnuD conformational changes observed upon zinc binding, its ability to elicit bactericidal antibodies suggests it may be an appropriate vaccine candidate for gonorrhea as well.</p><p>The structural studies we have discussed here not only give context to the function of our proteome-derived vaccine candidates, but also give insights into critical, surface-exposed portions of the proteins that can be targeted through structural vaccinology approaches.</p></sec><sec id="s9"><title>Concluding Remarks</title><list list-type="bullet"><list-item><p>Proteomics-driven vaccinology for gonorrhea has begun to deliver novel antigens and determined the contents of NeMVs from four different <italic toggle="yes">Ng</italic> isolates, which can further inform the vaccine development and manufacturing processes.</p></list-item><list-item><p>Proteomics-driven antigen discovery should be paired with comprehensive bioinformatic analyses to enable more informed decisions for rational development of subunit vaccines and facilitate the inclusion of highly conserved surface-exposed proteins with important functions.</p></list-item><list-item><p>Our proposed approach to vaccine candidate evaluation may facilitate development of the most effective vaccine against gonorrhea in a systematic and cost-effective way suitable for an academic setting.</p></list-item><list-item><p>The proteomics-derived antigens described participate in essential CE processes as well as pathogenesis. A subunit vaccine composed of several of these antigens has the potential to severely compromise <italic toggle="yes">Ng</italic> fitness.</p></list-item><list-item><p>Our discovery of SliC as a previously uncharacterized virulence factor illustrates that new lessons can still be learned about <italic toggle="yes">Ng</italic> biology and also highlights the importance of considering that infection occurs in a living host and involves numerous elements that cannot be replicated <italic toggle="yes">in vitro</italic>.</p></list-item><list-item><p>Structural vaccinology for gonorrhea is in its infancy and thus enhanced efforts should be dedicated to solving structures of all potential vaccine candidates.</p></list-item></list></sec><sec id="s10"><title>Author Contributions</title><p>FM, BB, and AS wrote the manuscript. BB and AS made final edits. AS provided illustrations.</p><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling Editor declared a past co-authorship with one of the authors AS.</p></sec></sec></body><back><fn-group><fn id="fn0001"><p><sup>1</sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/SignalP/">http://www.cbs.dtu.dk/services/SignalP/</ext-link></p></fn><fn id="fn0002"><p><sup>2</sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/LipoP/">http://www.cbs.dtu.dk/services/LipoP/</ext-link></p></fn><fn id="fn0003"><p><sup>3</sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/COG/">https://www.ncbi.nlm.nih.gov/COG/</ext-link></p></fn><fn id="fn0004"><p><sup>4</sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubmlst.org/neisseria/">https://pubmlst.org/neisseria/</ext-link></p></fn><fn id="fn0005"><p><sup>5</sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/TMHMM/">http://www.cbs.dtu.dk/services/TMHMM/</ext-link></p></fn><fn id="fn0006"><p><sup>6</sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.biomerieux-usa.com/clinical/etest">http://www.biomerieux-usa.com/clinical/etest</ext-link></p></fn><fn id="fn0007"><p><sup>7</sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://biolog.com/products-portfolio-overview/phenotype-microarrays-for-microbial-cells/">https://biolog.com/products-portfolio-overview/phenotype-microarrays-for-microbial-cells/</ext-link></p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> Funding was provided to AS by grant R01-AI117235 from the National Institute of Allergy &amp; Infectious Diseases, National Institutes of Health.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newman</surname><given-names>L</given-names></name><name name-style="western"><surname>Rowley</surname><given-names>J</given-names></name><name name-style="western"><surname>Vander Hoorn</surname><given-names>S</given-names></name><name name-style="western"><surname>Wijesooriya</surname><given-names>NS</given-names></name><name name-style="western"><surname>Unemo</surname><given-names>M</given-names></name><name name-style="western"><surname>Low</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting</article-title>. <source>PLoS ONE</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0143304</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0143304</pub-id><pub-id pub-id-type="pmid">26646541</pub-id><pub-id pub-id-type="pmcid">PMC4672879</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farley</surname><given-names>TA</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>DA</given-names></name><name name-style="western"><surname>Elkins</surname><given-names>W</given-names></name></person-group>. <article-title>Asymptomatic sexually transmitted diseases: the case for screening</article-title>. <source>Prev Med</source> (<year>2003</year>) <volume>36</volume>:<fpage>502</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-7435(02)00058-0</pub-id><pub-id pub-id-type="pmid">12649059</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Creighton</surname><given-names>S</given-names></name></person-group><article-title>Gonorrhoea</article-title>. <source>BMJ Clin Evid</source>. (<year>2011</year>) <volume>1604</volume>:<fpage>1</fpage>&#8211;<lpage>11</lpage>.<pub-id pub-id-type="pmcid">PMC3275146</pub-id><pub-id pub-id-type="pmid">21401969</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group> (<year>2011</year>). <source>Prevalence and Incidence of Selected Sexually Transmitted Infections. Chlamydia Trachomatis, Neisseria Gonorrhoeae, Syphilis and Trichomonas vaginalis. Methods and Results Used by WHO to Generate 2005 Estimates</source>. <publisher-name>WHO</publisher-name>, <fpage>36</fpage>.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yvert</surname><given-names>F</given-names></name><name name-style="western"><surname>Frost</surname><given-names>E</given-names></name><name name-style="western"><surname>Walter</surname><given-names>P</given-names></name><name name-style="western"><surname>Gass</surname><given-names>R</given-names></name><name name-style="western"><surname>Ivanoff</surname><given-names>B</given-names></name></person-group>. <article-title>Prepartal infection of the placenta with <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>Genitourin Med</source>. (<year>1985</year>) <volume>61</volume>:<fpage>103</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/sti.61.2.103</pub-id><pub-id pub-id-type="pmid">3920141</pub-id><pub-id pub-id-type="pmcid">PMC1011776</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>JL</given-names></name><name name-style="western"><surname>Apicella</surname><given-names>MA</given-names></name></person-group>. <article-title>The molecular mechanisms used by <italic toggle="yes">Neisseria gonorrhoeae</italic> to initiate infection differ between men and women</article-title>. <source>Clin Microbiol Rev.</source> (<year>2004</year>) <volume>17</volume>:<fpage>965</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.17.4.965-981.2004</pub-id><pub-id pub-id-type="pmid">15489357</pub-id><pub-id pub-id-type="pmcid">PMC523569</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coutanceau</surname><given-names>B</given-names></name><name name-style="western"><surname>Boujenah</surname><given-names>J</given-names></name><name name-style="western"><surname>Poncelet</surname><given-names>C</given-names></name></person-group>. <article-title>Gonococcal chorioamnionitis with antepartum fetal death <italic toggle="yes">in utero</italic></article-title>. <source>Case Rep Obstet Gynecol</source>. (<year>2015</year>) <volume>2015</volume>:<fpage>451247</fpage>. <pub-id pub-id-type="doi">10.1155/2015/451247</pub-id><pub-id pub-id-type="pmid">26114001</pub-id><pub-id pub-id-type="pmcid">PMC4465688</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woods</surname><given-names>CR</given-names></name></person-group>. <article-title>Gonococcal infections in neonates and young children</article-title>. <source>Semin Pediatr Infect Dis</source> (<year>2005</year>) <volume>16</volume>:<fpage>258</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1053/j.spid.2005.06.006</pub-id><pub-id pub-id-type="pmid">16210106</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Stringer</surname><given-names>VA</given-names></name><name name-style="western"><surname>Shafer</surname><given-names>WM</given-names></name></person-group>. <article-title>Off-target gene regulation mediated by transcriptional repressors of antimicrobial efflux pump genes in <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>Antimicrob Agents Chemother</source>. (<year>2011</year>) <volume>55</volume>:<fpage>2559</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00010-11</pub-id><pub-id pub-id-type="pmid">21422217</pub-id><pub-id pub-id-type="pmcid">PMC3101402</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>MF</given-names></name></person-group>. <article-title>The surgical pathology of epididymitis</article-title>. <source>Ann Surg</source>. (<year>1928</year>) <volume>88</volume>:<fpage>98</fpage>&#8211;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1097/00000658-192807000-00012</pub-id><pub-id pub-id-type="pmid">17865928</pub-id><pub-id pub-id-type="pmcid">PMC1398599</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trojian</surname><given-names>TH</given-names></name><name name-style="western"><surname>Lishnak</surname><given-names>TS</given-names></name><name name-style="western"><surname>Heiman</surname><given-names>D</given-names></name></person-group>. <article-title>Epididymitis and orchitis: an overview</article-title>. <source>Am Fam Physician</source> (<year>2009</year>) <volume>79</volume>:<fpage>583</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="pmid">19378875</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>SN</given-names></name></person-group>. <article-title>Epididymitis</article-title>. <source>Clin Infect Dis.</source> (<year>2015</year>) <volume>61</volume>(<issue>Suppl. 8</issue>):<fpage>S770</fpage>&#8211;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1093/cid/civ812</pub-id><pub-id pub-id-type="pmid">26602616</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miettinen</surname><given-names>A</given-names></name><name name-style="western"><surname>Heinonen</surname><given-names>PK</given-names></name><name name-style="western"><surname>Teisala</surname><given-names>K</given-names></name><name name-style="western"><surname>Hakkarainen</surname><given-names>K</given-names></name><name name-style="western"><surname>Punnonen</surname><given-names>R</given-names></name></person-group>. <article-title>Serologic evidence for the role of <italic toggle="yes">Chlamydia trachomatis, Neisseria gonorrhoeae</italic>, and <italic toggle="yes">Mycoplasma hominis</italic> in the etiology of tubal factor infertility and ectopic pregnancy</article-title>. <source>Sex Transm Dis</source>. (<year>1990</year>) <volume>17</volume>:<fpage>10</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1097/00007435-199017010-00003</pub-id><pub-id pub-id-type="pmid">2106171</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tapsall</surname><given-names>JW</given-names></name></person-group>. <article-title>Antibiotic resistance in <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>Clin Infect Dis.</source> (<year>2005</year>) <volume>41</volume>(<issue>Suppl. 4</issue>):<fpage>S263</fpage>&#8211;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1086/430787</pub-id><pub-id pub-id-type="pmid">16032562</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unemo</surname><given-names>M</given-names></name><name name-style="western"><surname>Shafer</surname><given-names>WM</given-names></name></person-group>. <article-title>Antimicrobial resistance in <italic toggle="yes">Neisseria gonorrhoeae</italic> in the 21st century: past, evolution, and future</article-title>. <source>Clin Microbiol Rev</source>. (<year>2014</year>) <volume>27</volume>:<fpage>587</fpage>&#8211;<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00010-14</pub-id><pub-id pub-id-type="pmid">24982323</pub-id><pub-id pub-id-type="pmcid">PMC4135894</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unemo</surname><given-names>M</given-names></name><name name-style="western"><surname>Del Rio</surname><given-names>C</given-names></name><name name-style="western"><surname>Shafer</surname><given-names>WM</given-names></name></person-group>. <article-title>Antimicrobial resistance expressed by <italic toggle="yes">Neisseria gonorrhoeae</italic>: a major global public health problem in the 21st century</article-title>. <source>Microbiol Spectr</source>. (<year>2016a</year>) <volume>4</volume>:<fpage>213</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1128/microbiolspec.EI10-0009-2015</pub-id><pub-id pub-id-type="pmid">27337478</pub-id><pub-id pub-id-type="pmcid">PMC4920088</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>CDC</collab></person-group><source>Gonococcal Infections - 2015 STD Treatment Guidelines</source> [Online]. (<year>2015</year>). Available online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/std/tg2015/gonorrhea.htm">https://www.cdc.gov/std/tg2015/gonorrhea.htm</ext-link></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Workowski</surname><given-names>KA</given-names></name></person-group>. <article-title>Centers for disease control and prevention sexually transmitted diseases treatment guidelines</article-title>. <source>Clin Infect Dis</source>. (<year>2015</year>) <volume>61</volume>(<issue>Suppl. 8</issue>):<fpage>S759</fpage>&#8211;<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1093/cid/civ771</pub-id><pub-id pub-id-type="pmid">26602614</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fifer</surname><given-names>H</given-names></name><name name-style="western"><surname>Natarajan</surname><given-names>U</given-names></name><name name-style="western"><surname>Jones</surname><given-names>L</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>S</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>G</given-names></name><name name-style="western"><surname>Golparian</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Failure of dual antimicrobial therapy in treatment of gonorrhea</article-title>. <source>N Engl J Med</source>. (<year>2016</year>) <volume>374</volume>:<fpage>2504</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc1512757</pub-id><pub-id pub-id-type="pmid">27332921</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wi</surname><given-names>T</given-names></name><name name-style="western"><surname>Lahra</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ndowa</surname><given-names>F</given-names></name><name name-style="western"><surname>Bala</surname><given-names>M</given-names></name><name name-style="western"><surname>Dillon</surname><given-names>JR</given-names></name><name name-style="western"><surname>Ramon-Pardo</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Antimicrobial resistance in <italic toggle="yes">Neisseria gonorrhoeae</italic>: global surveillance and a call for international collaborative action</article-title>. <source>PLoS Med</source>. (<year>2017</year>) <volume>14</volume>:<fpage>e1002344</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002344</pub-id><pub-id pub-id-type="pmid">28686231</pub-id><pub-id pub-id-type="pmcid">PMC5501266</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenberg</surname><given-names>L</given-names></name><name name-style="western"><surname>Diena</surname><given-names>BB</given-names></name><name name-style="western"><surname>Ashton</surname><given-names>FA</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>R</given-names></name><name name-style="western"><surname>Kenny</surname><given-names>CP</given-names></name><name name-style="western"><surname>Znamirowski</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Gonococcal vaccine studies in Inuvik</article-title>. <source>Can J Public Health</source> (<year>1974</year>) <volume>65</volume>:<fpage>29</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="pmid">4205640</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenberg</surname><given-names>L</given-names></name></person-group>. <article-title>Field trials of a gonococcal vaccine</article-title>. <source>J Reprod Med</source>. (<year>1975</year>) <volume>14</volume>:<fpage>34</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="pmid">1089158</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boslego</surname><given-names>JW</given-names></name><name name-style="western"><surname>Tramont</surname><given-names>EC</given-names></name><name name-style="western"><surname>Chung</surname><given-names>RC</given-names></name><name name-style="western"><surname>McChesney</surname><given-names>DG</given-names></name><name name-style="western"><surname>Ciak</surname><given-names>J</given-names></name><name name-style="western"><surname>Sadoff</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>Efficacy trial of a parenteral gonococcal pilus vaccine in men</article-title>. <source>Vaccine</source> (<year>1991</year>) <volume>9</volume>:<fpage>154</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/0264-410X(91)90147-X</pub-id><pub-id pub-id-type="pmid">1675029</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>CE</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><name name-style="western"><surname>Sparling</surname><given-names>PF</given-names></name></person-group>. <article-title>Vaccines for gonorrhea: can we rise to the challenge?</article-title><source>Front Microbiol</source>. (<year>2011</year>) <volume>2</volume>:<fpage>124</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2011.00124</pub-id><pub-id pub-id-type="pmid">21687431</pub-id><pub-id pub-id-type="pmcid">PMC3109613</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagblom</surname><given-names>P</given-names></name><name name-style="western"><surname>Segal</surname><given-names>E</given-names></name><name name-style="western"><surname>Billyard</surname><given-names>E</given-names></name><name name-style="western"><surname>So</surname><given-names>M</given-names></name></person-group>. <article-title>Intragenic recombination leads to pilus antigenic variation in <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>Nature</source> (<year>1985</year>) <volume>315</volume>:<fpage>156</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/315156a0</pub-id><pub-id pub-id-type="pmid">2859529</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haas</surname><given-names>R</given-names></name><name name-style="western"><surname>Veit</surname><given-names>S</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>TF</given-names></name></person-group>. <article-title>Silent pilin genes of <italic toggle="yes">Neisseria gonorrhoeae</italic> MS11 and the occurrence of related hypervariant sequences among other gonococcal isolates</article-title>. <source>Mol Microbiol</source>. (<year>1992</year>) <volume>6</volume>:<fpage>197</fpage>&#8211;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.1992.tb02001.x</pub-id><pub-id pub-id-type="pmid">1347637</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Criss</surname><given-names>AK</given-names></name><name name-style="western"><surname>Kline</surname><given-names>KA</given-names></name><name name-style="western"><surname>Seifert</surname><given-names>HS</given-names></name></person-group>. <article-title>The frequency and rate of pilin antigenic variation in <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>Mol Microbiol</source>. (<year>2005</year>) <volume>58</volume>:<fpage>510</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04838.x</pub-id><pub-id pub-id-type="pmid">16194236</pub-id><pub-id pub-id-type="pmcid">PMC2657081</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hill</surname><given-names>SA</given-names></name><name name-style="western"><surname>Davies</surname><given-names>JK</given-names></name></person-group>. <article-title>Pilin gene variation in <italic toggle="yes">Neisseria gonorrhoeae</italic>: reassessing the old paradigms</article-title>. <source>FEMS Microbiol Rev</source> (<year>2009</year>) <volume>33</volume>:<fpage>521</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6976.2009.00171.x</pub-id><pub-id pub-id-type="pmid">19396954</pub-id><pub-id pub-id-type="pmcid">PMC2753986</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swanson</surname><given-names>J</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>K</given-names></name><name name-style="western"><surname>Barrera</surname><given-names>O</given-names></name><name name-style="western"><surname>Corwin</surname><given-names>D</given-names></name><name name-style="western"><surname>Boslego</surname><given-names>J</given-names></name><name name-style="western"><surname>Ciak</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Gonococcal pilin variants in experimental gonorrhea</article-title>. <source>J Exp Med</source>. (<year>1987a</year>) <volume>165</volume>:<fpage>1344</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1084/jem.165.5.1344</pub-id><pub-id pub-id-type="pmid">3106555</pub-id><pub-id pub-id-type="pmcid">PMC2188307</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swanson</surname><given-names>J</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>K</given-names></name><name name-style="western"><surname>Barrera</surname><given-names>O</given-names></name><name name-style="western"><surname>Koomey</surname><given-names>JM</given-names></name></person-group>. <article-title>Gene conversion variations generate structurally distinct pilin polypeptides in <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>J Exp Med</source>. (<year>1987b</year>) <volume>165</volume>:<fpage>1016</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1084/jem.165.4.1016</pub-id><pub-id pub-id-type="pmid">2435829</pub-id><pub-id pub-id-type="pmcid">PMC2188579</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seifert</surname><given-names>HS</given-names></name><name name-style="western"><surname>Wright</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>MS</given-names></name><name name-style="western"><surname>Cannon</surname><given-names>JG</given-names></name></person-group>. <article-title>Multiple gonococcal pilin antigenic variants are produced during experimental human infections</article-title>. <source>J Clin Invest</source>. (<year>1994</year>) <volume>93</volume>:<fpage>2744</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1172/JCI117290</pub-id><pub-id pub-id-type="pmid">7911129</pub-id><pub-id pub-id-type="pmcid">PMC294533</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Segal</surname><given-names>E</given-names></name><name name-style="western"><surname>Billyard</surname><given-names>E</given-names></name><name name-style="western"><surname>So</surname><given-names>M</given-names></name><name name-style="western"><surname>Storzbach</surname><given-names>S</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>TF</given-names></name></person-group>. <article-title>Role of chromosomal rearrangement in <italic toggle="yes">N. gonorrhoeae</italic> pilus phase variation</article-title>. <source>Cell</source> (<year>1985</year>) <volume>40</volume>:<fpage>293</fpage>&#8211;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(85)90143-6</pub-id><pub-id pub-id-type="pmid">2857113</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rice</surname><given-names>PA</given-names></name><name name-style="western"><surname>Vayo</surname><given-names>HE</given-names></name><name name-style="western"><surname>Tam</surname><given-names>MR</given-names></name><name name-style="western"><surname>Blake</surname><given-names>MS</given-names></name></person-group>. <article-title>Immunoglobulin G antibodies directed against protein III block killing of serum-resistant <italic toggle="yes">Neisseria gonorrhoeae</italic> by immune serum</article-title>. <source>J Exp Med</source>. (<year>1986</year>) <volume>164</volume>:<fpage>1735</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1084/jem.164.5.1735</pub-id><pub-id pub-id-type="pmid">3095479</pub-id><pub-id pub-id-type="pmcid">PMC2188443</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Xie</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Mao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Antibodies with higher bactericidal activity induced by a <italic toggle="yes">Neisseria gonorrhoeae</italic> Rmp deletion mutant strain</article-title>. <source>PLoS ONE</source> (<year>2014</year>) <volume>9</volume>:<fpage>e90525</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0090525</pub-id><pub-id pub-id-type="pmid">24594737</pub-id><pub-id pub-id-type="pmcid">PMC3942440</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kraus</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Brown</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Arko</surname><given-names>RJ</given-names></name></person-group>. <article-title>Acquired and natural immunity to gonococcal infection in chimpanzees</article-title>. <source>J Clin Invest</source>. (<year>1975</year>) <volume>55</volume>:<fpage>1349</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1172/JCI108054</pub-id><pub-id pub-id-type="pmid">805797</pub-id><pub-id pub-id-type="pmcid">PMC301890</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plummer</surname><given-names>FA</given-names></name><name name-style="western"><surname>Simonsen</surname><given-names>JN</given-names></name><name name-style="western"><surname>Chubb</surname><given-names>H</given-names></name><name name-style="western"><surname>Slaney</surname><given-names>L</given-names></name><name name-style="western"><surname>Kimata</surname><given-names>J</given-names></name><name name-style="western"><surname>Bosire</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection</article-title>. <source>J Clin Invest</source>. (<year>1989</year>) <volume>83</volume>:<fpage>1472</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1172/JCI114040</pub-id><pub-id pub-id-type="pmid">2496142</pub-id><pub-id pub-id-type="pmcid">PMC303849</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>KK</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>JC</given-names></name><name name-style="western"><surname>Weiner</surname><given-names>DH</given-names></name><name name-style="western"><surname>Davis</surname><given-names>RH</given-names></name><name name-style="western"><surname>Sparling</surname><given-names>PF</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>MS</given-names></name></person-group>. <article-title>Longitudinal evaluation of serovar-specific immunity to <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>Am J Epidemiol</source>. (<year>1999</year>) <volume>149</volume>:<fpage>353</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a009820</pub-id><pub-id pub-id-type="pmid">10025478</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>KA</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>H</given-names></name><name name-style="western"><surname>Lindstrom</surname><given-names>JA</given-names></name><name name-style="western"><surname>Boslego</surname><given-names>JW</given-names></name><name name-style="western"><surname>Warren</surname><given-names>RA</given-names></name><name name-style="western"><surname>Van de Verg</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers</article-title>. <source>Sex Transm Dis</source>. (<year>2001</year>) <volume>28</volume>:<fpage>555</fpage>&#8211;<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1097/00007435-200110000-00001</pub-id><pub-id pub-id-type="pmid">11689753</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frasch</surname><given-names>CE</given-names></name><name name-style="western"><surname>Borrow</surname><given-names>R</given-names></name><name name-style="western"><surname>Donnelly</surname><given-names>J</given-names></name></person-group>. <article-title>Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease</article-title>. <source>Vaccine</source> (<year>2009</year>) <volume>27</volume>(<issue>Suppl. 2</issue>):<fpage>B112</fpage>&#8211;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.04.065</pub-id><pub-id pub-id-type="pmid">19464093</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Granoff</surname><given-names>DM</given-names></name></person-group>. <article-title>Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease</article-title>. <source>Vaccine</source> (<year>2009</year>) <volume>27</volume>(<issue>Suppl. 2</issue>):<fpage>B117</fpage>&#8211;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.04.066</pub-id><pub-id pub-id-type="pmid">19477054</pub-id><pub-id pub-id-type="pmcid">PMC2751589</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rice</surname><given-names>PA</given-names></name><name name-style="western"><surname>Shafer</surname><given-names>WM</given-names></name><name name-style="western"><surname>Ram</surname><given-names>S</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name></person-group>. <article-title><italic toggle="yes">Neisseria gonorrhoeae</italic>: drug resistance, mouse models, and vaccine development</article-title>. <source>Annu Rev Microbiol</source>. (<year>2017</year>) <volume>71</volume>:<fpage>665</fpage>&#8211;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-micro-090816-093530</pub-id><pub-id pub-id-type="pmid">28886683</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name></person-group>. <article-title>Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice</article-title>. <source>Infect Immun</source>. (<year>1999</year>) <volume>67</volume>:<fpage>5699</fpage>&#8211;<lpage>708</lpage>. <pub-id pub-id-type="pmid">10531218</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.67.11.5699-5708.1999</pub-id><pub-id pub-id-type="pmcid">PMC96944</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Packiam</surname><given-names>M</given-names></name><name name-style="western"><surname>Vonck</surname><given-names>RA</given-names></name><name name-style="western"><surname>Begum</surname><given-names>AA</given-names></name><name name-style="western"><surname>Garvin</surname><given-names>LE</given-names></name></person-group>. <article-title>Estradiol-treated female mice as surrogate hosts for <italic toggle="yes">Neisseria gonorrhoeae</italic> genital tract infections</article-title>. <source>Front Microbiol</source>. (<year>2011</year>) <volume>2</volume>:<fpage>107</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2011.00107</pub-id><pub-id pub-id-type="pmid">21747807</pub-id><pub-id pub-id-type="pmcid">PMC3129519</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><name name-style="western"><surname>Deal</surname><given-names>CD</given-names></name></person-group>. <article-title>Vaccine research for gonococcal infections: where are we?</article-title><source>Sex Transm Infect</source>. (<year>2013</year>) <volume>89</volume>(<issue>Suppl. 4</issue>):<fpage>iv63</fpage>&#8211;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1136/sextrans-2013-051225</pub-id><pub-id pub-id-type="pmid">24243883</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ouyang</surname><given-names>W</given-names></name><name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name></person-group>. <article-title>The biological functions of T helper 17 cell effector cytokines in inflammation</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>28</volume>:<fpage>454</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2008.03.004</pub-id><pub-id pub-id-type="pmid">18400188</pub-id><pub-id pub-id-type="pmcid">PMC3424508</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feinen</surname><given-names>B</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><name name-style="western"><surname>Gaffen</surname><given-names>SL</given-names></name><name name-style="western"><surname>Russell</surname><given-names>MW</given-names></name></person-group>. <article-title>Critical role of Th17 responses in a murine model of <italic toggle="yes">Neisseria gonorrhoeae</italic> genital infection</article-title>. <source>Mucosal Immunol</source>. (<year>2010</year>) <volume>3</volume>:<fpage>312</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2009.139</pub-id><pub-id pub-id-type="pmid">20107432</pub-id><pub-id pub-id-type="pmcid">PMC2857675</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Russell</surname><given-names>MW</given-names></name></person-group>. <article-title>Diversion of the immune response to <italic toggle="yes">Neisseria gonorrhoeae</italic> from Th17 to Th1/Th2 by treatment with anti-transforming growth factor beta antibody generates immunological memory and protective immunity</article-title>. <source>MBio</source> (<year>2011</year>) <volume>2</volume>:<fpage>e00095</fpage>&#8211;<lpage>00011</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.00095-11</pub-id><pub-id pub-id-type="pmid">21610119</pub-id><pub-id pub-id-type="pmcid">PMC3101786</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Islam</surname><given-names>EA</given-names></name><name name-style="western"><surname>Jarvis</surname><given-names>GA</given-names></name><name name-style="western"><surname>Gray-Owen</surname><given-names>SD</given-names></name><name name-style="western"><surname>Russell</surname><given-names>MW</given-names></name></person-group>. <article-title><italic toggle="yes">Neisseria gonorrhoeae</italic> selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-beta-dependent mechanisms</article-title>. <source>Mucosal Immunol</source>. (<year>2012</year>) <volume>5</volume>:<fpage>320</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.12</pub-id><pub-id pub-id-type="pmid">22354319</pub-id><pub-id pub-id-type="pmcid">PMC3328619</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Russell</surname><given-names>MW</given-names></name></person-group>. <article-title>Suppression of host adaptive immune responses by <italic toggle="yes">Neisseria gonorrhoeae</italic>: role of interleukin 10 and type 1 regulatory T cells</article-title>. <source>Mucosal Immunol</source>. (<year>2014</year>) <volume>7</volume>:<fpage>165</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2013.36</pub-id><pub-id pub-id-type="pmid">23757303</pub-id><pub-id pub-id-type="pmcid">PMC3812424</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Escobar</surname><given-names>A</given-names></name><name name-style="western"><surname>Candia</surname><given-names>E</given-names></name><name name-style="western"><surname>Reyes-Cerpa</surname><given-names>S</given-names></name><name name-style="western"><surname>Villegas-Valdes</surname><given-names>B</given-names></name><name name-style="western"><surname>Neira</surname><given-names>T</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>M</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">Neisseria gonorrhoeae</italic> induces a tolerogenic phenotype in macrophages to modulate host immunity</article-title>. <source>Mediators Inflamm</source>. (<year>2013</year>) <volume>2013</volume>:<fpage>127017</fpage>. <pub-id pub-id-type="doi">10.1155/2013/127017</pub-id><pub-id pub-id-type="pmid">24204097</pub-id><pub-id pub-id-type="pmcid">PMC3800590</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortiz</surname><given-names>MC</given-names></name><name name-style="western"><surname>Lefimil</surname><given-names>C</given-names></name><name name-style="western"><surname>Rodas</surname><given-names>PI</given-names></name><name name-style="western"><surname>Vernal</surname><given-names>R</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>M</given-names></name><name name-style="western"><surname>Acu&#241;a-Castillo</surname><given-names>C</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">Neisseria gonorrhoeae</italic> modulates immunity by polarizing human macrophages to a M2 profile</article-title>. <source>PLoS ONE</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0130713</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0130713</pub-id><pub-id pub-id-type="pmid">26125939</pub-id><pub-id pub-id-type="pmcid">PMC4488386</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>LA</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Hobbs</surname><given-names>MM</given-names></name><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name><etal/></person-group>. <article-title>Experimental vaccine induces Th1-driven immune responses and resistance to <italic toggle="yes">Neisseria gonorrhoeae</italic> infection in a murine model</article-title>. <source>Mucosal Immunol</source> (<year>2017a</year>) <volume>10</volume>:<fpage>1594</fpage>&#8211;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2017.11</pub-id><pub-id pub-id-type="pmid">28272393</pub-id><pub-id pub-id-type="pmcid">PMC5591041</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Perez</surname><given-names>J</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>LA</given-names></name><name name-style="western"><surname>Gallagher</surname><given-names>HC</given-names></name><name name-style="western"><surname>De Jesus</surname><given-names>M</given-names></name><name name-style="western"><surname>Egilmez</surname><given-names>NK</given-names></name><etal/></person-group>. <article-title>Intravaginal administration of interleukin 12 during genital gonococcal infection in mice induces immunity to heterologous strains of neisseria gonorrhoeae</article-title>. <source>mSphere</source> (<year>2018</year>) <volume>3</volume>:<fpage>e00421</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/mSphere.00421-17</pub-id><pub-id pub-id-type="pmid">29404418</pub-id><pub-id pub-id-type="pmcid">PMC5793040</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Egilmez</surname><given-names>NK</given-names></name><name name-style="western"><surname>Russell</surname><given-names>MW</given-names></name></person-group>. <article-title>Enhancement of adaptive immunity to <italic toggle="yes">Neisseria gonorrhoeae</italic> by local intravaginal administration of microencapsulated interleukin 12</article-title>. <source>J Infect Dis</source>. (<year>2013</year>) <volume>208</volume>:<fpage>1821</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jit354</pub-id><pub-id pub-id-type="pmid">24048962</pub-id><pub-id pub-id-type="pmcid">PMC3814831</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pizza</surname><given-names>M</given-names></name><name name-style="western"><surname>Scarlato</surname><given-names>V</given-names></name><name name-style="western"><surname>Masignani</surname><given-names>V</given-names></name><name name-style="western"><surname>Giuliani</surname><given-names>MM</given-names></name><name name-style="western"><surname>Arico</surname><given-names>B</given-names></name><name name-style="western"><surname>Comanducci</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing</article-title>. <source>Science</source> (<year>2000</year>) <volume>287</volume>:<fpage>1816</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5459.1816</pub-id><pub-id pub-id-type="pmid">10710308</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name></person-group><article-title>Reverse vaccinology</article-title>. <source>Curr Opin Microbiol</source>. (<year>2000</year>) <volume>3</volume>:<fpage>445</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/S1369-5274(00)00119-3</pub-id><pub-id pub-id-type="pmid">11050440</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tettelin</surname><given-names>H</given-names></name><name name-style="western"><surname>Saunders</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Heidelberg</surname><given-names>J</given-names></name><name name-style="western"><surname>Jeffries</surname><given-names>AC</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>KE</given-names></name><name name-style="western"><surname>Eisen</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Complete genome sequence of <italic toggle="yes">Neisseria meningitidis</italic> serogroup B strain MC58</article-title>. <source>Science</source> (<year>2000</year>) <volume>287</volume>:<fpage>1809</fpage>&#8211;<lpage>1815</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5459.1809</pub-id><pub-id pub-id-type="pmid">10710307</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name></person-group>. <article-title>Reverse vaccinology, a genome-based approach to vaccine development</article-title>. <source>Vaccine</source> (<year>2001</year>) <volume>19</volume>:<fpage>2688</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(00)00554-5</pub-id><pub-id pub-id-type="pmid">11257410</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seib</surname><given-names>KL</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name></person-group>. <article-title>Developing vaccines in the era of genomics: a decade of reverse vaccinology</article-title>. <source>Clin Microbiol Infect.</source> (<year>2012</year>) <volume>18</volume>(<issue>Suppl. 5</issue>):<fpage>109</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2012.03939.x</pub-id><pub-id pub-id-type="pmid">22882709</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Serruto</surname><given-names>D</given-names></name><name name-style="western"><surname>Bottomley</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ram</surname><given-names>S</given-names></name><name name-style="western"><surname>Giuliani</surname><given-names>MM</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name></person-group>. <article-title>The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens</article-title>. <source>Vaccine</source> (<year>2012</year>) <volume>30</volume>(<issue>Suppl. 2</issue>):<fpage>B87</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2012.01.033</pub-id><pub-id pub-id-type="pmid">22607904</pub-id><pub-id pub-id-type="pmcid">PMC3360877</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petousis-Harris</surname><given-names>H</given-names></name><name name-style="western"><surname>Paynter</surname><given-names>J</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>J</given-names></name><name name-style="western"><surname>Saxton</surname><given-names>P</given-names></name><name name-style="western"><surname>McArdle</surname><given-names>B</given-names></name><name name-style="western"><surname>Goodyear-Smith</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study</article-title>. <source>Lancet</source> (<year>2017</year>) <volume>390</volume>:<fpage>1603</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)31449-6</pub-id><pub-id pub-id-type="pmid">28705462</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unemo</surname><given-names>M</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group>. <article-title>Infection: proof of principle for effectiveness of a gonorrhoea vaccine</article-title>. <source>Nat Rev Urol</source> (<year>2017</year>) <volume>14</volume>:<fpage>643</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/nrurol.2017.139</pub-id><pub-id pub-id-type="pmid">28858332</pub-id><pub-id pub-id-type="pmcid">PMC5735823</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Wierzbicki</surname><given-names>IH</given-names></name><name name-style="western"><surname>Weber</surname><given-names>JV</given-names></name><name name-style="western"><surname>Gafken</surname><given-names>PR</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group>. <article-title>Quantitative proteomics of the <italic toggle="yes">Neisseria gonorrhoeae</italic> cell envelope and membrane vesicles for the discovery of potential therapeutic targets</article-title>. <source>Mol Cell Proteomics</source> (<year>2014b</year>) <volume>13</volume>:<fpage>1299</fpage>&#8211;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M113.029538</pub-id><pub-id pub-id-type="pmid">24607996</pub-id><pub-id pub-id-type="pmcid">PMC4014286</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Wierzbicki</surname><given-names>IH</given-names></name><name name-style="western"><surname>Baarda</surname><given-names>BI</given-names></name><name name-style="western"><surname>Gafken</surname><given-names>PR</given-names></name><name name-style="western"><surname>Soge</surname><given-names>OO</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>KK</given-names></name><etal/></person-group>. <article-title>Proteomics-driven antigen discovery for development of vaccines against gonorrhea</article-title>. <source>Mol Cell Proteomics</source> (<year>2016</year>) <volume>15</volume>:<fpage>2338</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M116.058800</pub-id><pub-id pub-id-type="pmid">27141096</pub-id><pub-id pub-id-type="pmcid">PMC4937508</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>BC</given-names></name><name name-style="western"><surname>Czajkowski</surname><given-names>L</given-names></name><name name-style="western"><surname>Hocking</surname><given-names>D</given-names></name><name name-style="western"><surname>Margetts</surname><given-names>M</given-names></name><name name-style="western"><surname>Webb</surname><given-names>E</given-names></name><name name-style="western"><surname>Rothel</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis</article-title>. <source>Vaccine</source> (<year>2001</year>) <volume>19</volume>:<fpage>4135</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(01)00173-6</pub-id><pub-id pub-id-type="pmid">11457538</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wizemann</surname><given-names>TM</given-names></name><name name-style="western"><surname>Heinrichs</surname><given-names>JH</given-names></name><name name-style="western"><surname>Adamou</surname><given-names>JE</given-names></name><name name-style="western"><surname>Erwin</surname><given-names>AL</given-names></name><name name-style="western"><surname>Kunsch</surname><given-names>C</given-names></name><name name-style="western"><surname>Choi</surname><given-names>GH</given-names></name><etal/></person-group>. <article-title>Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection</article-title>. <source>Infect Immun</source>. (<year>2001</year>) <volume>69</volume>:<fpage>1593</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.3.1593-1598.2001</pub-id><pub-id pub-id-type="pmid">11179332</pub-id><pub-id pub-id-type="pmcid">PMC98061</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etz</surname><given-names>H</given-names></name><name name-style="western"><surname>Minh</surname><given-names>DB</given-names></name><name name-style="western"><surname>Henics</surname><given-names>T</given-names></name><name name-style="western"><surname>Dryla</surname><given-names>A</given-names></name><name name-style="western"><surname>Winkler</surname><given-names>B</given-names></name><name name-style="western"><surname>Triska</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Identification of <italic toggle="yes">in vivo</italic> expressed vaccine candidate antigens from <italic toggle="yes">Staphylococcus aureus</italic></article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2002</year>) <volume>99</volume>:<fpage>6573</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.092569199</pub-id><pub-id pub-id-type="pmid">11997460</pub-id><pub-id pub-id-type="pmcid">PMC124444</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montigiani</surname><given-names>S</given-names></name><name name-style="western"><surname>Falugi</surname><given-names>F</given-names></name><name name-style="western"><surname>Scarselli</surname><given-names>M</given-names></name><name name-style="western"><surname>Finco</surname><given-names>O</given-names></name><name name-style="western"><surname>Petracca</surname><given-names>R</given-names></name><name name-style="western"><surname>Galli</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Genomic approach for analysis of surface proteins in <italic toggle="yes">Chlamydia pneumoniae</italic></article-title>. <source>Infect Immun</source>. (<year>2002</year>) <volume>70</volume>:<fpage>368</fpage>&#8211;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.70.1.368-379.2002</pub-id><pub-id pub-id-type="pmid">11748203</pub-id><pub-id pub-id-type="pmcid">PMC127649</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srinivasa Rao</surname><given-names>PS</given-names></name><name name-style="western"><surname>Lim</surname><given-names>TM</given-names></name><name name-style="western"><surname>Leung</surname><given-names>KY</given-names></name></person-group>. <article-title>Functional genomics approach to the identification of virulence genes involved in Edwardsiella tarda pathogenesis</article-title>. <source>Infect Immun</source>. (<year>2003</year>) <volume>71</volume>:<fpage>1343</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.3.1343-1351.2003</pub-id><pub-id pub-id-type="pmid">12595451</pub-id><pub-id pub-id-type="pmcid">PMC148833</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haider</surname><given-names>S</given-names></name><name name-style="western"><surname>Pal</surname><given-names>R</given-names></name></person-group>. <article-title>Integrated analysis of transcriptomic and proteomic data</article-title>. <source>Curr Genomics</source> (<year>2013</year>) <volume>14</volume>:<fpage>91</fpage>&#8211;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.2174/1389202911314020003</pub-id><pub-id pub-id-type="pmid">24082820</pub-id><pub-id pub-id-type="pmcid">PMC3637682</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baarda</surname><given-names>BI</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group>. <article-title>Proteomics of <italic toggle="yes">Neisseria gonorrhoeae</italic>: the treasure hunt for countermeasures against an old disease</article-title>. <source>Front Microbiol</source>. (<year>2015</year>) <volume>6</volume>:<fpage>1190</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.01190</pub-id><pub-id pub-id-type="pmid">26579097</pub-id><pub-id pub-id-type="pmcid">PMC4620152</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doro</surname><given-names>F</given-names></name><name name-style="western"><surname>Liberatori</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodriguez-Ortega</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Rinaudo</surname><given-names>CD</given-names></name><name name-style="western"><surname>Rosini</surname><given-names>R</given-names></name><name name-style="western"><surname>Mora</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1</article-title>. <source>Mol Cell Proteomics</source> (<year>2009</year>) <volume>8</volume>:<fpage>1728</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M800486-MCP200</pub-id><pub-id pub-id-type="pmid">19401597</pub-id><pub-id pub-id-type="pmcid">PMC2709197</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorward</surname><given-names>DW</given-names></name><name name-style="western"><surname>Garon</surname><given-names>CF</given-names></name><name name-style="western"><surname>Judd</surname><given-names>RC</given-names></name></person-group>. <article-title>Export and intercellular transfer of DNA via membrane blebs of <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>J Bacteriol</source>. (<year>1989</year>) <volume>171</volume>:<fpage>2499</fpage>&#8211;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1128/jb.171.5.2499-2505.1989</pub-id><pub-id pub-id-type="pmid">2496108</pub-id><pub-id pub-id-type="pmcid">PMC209926</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrari</surname><given-names>G</given-names></name><name name-style="western"><surname>Garaguso</surname><given-names>I</given-names></name><name name-style="western"><surname>Adu-Bobie</surname><given-names>J</given-names></name><name name-style="western"><surname>Doro</surname><given-names>F</given-names></name><name name-style="western"><surname>Taddei</surname><given-names>AR</given-names></name><name name-style="western"><surname>Biolchi</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Outer membrane vesicles from group B <italic toggle="yes">Neisseria meningitidis</italic> &#916;<italic toggle="yes">gna33</italic> mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles</article-title>. <source>Proteomics</source> (<year>2006</year>) <volume>6</volume>:<fpage>1856</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200500164</pub-id><pub-id pub-id-type="pmid">16456881</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>EY</given-names></name><name name-style="western"><surname>Choi</surname><given-names>DS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>KP</given-names></name><name name-style="western"><surname>Gho</surname><given-names>YS</given-names></name></person-group>. <article-title>Proteomics in gram-negative bacterial outer membrane vesicles</article-title>. <source>Mass Spectrom Rev</source>. (<year>2008</year>) <volume>27</volume>:<fpage>535</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1002/mas.20175</pub-id><pub-id pub-id-type="pmid">18421767</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>DS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DK</given-names></name><name name-style="western"><surname>Choi</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Choi</surname><given-names>JP</given-names></name><name name-style="western"><surname>Rho</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Proteomic analysis of outer membrane vesicles derived from <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title>. <source>Proteomics</source> (<year>2011</year>) <volume>11</volume>:<fpage>3424</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201000212</pub-id><pub-id pub-id-type="pmid">21751344</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Gafken</surname><given-names>PR</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group>. <article-title>Quantitative proteomic analysis of the cell envelopes and native membrane vesicles derived from gram-negative bacteria</article-title>. <source>Curr Protoc Microbiol.</source> (<year>2014a</year>) <volume>34</volume>:<fpage>1F 3 1</fpage>&#8211;<lpage>1F 3 16</lpage>. <pub-id pub-id-type="doi">10.1002/9780471729259.mc01f03s34</pub-id><pub-id pub-id-type="pmid">25082006</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group>. <article-title>Isolation of cell envelopes and naturally released membrane vesicles of <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>Curr Protoc Microbiol.</source> (<year>2014</year>) <volume>34</volume>:<fpage>4A 3 1</fpage>&#8211;<lpage>4A 3 17</lpage>. <pub-id pub-id-type="doi">10.1002/9780471729259.mc04a03s34</pub-id><pub-id pub-id-type="pmid">25082007</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name><name name-style="western"><surname>Wierzbicki</surname><given-names>IH</given-names></name><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Ryner</surname><given-names>RF</given-names></name><name name-style="western"><surname>Korotkov</surname><given-names>KV</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>SK</given-names></name><etal/></person-group>. <article-title>Structural functional insights into the role of BamD and BamE within the beta-barrel assembly machinery in <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>J Biol Chem</source>. (<year>2018</year>) <volume>293</volume>:<fpage>1106</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA117.000437</pub-id><pub-id pub-id-type="pmid">29229778</pub-id><pub-id pub-id-type="pmcid">PMC5787791</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Post</surname><given-names>DM</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name><name name-style="western"><surname>Eastvold</surname><given-names>JS</given-names></name><name name-style="western"><surname>Teghanemt</surname><given-names>A</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>BW</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>JP</given-names></name></person-group>. <article-title>Biochemical and functional characterization of membrane blebs purified from <italic toggle="yes">Neisseria meningitidis</italic> serogroup B</article-title>. <source>J Biol Chem</source>. (<year>2005</year>) <volume>280</volume>:<fpage>38383</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M508063200</pub-id><pub-id pub-id-type="pmid">16103114</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holst</surname><given-names>J</given-names></name><name name-style="western"><surname>Oster</surname><given-names>P</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>R</given-names></name><name name-style="western"><surname>Tatley</surname><given-names>MV</given-names></name><name name-style="western"><surname>Naess</surname><given-names>LM</given-names></name><name name-style="western"><surname>Aaberge</surname><given-names>IS</given-names></name><etal/></person-group>. <article-title>Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future</article-title>. <source>Hum Vaccin Immunother</source>. (<year>2013</year>) <volume>9</volume>:<fpage>1241</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.4161/hv.24129</pub-id><pub-id pub-id-type="pmid">23857274</pub-id><pub-id pub-id-type="pmcid">PMC3901813</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Pol</surname><given-names>L</given-names></name><name name-style="western"><surname>Stork</surname><given-names>M</given-names></name><name name-style="western"><surname>van der Ley</surname><given-names>P</given-names></name></person-group>. <article-title>Outer membrane vesicles as platform vaccine technology</article-title>. <source>Biotechnol J</source>. (<year>2015</year>) <volume>10</volume>:<fpage>1689</fpage>&#8211;<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1002/biot.201400395</pub-id><pub-id pub-id-type="pmid">26912077</pub-id><pub-id pub-id-type="pmcid">PMC4768646</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delany</surname><given-names>I</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name><name name-style="western"><surname>Seib</surname><given-names>KL</given-names></name></person-group>. <article-title>Vaccines, reverse vaccinology, and bacterial pathogenesis</article-title>. <source>Cold Spring Harb Perspect Med</source>. (<year>2013</year>) <volume>3</volume>:<fpage>a012476</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a012476</pub-id><pub-id pub-id-type="pmid">23637311</pub-id><pub-id pub-id-type="pmcid">PMC3633180</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basta</surname><given-names>NE</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>H</given-names></name></person-group>. <article-title>4CMenB vaccine effectiveness: reasons for optimism</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>388</volume>:<fpage>2719</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)32061-X</pub-id><pub-id pub-id-type="pmid">28100431</pub-id><pub-id pub-id-type="pmcid">PMC5424821</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parikh</surname><given-names>SR</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Beebeejaun</surname><given-names>K</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>H</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>S</given-names></name><name name-style="western"><surname>Ward</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>388</volume>:<fpage>2775</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)31921-3</pub-id><pub-id pub-id-type="pmid">28100432</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poetsch</surname><given-names>A</given-names></name><name name-style="western"><surname>Wolters</surname><given-names>D</given-names></name></person-group>. <article-title>Bacterial membrane proteomics</article-title>. <source>Proteomics</source> (<year>2008</year>) <volume>8</volume>:<fpage>4100</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200800273</pub-id><pub-id pub-id-type="pmid">18780352</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gardy</surname><given-names>JL</given-names></name><name name-style="western"><surname>Laird</surname><given-names>MR</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Rey</surname><given-names>S</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ester</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>PSORTb v</article-title>.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. <source>Bioinformatics</source> (<year>2005</year>) <volume>21</volume>:<fpage>617</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bti057</pub-id><pub-id pub-id-type="pmid">15501914</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>NY</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>JR</given-names></name><name name-style="western"><surname>Laird</surname><given-names>MR</given-names></name><name name-style="western"><surname>Melli</surname><given-names>G</given-names></name><name name-style="western"><surname>Rey</surname><given-names>S</given-names></name><name name-style="western"><surname>Lo</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>PSORTb 3</article-title>.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. <source>Bioinformatics</source> (<year>2010</year>) <volume>26</volume>:<fpage>1608</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq249</pub-id><pub-id pub-id-type="pmid">20472543</pub-id><pub-id pub-id-type="pmcid">PMC2887053</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imai</surname><given-names>K</given-names></name><name name-style="western"><surname>Asakawa</surname><given-names>N</given-names></name><name name-style="western"><surname>Tsuji</surname><given-names>T</given-names></name><name name-style="western"><surname>Akazawa</surname><given-names>F</given-names></name><name name-style="western"><surname>Ino</surname><given-names>A</given-names></name><name name-style="western"><surname>Sonoyama</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>SOSUI-GramN: high performance prediction for sub-cellular localization of proteins in gram-negative bacteria</article-title>. <source>Bioinformation</source> (<year>2008</year>) <volume>2</volume>:<fpage>417</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.6026/97320630002417</pub-id><pub-id pub-id-type="pmid">18795116</pub-id><pub-id pub-id-type="pmcid">PMC2533062</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>CS</given-names></name><name name-style="western"><surname>Lin</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>JK</given-names></name></person-group>. <article-title>Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions</article-title>. <source>Protein Sci</source>. (<year>2004</year>) <volume>13</volume>:<fpage>1402</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1110/ps.03479604</pub-id><pub-id pub-id-type="pmid">15096640</pub-id><pub-id pub-id-type="pmcid">PMC2286765</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>CS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YC</given-names></name><name name-style="western"><surname>Lu</surname><given-names>CH</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>JK</given-names></name></person-group>. <article-title>Prediction of protein subcellular localization</article-title>. <source>Proteins</source> (<year>2006</year>) <volume>64</volume>:<fpage>643</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1002/prot.21018</pub-id><pub-id pub-id-type="pmid">16752418</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>H</given-names></name><name name-style="western"><surname>Engelbrecht</surname><given-names>J</given-names></name><name name-style="western"><surname>Brunak</surname><given-names>S</given-names></name><name name-style="western"><surname>von Heijne</surname><given-names>G</given-names></name></person-group>. <article-title>Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites</article-title>. <source>Protein Eng</source>. (<year>1997</year>) <volume>10</volume>:<fpage>1</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/protein/10.1.1</pub-id><pub-id pub-id-type="pmid">9051728</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petersen</surname><given-names>TN</given-names></name><name name-style="western"><surname>Brunak</surname><given-names>S</given-names></name><name name-style="western"><surname>von Heijne</surname><given-names>G</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>H</given-names></name></person-group>. <article-title>SignalP 4</article-title>.0: discriminating signal peptides from transmembrane regions. <source>Nat Methods</source> (<year>2011</year>) <volume>8</volume>:<fpage>785</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1701</pub-id><pub-id pub-id-type="pmid">21959131</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juncker</surname><given-names>AS</given-names></name><name name-style="western"><surname>Willenbrock</surname><given-names>H</given-names></name><name name-style="western"><surname>Von Heijne</surname><given-names>G</given-names></name><name name-style="western"><surname>Brunak</surname><given-names>S</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>H</given-names></name><name name-style="western"><surname>Krogh</surname><given-names>A</given-names></name></person-group>. <article-title>Prediction of lipoprotein signal peptides in Gram-negative bacteria</article-title>. <source>Protein Sci</source>. (<year>2003</year>) <volume>12</volume>:<fpage>1652</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1110/ps.0303703</pub-id><pub-id pub-id-type="pmid">12876315</pub-id><pub-id pub-id-type="pmcid">PMC2323952</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakayama</surname><given-names>H</given-names></name><name name-style="western"><surname>Kurokawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>BL</given-names></name></person-group>. <article-title>Lipoproteins in bacteria: structures and biosynthetic pathways</article-title>. <source>FEBS J</source>. (<year>2012</year>) <volume>279</volume>:<fpage>4247</fpage>&#8211;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1111/febs.12041</pub-id><pub-id pub-id-type="pmid">23094979</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tatusov</surname><given-names>RL</given-names></name><name name-style="western"><surname>Galperin</surname><given-names>MY</given-names></name><name name-style="western"><surname>Natale</surname><given-names>DA</given-names></name><name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name></person-group>. <article-title>The COG database: a tool for genome-scale analysis of protein functions and evolution</article-title>. <source>Nucleic Acids Res</source>. (<year>2000</year>) <volume>28</volume>:<fpage>33</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.33</pub-id><pub-id pub-id-type="pmid">10592175</pub-id><pub-id pub-id-type="pmcid">PMC102395</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galperin</surname><given-names>MY</given-names></name><name name-style="western"><surname>Makarova</surname><given-names>KS</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>YI</given-names></name><name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name></person-group>. <article-title>Expanded microbial genome coverage and improved protein family annotation in the COG database</article-title>. <source>Nucleic Acids Res.</source> (<year>2015</year>) <volume>43</volume>:<fpage>D261</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1223</pub-id><pub-id pub-id-type="pmid">25428365</pub-id><pub-id pub-id-type="pmcid">PMC4383993</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jolley</surname><given-names>KA</given-names></name><name name-style="western"><surname>Maiden</surname><given-names>MC</given-names></name></person-group>. <article-title>BIGSdb: Scalable analysis of bacterial genome variation at the population level</article-title>. <source>BMC Bioinformatics</source> (<year>2010</year>) <volume>11</volume>:<fpage>595</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-11-595</pub-id><pub-id pub-id-type="pmid">21143983</pub-id><pub-id pub-id-type="pmcid">PMC3004885</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Le Van</surname><given-names>A</given-names></name><name name-style="western"><surname>Baarda</surname><given-names>BI</given-names></name><name name-style="western"><surname>Herrera</surname><given-names>MF</given-names></name><name name-style="western"><surname>Acosta</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><etal/></person-group>. <article-title>SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during <italic toggle="yes">Neisseria gonorrhoeae</italic> infection</article-title>. <source>PLoS Pathog</source>. (<year>2018</year>) <volume>14</volume>:<fpage>e1007081</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1007081</pub-id><pub-id pub-id-type="pmid">29975784</pub-id><pub-id pub-id-type="pmcid">PMC6033465</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krogh</surname><given-names>A</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>B</given-names></name><name name-style="western"><surname>von Heijne</surname><given-names>G</given-names></name><name name-style="western"><surname>Sonnhammer</surname><given-names>EL</given-names></name></person-group>. <article-title>Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes</article-title>. <source>J Mol Biol</source>. (<year>2001</year>) <volume>305</volume>:<fpage>567</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.2000.4315</pub-id><pub-id pub-id-type="pmid">11152613</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soria-Guerra</surname><given-names>RE</given-names></name><name name-style="western"><surname>Nieto-Gomez</surname><given-names>R</given-names></name><name name-style="western"><surname>Govea-Alonso</surname><given-names>DO</given-names></name><name name-style="western"><surname>Rosales-Mendoza</surname><given-names>S</given-names></name></person-group>. <article-title>An overview of bioinformatics tools for epitope prediction: implications on vaccine development</article-title>. <source>J Biomed Inform</source>. (<year>2015</year>) <volume>53</volume>:<fpage>405</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbi.2014.11.003</pub-id><pub-id pub-id-type="pmid">25464113</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Layh</surname><given-names>G</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>S</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>TM</given-names></name></person-group>. <article-title>Surface immunolabeling of <italic toggle="yes">Neisseria gonorrhoeae</italic> employing monoclonal antibodies to proteins IA and IB</article-title>. <source>Zentralbl Bakteriol Mikrobiol Hyg A</source> (<year>1988</year>) <volume>269</volume>:<fpage>34</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/S0176-6724(88)80082-8</pub-id><pub-id pub-id-type="pmid">3140531</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paques</surname><given-names>M</given-names></name><name name-style="western"><surname>Teppema</surname><given-names>JS</given-names></name><name name-style="western"><surname>Beuvery</surname><given-names>EC</given-names></name><name name-style="western"><surname>Abdillahi</surname><given-names>H</given-names></name><name name-style="western"><surname>Poolman</surname><given-names>JT</given-names></name><name name-style="western"><surname>Verkleij</surname><given-names>AJ</given-names></name></person-group>. <article-title>Accessibility of gonococcal and meningococcal surface antigens: immunogold labeling for quantitative electron microscopy</article-title>. <source>Infect Immun</source>. (<year>1989</year>) <volume>57</volume>:<fpage>582</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="pmid">2492264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.57.2.582-589.1989</pub-id><pub-id pub-id-type="pmcid">PMC313136</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unemo</surname><given-names>M</given-names></name><name name-style="western"><surname>Golparian</surname><given-names>D</given-names></name><name name-style="western"><surname>Sanchez-Buso</surname><given-names>L</given-names></name><name name-style="western"><surname>Grad</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jacobsson</surname><given-names>S</given-names></name><name name-style="western"><surname>Ohnishi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The novel 2016 WHO <italic toggle="yes">Neisseria gonorrhoeae</italic> reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization</article-title>. <source>J Antimicrob Chemother</source>. (<year>2016b</year>) <volume>71</volume>:<fpage>3096</fpage>&#8211;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkw288</pub-id><pub-id pub-id-type="pmid">27432602</pub-id><pub-id pub-id-type="pmcid">PMC5079299</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shewell</surname><given-names>LK</given-names></name><name name-style="western"><surname>Ku</surname><given-names>SC</given-names></name><name name-style="western"><surname>Schulz</surname><given-names>BL</given-names></name><name name-style="western"><surname>Jen</surname><given-names>FE</given-names></name><name name-style="western"><surname>Mubaiwa</surname><given-names>TD</given-names></name><name name-style="western"><surname>Ketterer</surname><given-names>MR</given-names></name><etal/></person-group>. <article-title>Recombinant truncated AniA of pathogenic Neisseria elicits a non-native immune response and functional blocking antibodies</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2013</year>) <volume>431</volume>:<fpage>215</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2012.12.132</pub-id><pub-id pub-id-type="pmid">23313483</pub-id><pub-id pub-id-type="pmcid">PMC4326246</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Semchenko</surname><given-names>EA</given-names></name><name name-style="western"><surname>Day</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Seib</surname><given-names>KL</given-names></name></person-group>. <article-title>MetQ of <italic toggle="yes">Neisseria gonorrhoeae</italic> is a surface-expressed antigen that elicits bactericidal and functional blocking antibodies</article-title>. <source>Infect Immun</source>. (<year>2017</year>) <volume>85</volume>:<fpage>e00898</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00898-16</pub-id><pub-id pub-id-type="pmid">27895130</pub-id><pub-id pub-id-type="pmcid">PMC5278169</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>MC</given-names></name><name name-style="western"><surname>Heckels</surname><given-names>JE</given-names></name><name name-style="western"><surname>Christodoulides</surname><given-names>M</given-names></name></person-group>. <article-title>The adhesin complex protein (ACP) of <italic toggle="yes">Neisseria meningitidis</italic> is a new adhesin with vaccine potential</article-title>. <source>MBio</source> (<year>2013</year>) <volume>4</volume>:<fpage>e00041</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.00041-13</pub-id><pub-id pub-id-type="pmid">23443003</pub-id><pub-id pub-id-type="pmcid">PMC3585444</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humbert</surname><given-names>MV</given-names></name><name name-style="western"><surname>Awanye</surname><given-names>AM</given-names></name><name name-style="western"><surname>Lian</surname><given-names>LY</given-names></name><name name-style="western"><surname>Derrick</surname><given-names>JP</given-names></name><name name-style="western"><surname>Christodoulides</surname><given-names>M</given-names></name></person-group>. <article-title>Structure of the Neisseria Adhesin Complex Protein (ACP) and its role as a novel lysozyme inhibitor</article-title>. <source>PLoS Pathog</source>. (<year>2017</year>) <volume>13</volume>:<fpage>e1006448</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006448</pub-id><pub-id pub-id-type="pmid">28662181</pub-id><pub-id pub-id-type="pmcid">PMC5507604</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ragland</surname><given-names>SA</given-names></name><name name-style="western"><surname>Humbert</surname><given-names>MV</given-names></name><name name-style="western"><surname>Christodoulides</surname><given-names>M</given-names></name><name name-style="western"><surname>Criss</surname><given-names>AK</given-names></name></person-group>. <article-title><italic toggle="yes">Neisseria gonorrhoeae</italic> employs two protein inhibitors to evade killing by human lysozyme</article-title>. <source>PLoS Pathog</source>. (<year>2018</year>) <volume>14</volume>:<fpage>e1007080</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1007080</pub-id><pub-id pub-id-type="pmid">29975775</pub-id><pub-id pub-id-type="pmcid">PMC6033460</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lomholt</surname><given-names>H</given-names></name><name name-style="western"><surname>Lind</surname><given-names>I</given-names></name><name name-style="western"><surname>Kilian</surname><given-names>M</given-names></name></person-group>. <article-title><italic toggle="yes">Neisseria gonorrhoeae</italic> IgA1 proteases share epitopes recognized by neutralizing antibodies</article-title>. <source>Vaccine</source> (<year>1995</year>) <volume>13</volume>:<fpage>1213</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0264-410X(95)00057-8</pub-id><pub-id pub-id-type="pmid">8578806</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madico</surname><given-names>G</given-names></name><name name-style="western"><surname>Welsch</surname><given-names>JA</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>LA</given-names></name><name name-style="western"><surname>McNaughton</surname><given-names>A</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>DH</given-names></name><name name-style="western"><surname>Costello</surname><given-names>CE</given-names></name><etal/></person-group>. <article-title>The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<fpage>501</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.1.501</pub-id><pub-id pub-id-type="pmid">16785547</pub-id><pub-id pub-id-type="pmcid">PMC2248442</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tavano</surname><given-names>R</given-names></name><name name-style="western"><surname>Capecchi</surname><given-names>B</given-names></name><name name-style="western"><surname>Montanari</surname><given-names>P</given-names></name><name name-style="western"><surname>Franzoso</surname><given-names>S</given-names></name><name name-style="western"><surname>Marin</surname><given-names>O</given-names></name><name name-style="western"><surname>Sztukowska</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Mapping of the <italic toggle="yes">Neisseria meningitidis</italic> NadA cell-binding site: relevance of predicted {alpha}-helices in the NH2-terminal and dimeric coiled-coil regions</article-title>. <source>J Bacteriol</source> (<year>2011</year>) <volume>193</volume>:<fpage>107</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00430-10</pub-id><pub-id pub-id-type="pmid">20971901</pub-id><pub-id pub-id-type="pmcid">PMC3019930</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vacca</surname><given-names>I</given-names></name><name name-style="western"><surname>Del Tordello</surname><given-names>E</given-names></name><name name-style="western"><surname>Gasperini</surname><given-names>G</given-names></name><name name-style="western"><surname>Pezzicoli</surname><given-names>A</given-names></name><name name-style="western"><surname>Di Fede</surname><given-names>M</given-names></name><name name-style="western"><surname>Rossi Paccani</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Neisserial Heparin Binding Antigen (NHBA) Contributes to the Adhesion of Neisseria meningitidis to Human Epithelial Cells</article-title>. <source>PLoS ONE</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0162878</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0162878</pub-id><pub-id pub-id-type="pmid">27780200</pub-id><pub-id pub-id-type="pmcid">PMC5079597</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forthal</surname><given-names>DN</given-names></name></person-group><article-title>Functions of antibodies</article-title>. <source>Microbiol Spectr</source>. (<year>2014</year>) <volume>2</volume>:<fpage>AID-0019-2014</fpage><pub-id pub-id-type="doi">10.1128/microbiolspec.AID-0019-2014</pub-id><pub-id pub-id-type="pmid">26104200</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bootz</surname><given-names>A</given-names></name><name name-style="western"><surname>Karbach</surname><given-names>A</given-names></name><name name-style="western"><surname>Spindler</surname><given-names>J</given-names></name><name name-style="western"><surname>Kropff</surname><given-names>B</given-names></name><name name-style="western"><surname>Reuter</surname><given-names>N</given-names></name><name name-style="western"><surname>Sticht</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus</article-title>. <source>PLoS Pathog</source>. (<year>2017</year>) <volume>13</volume>:<fpage>e1006601</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006601</pub-id><pub-id pub-id-type="pmid">28854233</pub-id><pub-id pub-id-type="pmcid">PMC5595347</pub-id></mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brodeur</surname><given-names>BR</given-names></name><name name-style="western"><surname>Boyer</surname><given-names>M</given-names></name><name name-style="western"><surname>Charlebois</surname><given-names>I</given-names></name><name name-style="western"><surname>Hamel</surname><given-names>J</given-names></name><name name-style="western"><surname>Couture</surname><given-names>F</given-names></name><name name-style="western"><surname>Rioux</surname><given-names>CR</given-names></name><etal/></person-group>. <article-title>Identification of group B streptococcal Sip protein, which elicits cross-protective immunity</article-title>. <source>Infect Immun</source>. (<year>2000</year>) <volume>68</volume>:<fpage>5610</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.68.10.5610-5618.2000</pub-id><pub-id pub-id-type="pmid">10992461</pub-id><pub-id pub-id-type="pmcid">PMC101513</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>XD</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Terwilliger</surname><given-names>TC</given-names></name><name name-style="western"><surname>Liljas</surname><given-names>A</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name></person-group>. <article-title>Protein crystallography from the perspective of technology developments</article-title>. <source>Crystallogr Rev</source>. (<year>2015</year>) <volume>21</volume>:<fpage>122</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1080/0889311X.2014.973868</pub-id><pub-id pub-id-type="pmid">25983389</pub-id><pub-id pub-id-type="pmcid">PMC4430849</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W</given-names></name></person-group>. <article-title>Structural proteomics by NMR spectroscopy</article-title>. <source>Expert Rev Proteomics</source> (<year>2008</year>) <volume>5</volume>:<fpage>589</fpage>&#8211;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1586/14789450.5.4.589</pub-id><pub-id pub-id-type="pmid">18761469</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuravleva</surname><given-names>A</given-names></name><name name-style="western"><surname>Korzhnev</surname><given-names>DM</given-names></name></person-group>. <article-title>Protein folding by NMR</article-title>. <source>Prog Nucl Mag Resonan Spectr.</source> (<year>2017</year>) <volume>100</volume>:<fpage>52</fpage>&#8211;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnmrs.2016.10.002</pub-id><pub-id pub-id-type="pmid">28552172</pub-id></mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stura</surname><given-names>EA</given-names></name><name name-style="western"><surname>Fieser</surname><given-names>GG</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>IA</given-names></name></person-group><article-title>Crystallization of antibodies and antibody-antigen complexes</article-title>. <source>ImmunoMethods</source> (<year>1993</year>) <volume>3</volume>:<fpage>164</fpage>&#8211;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1006/immu.1993.1051</pub-id></mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obmolova</surname><given-names>G</given-names></name><name name-style="western"><surname>Malia</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Teplyakov</surname><given-names>A</given-names></name><name name-style="western"><surname>Sweet</surname><given-names>R</given-names></name><name name-style="western"><surname>Gilliland</surname><given-names>GL</given-names></name></person-group>. <article-title>Promoting crystallization of antibody-antigen complexes via microseed matrix screening</article-title>. <source>Acta Crystallogr D Biol Crystallogr.</source> (<year>2010</year>) <volume>66</volume>:<fpage>927</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444910026041</pub-id><pub-id pub-id-type="pmid">20693692</pub-id><pub-id pub-id-type="pmcid">PMC2917276</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malia</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Obmolova</surname><given-names>G</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name><name name-style="western"><surname>Teplyakov</surname><given-names>A</given-names></name><name name-style="western"><surname>Sweet</surname><given-names>R</given-names></name><name name-style="western"><surname>Gilliland</surname><given-names>GL</given-names></name></person-group>. <article-title>Crystallization of a challenging antigen-antibody complex: TLR3 ECD with three noncompeting Fabs</article-title>. <source>Acta Crystallogr Sect F Struct Biol Cryst Commun.</source> (<year>2011</year>) <volume>67</volume>:<fpage>1290</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1107/S1744309111030983</pub-id><pub-id pub-id-type="pmid">22102050</pub-id><pub-id pub-id-type="pmcid">PMC3212385</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lipman</surname><given-names>NS</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>LR</given-names></name><name name-style="western"><surname>Trudel</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Weis-Garcia</surname><given-names>F</given-names></name></person-group>. <article-title>Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources</article-title>. <source>ILAR J</source> (<year>2005</year>) <volume>46</volume>:<fpage>258</fpage>&#8211;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1093/ilar.46.3.258</pub-id><pub-id pub-id-type="pmid">15953833</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>M</given-names></name><name name-style="western"><surname>Cao</surname><given-names>E</given-names></name><name name-style="western"><surname>Julius</surname><given-names>D</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name></person-group>. <article-title>Structure of the TRPV1 ion channel determined by electron cryo-microscopy</article-title>. <source>Nature</source> (<year>2013</year>) <volume>504</volume>:<fpage>107</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/nature12822</pub-id><pub-id pub-id-type="pmid">24305160</pub-id><pub-id pub-id-type="pmcid">PMC4078027</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>J</given-names></name><name name-style="western"><surname>Jenni</surname><given-names>S</given-names></name><name name-style="western"><surname>Raymond</surname><given-names>DD</given-names></name><name name-style="western"><surname>Caradonna</surname><given-names>T</given-names></name><name name-style="western"><surname>Do</surname><given-names>KT</given-names></name><etal/></person-group>. <article-title>CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface</article-title>. <source>J Mol Biol</source>. (<year>2017b</year>) <volume>429</volume>:<fpage>1829</fpage>&#8211;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2017.05.011</pub-id><pub-id pub-id-type="pmid">28506635</pub-id><pub-id pub-id-type="pmcid">PMC5535819</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Earl</surname><given-names>LA</given-names></name><name name-style="western"><surname>Falconieri</surname><given-names>V</given-names></name><name name-style="western"><surname>Milne</surname><given-names>JL</given-names></name><name name-style="western"><surname>Subramaniam</surname><given-names>S</given-names></name></person-group>. <article-title>Cryo-EM: beyond the microscope</article-title>. <source>Curr Opin Struct Biol</source>. (<year>2017</year>) <volume>46</volume>:<fpage>71</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2017.06.002</pub-id><pub-id pub-id-type="pmid">28646653</pub-id><pub-id pub-id-type="pmcid">PMC5683925</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plante</surname><given-names>M</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>A</given-names></name><name name-style="western"><surname>Hamel</surname><given-names>J</given-names></name><name name-style="western"><surname>Couture</surname><given-names>F</given-names></name><name name-style="western"><surname>Rioux</surname><given-names>CR</given-names></name><name name-style="western"><surname>Brodeur</surname><given-names>BR</given-names></name><etal/></person-group>. <article-title>Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by <italic toggle="yes">Neisseria gonorrhoeae</italic></article-title>. <source>J Infect Dis</source>. (<year>2000</year>) <volume>182</volume>:<fpage>848</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1086/315801</pub-id><pub-id pub-id-type="pmid">10950780</pub-id></mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulati</surname><given-names>S</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>B</given-names></name><name name-style="western"><surname>Reed</surname><given-names>GW</given-names></name><name name-style="western"><surname>Su</surname><given-names>X</given-names></name><name name-style="western"><surname>Cox</surname><given-names>AD</given-names></name><name name-style="western"><surname>St Michael</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection</article-title>. <source>PLoS Pathog.</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003559</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003559</pub-id><pub-id pub-id-type="pmid">24009500</pub-id><pub-id pub-id-type="pmcid">PMC3757034</pub-id></mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karch</surname><given-names>CP</given-names></name><name name-style="western"><surname>Burkhard</surname><given-names>P</given-names></name></person-group>. <article-title>Vaccine technologies: From whole organisms to rationally designed protein assemblies</article-title>. <source>Biochem Pharmacol</source>. (<year>2016</year>) <volume>120</volume>:<fpage>1</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2016.05.001</pub-id><pub-id pub-id-type="pmid">27157411</pub-id><pub-id pub-id-type="pmcid">PMC5079805</pub-id></mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bobbala</surname><given-names>S</given-names></name><name name-style="western"><surname>Hook</surname><given-names>S</given-names></name></person-group>. <article-title>Is there an optimal formulation and delivery strategy for subunit vaccines?</article-title><source>Pharm Res</source>. (<year>2016</year>) <volume>33</volume>:<fpage>2078</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-016-1979-0</pub-id><pub-id pub-id-type="pmid">27380191</pub-id></mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>MT</given-names></name></person-group>. <article-title>Recent advances of vaccine adjuvants for infectious diseases</article-title>. <source>Immune Netw</source>. (<year>2015</year>) <volume>15</volume>:<fpage>51</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4110/in.2015.15.2.51</pub-id><pub-id pub-id-type="pmid">25922593</pub-id><pub-id pub-id-type="pmcid">PMC4411509</pub-id></mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Awasthi</surname><given-names>S</given-names></name><name name-style="western"><surname>Hook</surname><given-names>LM</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>CE</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>HM</given-names></name></person-group>. <article-title>A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model</article-title>. <source>Hum Vaccin Immunother</source>. (<year>2017</year>) <volume>13</volume>:<fpage>2785</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1080/21645515.2017.1323604</pub-id><pub-id pub-id-type="pmid">28481687</pub-id><pub-id pub-id-type="pmcid">PMC5718817</pub-id></mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernstein</surname><given-names>DI</given-names></name><name name-style="western"><surname>Wald</surname><given-names>A</given-names></name><name name-style="western"><surname>Warren</surname><given-names>T</given-names></name><name name-style="western"><surname>Fife</surname><given-names>K</given-names></name><name name-style="western"><surname>Tyring</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Therapeutic vaccine for genital herpes simplex virus-2 infection: findings from a randomized trial</article-title>. <source>J Infect Dis</source>. (<year>2017</year>) <volume>215</volume>:<fpage>856</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jix004</pub-id><pub-id pub-id-type="pmid">28329211</pub-id><pub-id pub-id-type="pmcid">PMC7206854</pub-id></mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Wagoner</surname><given-names>N</given-names></name><name name-style="western"><surname>Fife</surname><given-names>K</given-names></name><name name-style="western"><surname>Leone</surname><given-names>PA</given-names></name><name name-style="western"><surname>Bernstein</surname><given-names>DI</given-names></name><name name-style="western"><surname>Warren</surname><given-names>T</given-names></name><name name-style="western"><surname>Panther</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Effects of different doses of GEN-003, a therapeutic vaccine for genital herpes simplex virus-2, on viral shedding and lesions: results of a randomized placebo-controlled trial</article-title>. <source>J Infect Dis</source>. (<year>2018</year>) <volume>218</volume>:<fpage>1890</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiy415</pub-id><pub-id pub-id-type="pmid">29982727</pub-id><pub-id pub-id-type="pmcid">PMC7191615</pub-id></mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>M</given-names></name><name name-style="western"><surname>Silhavy</surname><given-names>TJ</given-names></name></person-group>. <article-title>Imp/OstA is required for cell envelope biogenesis in <italic toggle="yes">Escherichia coli</italic></article-title>. <source>Mol Microbiol.</source> (<year>2002</year>) <volume>45</volume>:<fpage>1289</fpage>&#8211;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03091.x</pub-id><pub-id pub-id-type="pmid">12207697</pub-id></mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruiz</surname><given-names>N</given-names></name><name name-style="western"><surname>Kahne</surname><given-names>D</given-names></name><name name-style="western"><surname>Silhavy</surname><given-names>TJ</given-names></name></person-group>. <article-title>Transport of lipopolysaccharide across the cell envelope: the long road of discovery</article-title>. <source>Nat Rev Microbiol</source>. (<year>2009</year>) <volume>7</volume>:<fpage>677</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2184</pub-id><pub-id pub-id-type="pmid">19633680</pub-id><pub-id pub-id-type="pmcid">PMC2790178</pub-id></mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bos</surname><given-names>MP</given-names></name><name name-style="western"><surname>Tefsen</surname><given-names>B</given-names></name><name name-style="western"><surname>Geurtsen</surname><given-names>J</given-names></name><name name-style="western"><surname>Tommassen</surname><given-names>J</given-names></name></person-group>. <article-title>Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2004</year>) <volume>101</volume>:<fpage>9417</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0402340101</pub-id><pub-id pub-id-type="pmid">15192148</pub-id><pub-id pub-id-type="pmcid">PMC438991</pub-id></mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Welsch</surname><given-names>JA</given-names></name><name name-style="western"><surname>Ram</surname><given-names>S</given-names></name></person-group>. <article-title>Factor H and neisserial pathogenesis</article-title>. <source>Vaccine</source> (<year>2008</year>) <volume>26</volume>(<issue>Suppl. 8</issue>):<fpage>I.40</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2008.11.060</pub-id><pub-id pub-id-type="pmid">19388163</pub-id><pub-id pub-id-type="pmcid">PMC2768413</pub-id></mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>SC</given-names></name><name name-style="western"><surname>Maragathavally</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Coates</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Kaminski</surname><given-names>JM</given-names></name></person-group>. <article-title>Steps toward targeted insertional mutagenesis with class II transposable elements</article-title>. <source>Methods Mol Biol</source>. (<year>2008</year>) <volume>435</volume>:<fpage>139</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-59745-232-8_10</pub-id><pub-id pub-id-type="pmid">18370073</pub-id></mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Wierzbicki</surname><given-names>IH</given-names></name><name name-style="western"><surname>Baarda</surname><given-names>BI</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group>. <article-title>The <italic toggle="yes">Neisseria gonorrhoeae</italic> Obg protein is an essential ribosome-associated GTPase and a potential drug target</article-title>. <source>BMC Microbiol</source>. (<year>2015</year>) <volume>15</volume>:<fpage>129</fpage>. <pub-id pub-id-type="doi">10.1186/s12866-015-0453-1</pub-id><pub-id pub-id-type="pmid">26122105</pub-id><pub-id pub-id-type="pmcid">PMC4487204</pub-id></mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wierzbicki</surname><given-names>IH</given-names></name><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Korotkov</surname><given-names>KV</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group>. <article-title>Functional and structural studies on the <italic toggle="yes">Neisseria gonorrhoeae</italic> GmhA, the first enzyme in the glycero-manno-heptose biosynthesis pathways, demonstrate a critical role in lipooligosaccharide synthesis and gonococcal viability</article-title>. <source>Microbiologyopen</source> (<year>2017</year>) <volume>6</volume>:<fpage>e00432</fpage>. <pub-id pub-id-type="doi">10.1002/mbo3.432</pub-id><pub-id pub-id-type="pmid">28063198</pub-id><pub-id pub-id-type="pmcid">PMC5387315</pub-id></mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name><name name-style="western"><surname>Mills</surname><given-names>RH</given-names></name><name name-style="western"><surname>Weber</surname><given-names>JV</given-names></name><name name-style="western"><surname>Hamza</surname><given-names>A</given-names></name><name name-style="western"><surname>Passow</surname><given-names>BW</given-names></name><name name-style="western"><surname>Romaine</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Peptide Inhibitors Targeting the <italic toggle="yes">Neisseria gonorrhoeae</italic> Pivotal anaerobic respiration factor AniA</article-title>. <source>Antimicrob Agents Chemother</source>. (<year>2017</year>) <volume>61</volume>:<fpage>e00186</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00186-17</pub-id><pub-id pub-id-type="pmid">28584144</pub-id><pub-id pub-id-type="pmcid">PMC5527597</pub-id></mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulp</surname><given-names>A</given-names></name><name name-style="western"><surname>Kuehn</surname><given-names>MJ</given-names></name></person-group>. <article-title>Biological functions and biogenesis of secreted bacterial outer membrane vesicles</article-title>. <source>Annu Rev Microbiol</source>. (<year>2010</year>) <volume>64</volume>:<fpage>163</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.091208.073413</pub-id><pub-id pub-id-type="pmid">20825345</pub-id><pub-id pub-id-type="pmcid">PMC3525469</pub-id></mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulkarni</surname><given-names>HM</given-names></name><name name-style="western"><surname>Jagannadham</surname><given-names>MV</given-names></name></person-group>. <article-title>Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria</article-title>. <source>Microbiology</source> (<year>2014</year>) <volume>160</volume>:<fpage>2109</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.079400-0</pub-id><pub-id pub-id-type="pmid">25069453</pub-id></mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haurat</surname><given-names>MF</given-names></name><name name-style="western"><surname>Elhenawy</surname><given-names>W</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name></person-group>. <article-title>Prokaryotic membrane vesicles: new insights on biogenesis and biological roles</article-title>. <source>Biol Chem</source>. (<year>2015</year>) <volume>396</volume>:<fpage>95</fpage>&#8211;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1515/hsz-2014-0183</pub-id><pub-id pub-id-type="pmid">25178905</pub-id></mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>F</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Dong</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>The outer membrane phospholipase A is essential for membrane integrity and type III secretion in <italic toggle="yes">Shigella flexneri</italic></article-title>. <source>Open Biol.</source> (<year>2016</year>) <volume>6</volume>:<fpage>160073</fpage>. <pub-id pub-id-type="doi">10.1098/rsob.160073</pub-id><pub-id pub-id-type="pmid">27655730</pub-id><pub-id pub-id-type="pmcid">PMC5043575</pub-id></mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baarda</surname><given-names>BI</given-names></name><name name-style="western"><surname>Emerson</surname><given-names>S</given-names></name><name name-style="western"><surname>Proteau</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group><article-title>Deciphering the function of new gonococcal vaccine antigens using phenotypic microarrays</article-title>. <source>J Bacteriol</source>. (<year>2017</year>) <volume>199</volume>:<fpage>1</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00037-17</pub-id><pub-id pub-id-type="pmcid">PMC5553031</pub-id><pub-id pub-id-type="pmid">28630127</pub-id></mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Seib</surname><given-names>KL</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>JL</given-names></name><name name-style="western"><surname>Apicella</surname><given-names>MA</given-names></name><name name-style="western"><surname>McEwan</surname><given-names>AG</given-names></name><name name-style="western"><surname>Jennings</surname><given-names>MP</given-names></name></person-group>. <article-title>Azurin of pathogenic <italic toggle="yes">Neisseria</italic> spp</article-title>. is involved in defense against hydrogen peroxide and survival within cervical epithelial cells<source>. Infect Immun</source>. (<year>2005</year>) <volume>73</volume>:<fpage>8444</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.73.12.8444-8448.2005</pub-id><pub-id pub-id-type="pmid">16299348</pub-id><pub-id pub-id-type="pmcid">PMC1307039</pub-id></mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cole</surname><given-names>JG</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name></person-group>. <article-title>Functional characterization of antibodies against <italic toggle="yes">Neisseria gonorrhoeae</italic> opacity protein loops</article-title>. <source>PLoS ONE</source> (<year>2009</year>) <volume>4</volume>:<fpage>e8108</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0008108</pub-id><pub-id pub-id-type="pmid">19956622</pub-id><pub-id pub-id-type="pmcid">PMC2779592</pub-id></mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bochner</surname><given-names>BR</given-names></name><name name-style="western"><surname>Gadzinski</surname><given-names>P</given-names></name><name name-style="western"><surname>Panomitros</surname><given-names>E</given-names></name></person-group>. <article-title>Phenotype microarrays for high-throughput phenotypic testing and assay of gene function</article-title>. <source>Genome Res</source>. (<year>2001</year>) <volume>11</volume>:<fpage>1246</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1101/gr.186501</pub-id><pub-id pub-id-type="pmid">11435407</pub-id><pub-id pub-id-type="pmcid">PMC311101</pub-id></mixed-citation></ref><ref id="B151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shea</surname><given-names>A</given-names></name><name name-style="western"><surname>Wolcott</surname><given-names>M</given-names></name><name name-style="western"><surname>Daefler</surname><given-names>S</given-names></name><name name-style="western"><surname>Rozak</surname><given-names>DA</given-names></name></person-group>. <article-title>Biolog phenotype microarrays</article-title>. <source>Methods Mol Biol.</source> (<year>2012</year>) <volume>881</volume>:<fpage>331</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-827-6_12</pub-id><pub-id pub-id-type="pmid">22639219</pub-id></mixed-citation></ref><ref id="B152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morse</surname><given-names>SA</given-names></name></person-group>. <article-title>The biology of the gonococcus</article-title>. <source>CRC Crit Rev Microbiol</source>. (<year>1978</year>) <volume>7</volume>:<fpage>93</fpage>&#8211;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.3109/10408417909083071</pub-id><pub-id pub-id-type="pmid">113174</pub-id></mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>ND</given-names></name><name name-style="western"><surname>Simms</surname><given-names>AN</given-names></name><name name-style="western"><surname>Crow</surname><given-names>ET</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>LA</given-names></name><name name-style="western"><surname>Shafer</surname><given-names>WM</given-names></name></person-group>. <article-title>A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection</article-title>. <source>Infect Immun</source>. (<year>2003</year>) <volume>71</volume>:<fpage>5576</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.10.5576-5582.2003</pub-id><pub-id pub-id-type="pmid">14500476</pub-id><pub-id pub-id-type="pmcid">PMC201053</pub-id></mixed-citation></ref><ref id="B154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Preston</surname><given-names>A</given-names></name><name name-style="western"><surname>Mandrell</surname><given-names>RE</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>BW</given-names></name><name name-style="western"><surname>Apicella</surname><given-names>MA</given-names></name></person-group>. <article-title>The lipooligosaccharides of pathogenic gram-negative bacteria</article-title>. <source>Crit Rev Microbiol</source>. (<year>1996</year>) <volume>22</volume>:<fpage>139</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.3109/10408419609106458</pub-id><pub-id pub-id-type="pmid">8894399</pub-id></mixed-citation></ref><ref id="B155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silhavy</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Kahne</surname><given-names>D</given-names></name><name name-style="western"><surname>Walker</surname><given-names>S</given-names></name></person-group>. <article-title>The bacterial cell envelope</article-title>. <source>Cold Spring Harb Perspect Biol.</source> (<year>2010</year>) <volume>2</volume>:<fpage>a000414</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a000414</pub-id><pub-id pub-id-type="pmid">20452953</pub-id><pub-id pub-id-type="pmcid">PMC2857177</pub-id></mixed-citation></ref><ref id="B156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wierzbicki</surname><given-names>IH</given-names></name><name name-style="western"><surname>ZR</surname><given-names>A</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><name name-style="western"><surname>Begum</surname><given-names>AA</given-names></name><name name-style="western"><surname>Unemo</surname><given-names>M</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group><article-title>NGO1985 is a surface-exposed outer membrane lipoprotein involved in <italic toggle="yes">Neisseria gonorrhoeae</italic> cell envelope homeostasis and a novel gonorrhea vaccine candidate</article-title>. In: <source>International Pathogenic Neisseria Conference</source> (<year>2016</year>).</mixed-citation></ref><ref id="B157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagan</surname><given-names>CL</given-names></name><name name-style="western"><surname>Silhavy</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Kahne</surname><given-names>D</given-names></name></person-group>. <article-title>&#946;-Barrel membrane protein assembly by the Bam complex</article-title>. <source>Annu Rev Biochem</source>. (<year>2011</year>) <volume>80</volume>:<fpage>189</fpage>&#8211;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-061408-144611</pub-id><pub-id pub-id-type="pmid">21370981</pub-id></mixed-citation></ref><ref id="B158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ricci</surname><given-names>DP</given-names></name><name name-style="western"><surname>Silhavy</surname><given-names>TJ</given-names></name></person-group>. <article-title>The Bam machine: a molecular cooper</article-title>. <source>Biochim Biophys Acta</source> (<year>2012</year>) <volume>1818</volume>:<fpage>1067</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2011.08.020</pub-id><pub-id pub-id-type="pmid">21893027</pub-id><pub-id pub-id-type="pmcid">PMC3253334</pub-id></mixed-citation></ref><ref id="B159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volokhina</surname><given-names>EB</given-names></name><name name-style="western"><surname>Beckers</surname><given-names>F</given-names></name><name name-style="western"><surname>Tommassen</surname><given-names>J</given-names></name><name name-style="western"><surname>Bos</surname><given-names>MP</given-names></name></person-group>. <article-title>The &#946;-barrel outer membrane protein assembly complex of <italic toggle="yes">Neisseria meningitidis</italic></article-title>. <source>J Bacteriol</source>. (<year>2009</year>) <volume>191</volume>:<fpage>7074</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00737-09</pub-id><pub-id pub-id-type="pmid">19767435</pub-id><pub-id pub-id-type="pmcid">PMC2772484</pub-id></mixed-citation></ref><ref id="B160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voulhoux</surname><given-names>R</given-names></name><name name-style="western"><surname>Bos</surname><given-names>MP</given-names></name><name name-style="western"><surname>Geurtsen</surname><given-names>J</given-names></name><name name-style="western"><surname>Mols</surname><given-names>M</given-names></name><name name-style="western"><surname>Tommassen</surname><given-names>J</given-names></name></person-group>. <article-title>Role of a highly conserved bacterial protein in outer membrane protein assembly</article-title>. <source>Science</source> (<year>2003</year>) <volume>299</volume>:<fpage>262</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.1078973</pub-id><pub-id pub-id-type="pmid">12522254</pub-id></mixed-citation></ref><ref id="B161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gentle</surname><given-names>I</given-names></name><name name-style="western"><surname>Gabriel</surname><given-names>K</given-names></name><name name-style="western"><surname>Beech</surname><given-names>P</given-names></name><name name-style="western"><surname>Waller</surname><given-names>R</given-names></name><name name-style="western"><surname>Lithgow</surname><given-names>T</given-names></name></person-group>. <article-title>The Omp85 family of proteins is essential for outer membrane biogenesis in mitochondria and bacteria</article-title>. <source>J Cell Biol</source>. (<year>2004</year>) <volume>164</volume>:<fpage>19</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200310092</pub-id><pub-id pub-id-type="pmid">14699090</pub-id><pub-id pub-id-type="pmcid">PMC2171957</pub-id></mixed-citation></ref><ref id="B162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onufryk</surname><given-names>C</given-names></name><name name-style="western"><surname>Crouch</surname><given-names>ML</given-names></name><name name-style="western"><surname>Fang</surname><given-names>FC</given-names></name><name name-style="western"><surname>Gross</surname><given-names>CA</given-names></name></person-group>. <article-title>Characterization of six lipoproteins in the sigmaE regulon</article-title>. <source>J Bacteriol</source>. (<year>2005</year>) <volume>187</volume>:<fpage>4552</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1128/JB.187.13.4552-4561.2005</pub-id><pub-id pub-id-type="pmid">15968066</pub-id><pub-id pub-id-type="pmcid">PMC1151791</pub-id></mixed-citation></ref><ref id="B163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liechty</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Jain</surname><given-names>MK</given-names></name></person-group>. <article-title>Origin of antibacterial stasis by polymyxin B in <italic toggle="yes">Escherichia coli</italic></article-title>. <source>Biochim Biophys Acta</source> (<year>2000</year>) <volume>1463</volume>:<fpage>55</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/S0005-2736(99)00178-9</pub-id><pub-id pub-id-type="pmid">10631294</pub-id></mixed-citation></ref><ref id="B164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>JT</given-names></name><name name-style="western"><surname>Cajal</surname><given-names>Y</given-names></name><name name-style="western"><surname>Skowronska</surname><given-names>EM</given-names></name><name name-style="western"><surname>Belkin</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Van Dyk</surname><given-names>TK</given-names></name><etal/></person-group>. <article-title>Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli</article-title>. <source>Biochim Biophys Acta</source> (<year>2000</year>) <volume>1463</volume>:<fpage>43</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/S0005-2736(99)00177-7</pub-id><pub-id pub-id-type="pmid">10631293</pub-id></mixed-citation></ref><ref id="B165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeats</surname><given-names>C</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>A</given-names></name></person-group>. <article-title>The BON domain: a putative membrane-binding domain</article-title>. <source>Trends Biochem Sci</source>. (<year>2003</year>) <volume>28</volume>:<fpage>352</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/S0968-0004(03)00115-4</pub-id><pub-id pub-id-type="pmid">12878000</pub-id></mixed-citation></ref><ref id="B166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahoney</surname><given-names>TF</given-names></name><name name-style="western"><surname>Ricci</surname><given-names>DP</given-names></name><name name-style="western"><surname>Silhavy</surname><given-names>TJ</given-names></name></person-group>. <article-title>Classifying beta-Barrel assembly substrates by manipulating essential bam complex members</article-title>. <source>J Bacteriol</source>. (<year>2016</year>) <volume>198</volume>:<fpage>1984</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00263-16</pub-id><pub-id pub-id-type="pmid">27161117</pub-id><pub-id pub-id-type="pmcid">PMC4936103</pub-id></mixed-citation></ref><ref id="B167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiao</surname><given-names>S</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>XC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name></person-group>. <article-title>Structural basis for lipopolysaccharide insertion in the bacterial outer membrane</article-title>. <source>Nature</source> (<year>2014</year>) <volume>511</volume>:<fpage>108</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/nature13484</pub-id><pub-id pub-id-type="pmid">24990751</pub-id></mixed-citation></ref><ref id="B168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bos</surname><given-names>MP</given-names></name><name name-style="western"><surname>Tommassen</surname><given-names>J</given-names></name></person-group><article-title>The LptD chaperone LptE is not directly involved in lipopolysaccharide transport in Neisseria meningitidis</article-title>. <source>J Biol Chem</source>. (<year>2011</year>) <volume>286</volume>:<fpage>28688</fpage>&#8211;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.239673</pub-id><pub-id pub-id-type="pmid">21705335</pub-id><pub-id pub-id-type="pmcid">PMC3190676</pub-id></mixed-citation></ref><ref id="B169"><label>169.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malinverni</surname><given-names>JC</given-names></name><name name-style="western"><surname>Silhavy</surname><given-names>TJ</given-names></name></person-group>. <article-title>An ABC transport system that maintains lipid asymmetry in the gram-negative outer membrane</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2009</year>) <volume>106</volume>:<fpage>8009</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0903229106</pub-id><pub-id pub-id-type="pmid">19383799</pub-id><pub-id pub-id-type="pmcid">PMC2683108</pub-id></mixed-citation></ref><ref id="B170"><label>170.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abellon-Ruiz</surname><given-names>J</given-names></name><name name-style="western"><surname>Kaptan</surname><given-names>SS</given-names></name><name name-style="western"><surname>Basle</surname><given-names>A</given-names></name><name name-style="western"><surname>Claudi</surname><given-names>B</given-names></name><name name-style="western"><surname>Bumann</surname><given-names>D</given-names></name><name name-style="western"><surname>Kleinekathofer</surname><given-names>U</given-names></name><etal/></person-group><article-title>Structural basis for maintenance of bacterial outer membrane lipid asymmetry</article-title>. <source>Nat Microbiol</source>. (<year>2017</year>) <volume>1</volume>:<fpage>1616</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-017-0046-x</pub-id><pub-id pub-id-type="pmid">29038444</pub-id></mixed-citation></ref><ref id="B171"><label>171.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baarda</surname><given-names>BI</given-names></name><name name-style="western"><surname>Zielke</surname><given-names>RA</given-names></name><name name-style="western"><surname>Le Van</surname><given-names>A</given-names></name><name name-style="western"><surname>Jerse</surname><given-names>AE</given-names></name><name name-style="western"><surname>Sikora</surname><given-names>AE</given-names></name></person-group><article-title>A novel outer membrane protein, NGO2121, influences membrane vesicle production and virulence of Neisseria gonorrhoeae</article-title>. In: <source>International Pathogenic Neisseria Conference</source> (<year>2016</year>).</mixed-citation></ref><ref id="B172"><label>172.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roier</surname><given-names>S</given-names></name><name name-style="western"><surname>Zingl</surname><given-names>FG</given-names></name><name name-style="western"><surname>Cakar</surname><given-names>F</given-names></name><name name-style="western"><surname>Durakovic</surname><given-names>S</given-names></name><name name-style="western"><surname>Kohl</surname><given-names>P</given-names></name><name name-style="western"><surname>Eichmann</surname><given-names>TO</given-names></name><etal/></person-group>. <article-title>A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria</article-title>. <source>Nat Commun.</source> (<year>2016</year>) <volume>7</volume>:<fpage>10515</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms10515</pub-id><pub-id pub-id-type="pmid">26806181</pub-id><pub-id pub-id-type="pmcid">PMC4737802</pub-id></mixed-citation></ref><ref id="B173"><label>173.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kovacs-Simon</surname><given-names>A</given-names></name><name name-style="western"><surname>Titball</surname><given-names>RW</given-names></name><name name-style="western"><surname>Michell</surname><given-names>SL</given-names></name></person-group>. <article-title>Lipoproteins of bacterial pathogens</article-title>. <source>Infect Immun</source>. (<year>2011</year>) <volume>79</volume>:<fpage>548</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00682-10</pub-id><pub-id pub-id-type="pmid">20974828</pub-id><pub-id pub-id-type="pmcid">PMC3028857</pub-id></mixed-citation></ref><ref id="B174"><label>174.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hooda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lai</surname><given-names>CC</given-names></name><name name-style="western"><surname>Judd</surname><given-names>A</given-names></name><name name-style="western"><surname>Buckwalter</surname><given-names>CM</given-names></name><name name-style="western"><surname>Shin</surname><given-names>HE</given-names></name><name name-style="western"><surname>Gray-Owen</surname><given-names>SD</given-names></name><etal/></person-group>. <article-title>Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria</article-title>. <source>Nat Microbiol</source>. (<year>2016</year>) <volume>1</volume>:<fpage>16009</fpage>. <pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.9</pub-id><pub-id pub-id-type="pmid">27572441</pub-id></mixed-citation></ref><ref id="B175"><label>175.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stabler</surname><given-names>RA</given-names></name><name name-style="western"><surname>Marsden</surname><given-names>GL</given-names></name><name name-style="western"><surname>Witney</surname><given-names>AA</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bentley</surname><given-names>SD</given-names></name><name name-style="western"><surname>Tang</surname><given-names>CM</given-names></name><etal/></person-group>. <article-title>Identification of pathogen-specific genes through microarray analysis of pathogenic and commensal Neisseria species</article-title>. <source>Microbiology</source> (<year>2005</year>) <volume>151</volume>:<fpage>2907</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.28099-0</pub-id><pub-id pub-id-type="pmid">16151203</pub-id></mixed-citation></ref><ref id="B176"><label>176.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tommassen</surname><given-names>J</given-names></name><name name-style="western"><surname>Arenas</surname><given-names>J</given-names></name></person-group>. <article-title>Biological functions of the secretome of <italic toggle="yes">Neisseria meningitidis</italic></article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2017</year>) <volume>7</volume>:<fpage>256</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00256</pub-id><pub-id pub-id-type="pmid">28670572</pub-id><pub-id pub-id-type="pmcid">PMC5472700</pub-id></mixed-citation></ref><ref id="B177"><label>177.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>M</given-names></name><name name-style="western"><surname>Misra</surname><given-names>R</given-names></name></person-group>. <article-title>Examination of AsmA and its effect on the assembly of <italic toggle="yes">Escherichia coli</italic> outer membrane proteins</article-title>. <source>Mol Microbiol</source>. (<year>1996</year>) <volume>21</volume>:<fpage>605</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.1996.tb02568.x</pub-id><pub-id pub-id-type="pmid">8866482</pub-id></mixed-citation></ref><ref id="B178"><label>178.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Putker</surname><given-names>F</given-names></name><name name-style="western"><surname>Grutsch</surname><given-names>A</given-names></name><name name-style="western"><surname>Tommassen</surname><given-names>J</given-names></name><name name-style="western"><surname>Bos</surname><given-names>MP</given-names></name></person-group>. <article-title>Ght protein of <italic toggle="yes">Neisseria meningitidis</italic> is involved in the regulation of lipopolysaccharide biosynthesis</article-title>. <source>J Bacteriol</source>. (<year>2014</year>) <volume>196</volume>:<fpage>780</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00943-13</pub-id><pub-id pub-id-type="pmid">24296673</pub-id><pub-id pub-id-type="pmcid">PMC3911185</pub-id></mixed-citation></ref><ref id="B179"><label>179.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barondess</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Beckwith</surname><given-names>J</given-names></name></person-group>. <article-title>A bacterial virulence determinant encoded by lysogenic coliphage lambda</article-title>. <source>Nature</source> (<year>1990</year>) <volume>346</volume>:<fpage>871</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/346871a0</pub-id><pub-id pub-id-type="pmid">2144037</pub-id></mixed-citation></ref><ref id="B180"><label>180.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lin-Lee</surname><given-names>YC</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Dai</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name><name name-style="western"><surname>Rassool</surname><given-names>FV</given-names></name><etal/></person-group>. <article-title>Molecular cloning of Chinese hamster 1q31 chromosomal fragile site DNA that is important to mdr1 gene amplification reveals a novel gene whose expression is associated with spermatocyte and adipocyte differentiation</article-title>. <source>Gene</source> (<year>2006</year>) <volume>372</volume>:<fpage>44</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2005.12.024</pub-id><pub-id pub-id-type="pmid">16545529</pub-id></mixed-citation></ref><ref id="B181"><label>181.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calmettes</surname><given-names>C</given-names></name><name name-style="western"><surname>Ing</surname><given-names>C</given-names></name><name name-style="western"><surname>Buckwalter</surname><given-names>CM</given-names></name><name name-style="western"><surname>El Bakkouri</surname><given-names>M</given-names></name><name name-style="western"><surname>Chieh-Lin</surname><given-names>Lai C</given-names></name><name name-style="western"><surname>Pogoutse</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The molecular mechanism of Zinc acquisition by the neisserial outer-membrane transporter ZnuD</article-title>. <source>Nat Commun</source>. (<year>2015</year>) <volume>6</volume>:<fpage>7996</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8996</pub-id><pub-id pub-id-type="pmid">26282243</pub-id><pub-id pub-id-type="pmcid">PMC4557270</pub-id></mixed-citation></ref><ref id="B182"><label>182.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lappann</surname><given-names>M</given-names></name><name name-style="western"><surname>Danhof</surname><given-names>S</given-names></name><name name-style="western"><surname>Guenther</surname><given-names>F</given-names></name><name name-style="western"><surname>Olivares-Florez</surname><given-names>S</given-names></name><name name-style="western"><surname>Mordhorst</surname><given-names>IL</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>U</given-names></name></person-group>. <article-title><italic toggle="yes">In vitro</italic> resistance mechanisms of <italic toggle="yes">Neisseria meningitidis</italic> against neutrophil extracellular traps</article-title>. <source>Mol Microbiol</source>. (<year>2013</year>) <volume>89</volume>:<fpage>433</fpage>&#8211;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.12288</pub-id><pub-id pub-id-type="pmid">23750848</pub-id></mixed-citation></ref><ref id="B183"><label>183.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urban</surname><given-names>CF</given-names></name><name name-style="western"><surname>Ermert</surname><given-names>D</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>M</given-names></name><name name-style="western"><surname>Abu-Abed</surname><given-names>U</given-names></name><name name-style="western"><surname>Goosmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Nacken</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against <italic toggle="yes">Candida albicans</italic></article-title>. <source>PLoS Pathog</source>. (<year>2009</year>) <volume>5</volume>:<fpage>e1000639</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000639</pub-id><pub-id pub-id-type="pmid">19876394</pub-id><pub-id pub-id-type="pmcid">PMC2763347</pub-id></mixed-citation></ref><ref id="B184"><label>184.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagen</surname><given-names>TA</given-names></name><name name-style="western"><surname>Cornelissen</surname><given-names>CN</given-names></name></person-group>. <article-title><italic toggle="yes">Neisseria gonorrhoeae</italic> requires expression of TonB and the putative transporter TdfF to replicate within cervical epithelial cells</article-title>. <source>Mol Microbiol</source>. (<year>2006</year>) <volume>62</volume>:<fpage>1144</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05429.x</pub-id><pub-id pub-id-type="pmid">17038122</pub-id></mixed-citation></ref><ref id="B185"><label>185.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Callewaert</surname><given-names>L</given-names></name><name name-style="western"><surname>Van Herreweghe</surname><given-names>JM</given-names></name><name name-style="western"><surname>Vanderkelen</surname><given-names>L</given-names></name><name name-style="western"><surname>Leysen</surname><given-names>S</given-names></name><name name-style="western"><surname>Voet</surname><given-names>A</given-names></name><name name-style="western"><surname>Michiels</surname><given-names>CW</given-names></name></person-group>. <article-title>Guards of the great wall: bacterial lysozyme inhibitors</article-title>. <source>Trends Microbiol</source>. (<year>2012</year>) <volume>20</volume>:<fpage>501</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2012.06.005</pub-id><pub-id pub-id-type="pmid">22840966</pub-id></mixed-citation></ref><ref id="B186"><label>186.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lefevre</surname><given-names>P</given-names></name><name name-style="western"><surname>Braibant</surname><given-names>M</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>L</given-names></name><name name-style="western"><surname>Kalai</surname><given-names>M</given-names></name><name name-style="western"><surname>Roeper</surname><given-names>D</given-names></name><name name-style="western"><surname>Grotzinger</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG</article-title>. <source>J Bacteriol</source>. (<year>1997</year>) <volume>179</volume>:<fpage>2900</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1128/jb.179.9.2900-2906.1997</pub-id><pub-id pub-id-type="pmid">9139906</pub-id><pub-id pub-id-type="pmcid">PMC179052</pub-id></mixed-citation></ref><ref id="B187"><label>187.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kovacs-Simon</surname><given-names>A</given-names></name><name name-style="western"><surname>Leuzzi</surname><given-names>R</given-names></name><name name-style="western"><surname>Kasendra</surname><given-names>M</given-names></name><name name-style="western"><surname>Minton</surname><given-names>N</given-names></name><name name-style="western"><surname>Titball</surname><given-names>RW</given-names></name><name name-style="western"><surname>Michell</surname><given-names>SL</given-names></name></person-group>. <article-title>Lipoprotein CD0873 is a novel adhesin of Clostridium difficile</article-title>. <source>J Infect Dis</source>. (<year>2014</year>) <volume>210</volume>:<fpage>274</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiu070</pub-id><pub-id pub-id-type="pmid">24482399</pub-id></mixed-citation></ref><ref id="B188"><label>188.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dormitzer</surname><given-names>PR</given-names></name><name name-style="western"><surname>Grandi</surname><given-names>G</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name></person-group>. <article-title>Structural vaccinology starts to deliver</article-title>. <source>Nat Rev Microbiol</source>. (<year>2012</year>) <volume>10</volume>:<fpage>807</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2893</pub-id><pub-id pub-id-type="pmid">23154260</pub-id></mixed-citation></ref><ref id="B189"><label>189.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liljeroos</surname><given-names>L</given-names></name><name name-style="western"><surname>Malito</surname><given-names>E</given-names></name><name name-style="western"><surname>Ferlenghi</surname><given-names>I</given-names></name><name name-style="western"><surname>Bottomley</surname><given-names>MJ</given-names></name></person-group>. <article-title>Structural and computational biology in the design of immunogenic vaccine antigens</article-title>. <source>J Immunol Res</source>. (<year>2015</year>) <volume>2015</volume>:<fpage>156241</fpage>. <pub-id pub-id-type="doi">10.1155/2015/156241</pub-id><pub-id pub-id-type="pmid">26526043</pub-id><pub-id pub-id-type="pmcid">PMC4615220</pub-id></mixed-citation></ref><ref id="B190"><label>190.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noinaj</surname><given-names>N</given-names></name><name name-style="western"><surname>Kuszak</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Gumbart</surname><given-names>JC</given-names></name><name name-style="western"><surname>Lukacik</surname><given-names>P</given-names></name><name name-style="western"><surname>Chang</surname><given-names>H</given-names></name><name name-style="western"><surname>Easley</surname><given-names>NC</given-names></name><etal/></person-group>. <article-title>Structural insight into the biogenesis of beta-barrel membrane proteins</article-title>. <source>Nature</source> (<year>2013</year>) <volume>501</volume>:<fpage>385</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1038/nature12521</pub-id><pub-id pub-id-type="pmid">23995689</pub-id><pub-id pub-id-type="pmcid">PMC3779476</pub-id></mixed-citation></ref><ref id="B191"><label>191.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albrecht</surname><given-names>R</given-names></name><name name-style="western"><surname>Sch&#252;tz</surname><given-names>M</given-names></name><name name-style="western"><surname>Oberhettinger</surname><given-names>P</given-names></name><name name-style="western"><surname>Faulstich</surname><given-names>M</given-names></name><name name-style="western"><surname>Bermejo</surname><given-names>I</given-names></name><name name-style="western"><surname>Rudel</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Structure of BamA, an essential factor in outer membrane protein biogenesis</article-title>. <source>Acta Crystallogr D Biol Crystallogr.</source> (<year>2014</year>) <volume>70</volume>:<fpage>1779</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1107/S1399004714007482</pub-id><pub-id pub-id-type="pmid">24914988</pub-id></mixed-citation></ref><ref id="B192"><label>192.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Sutterlin</surname><given-names>HA</given-names></name><name name-style="western"><surname>Wzorek</surname><given-names>JS</given-names></name><name name-style="western"><surname>Mandler</surname><given-names>MD</given-names></name><name name-style="western"><surname>Hagan</surname><given-names>CL</given-names></name><name name-style="western"><surname>Grabowicz</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Substrate binding to BamD triggers a conformational change in BamA to control membrane insertion</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2018</year>) <volume>115</volume>:<fpage>2359</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1711727115</pub-id><pub-id pub-id-type="pmid">29463713</pub-id><pub-id pub-id-type="pmcid">PMC5877925</pub-id></mixed-citation></ref><ref id="B193"><label>193.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>KR</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>JA</given-names></name><name name-style="western"><surname>Bowers</surname><given-names>LM</given-names></name></person-group>. <article-title>The BAM complex subunit BamE (SmpA) is required for membrane integrity, stalk growth and normal levels of outer membrane &#946;-barrel proteins in <italic toggle="yes">Caulobacter crescentus</italic></article-title>. <source>Microbiology</source> (<year>2010</year>) <volume>156</volume>:<fpage>742</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.035055-0</pub-id><pub-id pub-id-type="pmid">19959579</pub-id><pub-id pub-id-type="pmcid">PMC2889432</pub-id></mixed-citation></ref><ref id="B194"><label>194.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knowles</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Browning</surname><given-names>DF</given-names></name><name name-style="western"><surname>Jeeves</surname><given-names>M</given-names></name><name name-style="western"><surname>Maderbocus</surname><given-names>R</given-names></name><name name-style="western"><surname>Rajesh</surname><given-names>S</given-names></name><name name-style="western"><surname>Sridhar</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Structure and function of BamE within the outer membrane and the beta-barrel assembly machine</article-title>. <source>EMBO Rep</source>. (<year>2011</year>) <volume>12</volume>:<fpage>123</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/embor.2010.202</pub-id><pub-id pub-id-type="pmid">21212804</pub-id><pub-id pub-id-type="pmcid">PMC3049429</pub-id></mixed-citation></ref><ref id="B195"><label>195.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albrecht</surname><given-names>R</given-names></name><name name-style="western"><surname>Zeth</surname><given-names>K</given-names></name></person-group>. <article-title>Structural basis of outer membrane protein biogenesis in bacteria</article-title>. <source>J Biol Chem</source>. (<year>2011</year>) <volume>286</volume>:<fpage>27792</fpage>&#8211;<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.238931</pub-id><pub-id pub-id-type="pmid">21586578</pub-id><pub-id pub-id-type="pmcid">PMC3149369</pub-id></mixed-citation></ref><ref id="B196"><label>196.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>KH</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HS</given-names></name><name name-style="western"><surname>Okon</surname><given-names>M</given-names></name><name name-style="western"><surname>Escobar-Cabrera</surname><given-names>E</given-names></name><name name-style="western"><surname>McIntosh</surname><given-names>LP</given-names></name><name name-style="western"><surname>Paetzel</surname><given-names>M</given-names></name></person-group>. <article-title>Structural characterization of Escherichia coli BamE, a lipoprotein component of the beta-barrel assembly machinery complex</article-title>. <source>Biochemistry</source> (<year>2011</year>) <volume>50</volume>:<fpage>1081</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1021/bi101659u</pub-id><pub-id pub-id-type="pmid">21207987</pub-id></mixed-citation></ref><ref id="B197"><label>197.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>HH</given-names></name><name name-style="western"><surname>Leyton</surname><given-names>DL</given-names></name><name name-style="western"><surname>Shiota</surname><given-names>T</given-names></name><name name-style="western"><surname>Belousoff</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Noinaj</surname><given-names>N</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Reconstitution of a nanomachine driving the assembly of proteins into bacterial outer membranes</article-title>. <source>Nat Commun.</source> (<year>2014</year>) <volume>5</volume>:<fpage>5078</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms6078</pub-id><pub-id pub-id-type="pmid">25341963</pub-id><pub-id pub-id-type="pmcid">PMC4633281</pub-id></mixed-citation></ref><ref id="B198"><label>198.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henderson</surname><given-names>IR</given-names></name><name name-style="western"><surname>Nataro</surname><given-names>JP</given-names></name></person-group>. <article-title>Virulence functions of autotransporter proteins</article-title>. <source>Infect Immun</source>. (<year>2001</year>) <volume>69</volume>:<fpage>1231</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.3.1231-1243.2001</pub-id><pub-id pub-id-type="pmid">11179284</pub-id><pub-id pub-id-type="pmcid">PMC98013</pub-id></mixed-citation></ref><ref id="B199"><label>199.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selkrig</surname><given-names>J</given-names></name><name name-style="western"><surname>Leyton</surname><given-names>DL</given-names></name><name name-style="western"><surname>Webb</surname><given-names>CT</given-names></name><name name-style="western"><surname>Lithgow</surname><given-names>T</given-names></name></person-group>. <article-title>Assembly of beta-barrel proteins into bacterial outer membranes</article-title>. <source>Biochim Biophys Acta</source> (<year>2014</year>) <volume>1843</volume>:<fpage>1542</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2013.10.009</pub-id><pub-id pub-id-type="pmid">24135059</pub-id></mixed-citation></ref><ref id="B200"><label>200.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heinz</surname><given-names>E</given-names></name><name name-style="western"><surname>Selkrig</surname><given-names>J</given-names></name><name name-style="western"><surname>Belousoff</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Lithgow</surname><given-names>T</given-names></name></person-group>. (<year>2015</year>). <article-title>Evolution of the translocation and assembly module (TAM)</article-title>. <source>Genome Biol Evol.</source><volume>7</volume>, <fpage>1628</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1093/gbe/evv097</pub-id><pub-id pub-id-type="pmid">25994932</pub-id><pub-id pub-id-type="pmcid">PMC4494059</pub-id></mixed-citation></ref><ref id="B201"><label>201.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gruss</surname><given-names>F</given-names></name><name name-style="western"><surname>Zahringer</surname><given-names>F</given-names></name><name name-style="western"><surname>Jakob</surname><given-names>RP</given-names></name><name name-style="western"><surname>Burmann</surname><given-names>BM</given-names></name><name name-style="western"><surname>Hiller</surname><given-names>S</given-names></name><name name-style="western"><surname>Maier</surname><given-names>T</given-names></name></person-group>. <article-title>The structural basis of autotransporter translocation by TamA</article-title>. <source>Nat Struct Mol Biol</source>. (<year>2013</year>) <volume>20</volume>:<fpage>1318</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2689</pub-id><pub-id pub-id-type="pmid">24056943</pub-id></mixed-citation></ref><ref id="B202"><label>202.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botos</surname><given-names>I</given-names></name><name name-style="western"><surname>Majdalani</surname><given-names>N</given-names></name><name name-style="western"><surname>Mayclin</surname><given-names>SJ</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>JG</given-names></name><name name-style="western"><surname>Lundquist</surname><given-names>K</given-names></name><name name-style="western"><surname>Wojtowicz</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Structural and functional characterization of the LPS transporter LptDE from gram-negative pathogens</article-title>. <source>Structure</source> (<year>2016</year>) <volume>24</volume>:<fpage>965</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2016.03.026</pub-id><pub-id pub-id-type="pmid">27161977</pub-id><pub-id pub-id-type="pmcid">PMC4899211</pub-id></mixed-citation></ref><ref id="B203"><label>203.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nie</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Characterization of ST-4821 complex, a unique <italic toggle="yes">Neisseria meningitidis</italic> clone</article-title>. <source>Genomics</source> (<year>2008</year>) <volume>91</volume>:<fpage>78</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2007.10.004</pub-id><pub-id pub-id-type="pmid">18031983</pub-id></mixed-citation></ref><ref id="B204"><label>204.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name></person-group>. <article-title>Crystal structure of lipoprotein GNA1946 from <italic toggle="yes">Neisseria meningitidis</italic></article-title>. <source>J Struct Biol</source>. (<year>2009</year>) <volume>168</volume>:<fpage>437</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsb.2009.09.001</pub-id><pub-id pub-id-type="pmid">19733245</pub-id></mixed-citation></ref><ref id="B205"><label>205.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cava</surname><given-names>F</given-names></name><name name-style="western"><surname>Lam</surname><given-names>H</given-names></name><name name-style="western"><surname>de Pedro</surname><given-names>MA</given-names></name><name name-style="western"><surname>Waldor</surname><given-names>MK</given-names></name></person-group>. <article-title>Emerging knowledge of regulatory roles of D-amino acids in bacteria</article-title>. <source>Cell Mol Life Sci</source>. (<year>2011</year>) <volume>68</volume>:<fpage>817</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-010-0571-8</pub-id><pub-id pub-id-type="pmid">21161322</pub-id><pub-id pub-id-type="pmcid">PMC3037491</pub-id></mixed-citation></ref><ref id="B206"><label>206.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sankaranarayanan</surname><given-names>R</given-names></name><name name-style="western"><surname>Moras</surname><given-names>D</given-names></name></person-group>. <article-title>The fidelity of the translation of the genetic code</article-title>. <source>Acta Biochim Pol</source>. (<year>2001</year>) <volume>48</volume>:<fpage>323</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="pmid">11732604</pub-id></mixed-citation></ref><ref id="B207"><label>207.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hondorp</surname><given-names>ER</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>RG</given-names></name></person-group><article-title>Methionine</article-title>. <source>EcoSal Plus</source> (<year>2006</year>) <volume>2</volume>:<fpage>1</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1128/ecosalplus.3.6.1.7</pub-id><pub-id pub-id-type="pmid">26443567</pub-id></mixed-citation></ref><ref id="B208"><label>208.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noinaj</surname><given-names>N</given-names></name><name name-style="western"><surname>Guillier</surname><given-names>M</given-names></name><name name-style="western"><surname>Barnard</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>SK</given-names></name></person-group>. <article-title>TonB-dependent transporters: regulation, structure, and function</article-title>. <source>Annu Rev Microbiol</source>. (<year>2010</year>) <volume>64</volume>:<fpage>43</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.112408.134247</pub-id><pub-id pub-id-type="pmid">20420522</pub-id><pub-id pub-id-type="pmcid">PMC3108441</pub-id></mixed-citation></ref><ref id="B209"><label>209.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Terwilliger</surname><given-names>A</given-names></name><name name-style="western"><surname>Maresso</surname><given-names>AW</given-names></name></person-group>. <article-title>Iron and zinc exploitation during bacterial pathogenesis</article-title>. <source>Metallomics</source> (<year>2015</year>) <volume>7</volume>:<fpage>1541</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1039/C5MT00170F</pub-id><pub-id pub-id-type="pmid">26497057</pub-id><pub-id pub-id-type="pmcid">PMC4836889</pub-id></mixed-citation></ref><ref id="B210"><label>210.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krieg</surname><given-names>S</given-names></name><name name-style="western"><surname>Huche</surname><given-names>F</given-names></name><name name-style="western"><surname>Diederichs</surname><given-names>K</given-names></name><name name-style="western"><surname>Izadi-Pruneyre</surname><given-names>N</given-names></name><name name-style="western"><surname>Lecroisey</surname><given-names>A</given-names></name><name name-style="western"><surname>Wandersman</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Heme uptake across the outer membrane as revealed by crystal structures of the receptor-hemophore complex</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2009</year>) <volume>106</volume>:<fpage>1045</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0809406106</pub-id><pub-id pub-id-type="pmid">19144921</pub-id><pub-id pub-id-type="pmcid">PMC2633585</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>